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ABSTRACT 
Two new ~-carboline alkaloids were isolated from the bryozoan Cribricellina 
cribraria. One of these, i-vinyl-8-hydroxy-~-carboline, was the major cytotoxic 
component of the extract, while the other had a novel sui phone structure. Several 
other known ~-carboline alkaloids were also isolated from the extract. To investigate 
structure-activity relationships in these compounds, several derivatives of the major 
alkaloid were prepared and a number of i-substituted ~-carboline alkaloids 
synthesised. Nmr spectroscopic studies of these compounds were carried out and 
previously published 13C nmr data for some of these compounds revised. Homarine 
was isolated as the major water soluble component of the extract and the sterol 
composition examined. Known ~-carboline alkaloids were isolated from the related 
bryozoan Margaretta barbata. 
The known biologically active compounds, girolline and hymenialdisine were 
isolated from the sponge Axinel/a sp. 2. As some discrepancies between the 
experimental and published data on hymenialdisine were noted, an X-ray crystal 
structure analysis was performed. Oroidin, homarine and taurine were also isolated 
from the extract and the sterol composition found to consist exclusively of 
ring-contracted A norstanols. 
An extract of the sponge Sty/opus australis was found to contain a new sterol 
sulphate and two derivatives of this compound were prepared. The full assignment of 
the 1 H nmr spectrum of the sulphate was achieved with the aid of COSY, nOe, 
HETCOR and XCORFE nmr experiments. The glyceryl ether, chimyl alcohol was also 
isolated from the sponge. 
An extract of the related sponge, Hymedesmia sp. 1 was examined and 
rhodoic acid isolated as the major water soluble component, along with homarine. 
The sterol compositions of Sty/opus australis and Hymedesmia species 1 and 2 were 
examined for comparative purposes. 
Studies on an extract of the sponge Hymeniacidon hauraki led to the isolation 
of a new furan fatty acid. The sterol corbisterol and its peroxide were isolated from 
one sample of the sponge and this led to an examination of infraspecific sterol 
variation in this species. 
A screening procedure of biologically active natural product extracts has been 
developed. The procedure involves examining the chromatographic behaviour of 
the biological activity of an extract and is deSigned to detect known biologically active 
compounds and to determine the best means of handling extracts containing 
unknown biologically active components. 
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CHAPTER ONE 
1.1 INTRODUCTION 
Secondary metabolites, which are also known as natural products, may be 
defined as compounds with no clearly recognisable function in the internal economy 
of the organism that produces them1•2. The often complex structure of secondary 
metabolites, coupled with the great variation in secondary metabolism, both within 
one type of organism or between organisms, make them ideal candidates for 
pharmaceutical il1vestigations2• Indeed, the study of natural product extracts has 
yielded a great number of compounds of use to man, many of which are 
pharmaceuticals, for example, penicillin, morphine and aspirin. To date, the majority 
of these compounds have been derived from terrestrial sources. 
The oceans however, cover nearly 71 % of the earth's surface3 and are a 
vast, largely untapped chemical resource. The oceans represent a more stable 
environment than the land and approximately 90% of all species of living organisms 
dwell there4. All life is derived from the sea and it follows that those species that 
never left the oceans have had more time to adapt to their environment than their 
terrestrial coul1terparts5. Twenty six of the twenty eight main phyla in the animal 
kingdom are aquatic to some degree and eight of these phyla such as the Porifera, 
Bryozoa and Echinodermata, are exclusively aquatic and largely marine dwelling5. 
Statistically therefore, it is not surprising that man's attention has finally been drawn 
to the sea as a potential source of biologically active compounds and as a source of 
compounds with novel structures. 
Until relatively recently, there were procurement problems involved in the 
study of marine organisms, both in terms of accessibility and in getting sufficient 
material to work with. The latter problem may still be a significant one in some cases, 
but with the advance of technology and in particular the advent of SCUBA diving, the 
ocean environment has become much more accessible to man. Some drugs from 
the sea are already in use, an example being tetrodotoxin (1), which is derived from 
pufferfish and selectively blocks the sodium channels of nerve membranes. It is used 
to relax muscle spasms3 and as a probe for the study of neurophysiological 
mechanisms6. 
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(1 ) 
The isolation of a ohemioally pure substanoe from a orude marine natural 
produot .extraot is not a simple matter. Not only is the desired substanoe usually part 
of the oomplex matrix of oomponents whioh oonstitute the extraot, making purifioation 
inherently difficult, but often it is also present at a low level in the organism, which 
compounds the isolation problem and may make it diffioult to obtain enough of the 
chemical for characterisation or further experimentation. A compound might also be 
unstable when purified, or subject to chemical modification in the isolation procedure. 
This introduces another problem, namely that of identifying the true source of 
a particular compound. A compound may be an artefact of the isolation procedure 
used, it may be a metabolite of the organism under study, concentrated from a dietary 
source or derived from a symbiotic organism. Sometimes this problem can be 
resolved, by, for example, changing the isolation conditions, cell fractionation or 
ecological studies. It has been'shown for example, that tetrodotoxin (1) is actually 
produced by a symbiotic bacterium of the genus Pseudomonas which has been 
isolated from the skin of the pufferfish. and not by the pufferfish itself? Tetrodotoxin 
has also been isolated from other marine bacteria? Too often however, the actual 
source of a marine metabolite remains unclear. This is particularly true for sessile 
marine invertebrates which are subject to overgrowth by surrounding and encrusting 
species, or are vulnerable to invasion by microorganisms. 
Over the years, routine screening of marine species for biological activity has 
shown that it is these sessile marine organisms that are most likely to contain 
compounds with promising biological activity8. Soft-bodied marine invertebrates 
such as tunicates and sponges without spicules, would seem especially vulnerable to 
predation9, but many of the biologically active marine natural products isolated thus 
far have been from such organisms. It is thought that the animals may produce these 
compounds as a chemical defence against predation, overgrowth or microscopic 
infection 9. In fact, a survey of the incidence of antiviral activity and cytotoxicity in 
sponges in the Canterbury Marine Chemistry group's collection, has shown a higher 
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incidence of biological activity in encroached and encrusting sponges than in the 
solitary species which are not competing for space10. 
Screening programmes of marine species initiated to date have varied 
widely in both scope and focus. Some screening is purely chemical in nature, the 
aim being to isolate and purify the major components from a given organism. These 
compounds may subsequently be assayed for biological activity11. This form of 
screening may lead to the discovery of novel chemical structures or give taxonomic or 
ecological information. It may also lead to the discovery of compounds with useful 
biological activity but it does not maximise the probability of this. Of the thousands of 
new compounds isolated from marine organisms with published structures, less than 
5% have been investigated by pharmacologists12. As published structural types 
cannot be patented, it is unlikely that any of these compounds will be used for drug 
prototype development. Thus, it is somewhat ironic that the emphasis on chemistry of 
marine compounds has hindered the development of these compounds as potential 
pharmaceutical leads 12. 
A more useful approach than chemistry~driven screening, is bioactivity~based 
screening, which employs biological assays in each step of the procedure used in the 
chemical isolation, in an attempt to determine the component or components 
responsible for the biological activity of the extract under consideration. The 
probability of finding useful biological activity might be further increased by targeting 
the collection of selected phyla which past screening has shown to contain a high 
incidence of species with biological activity, however this method may preclude the 
location of highly active species in other phyla8. 
A wide variety of biological assay methods are currently available for use in 
this work, including both In vitro and in vivo techniques but a given research group 
will only use those assay methods designed to detect the types of biological activity in 
which its interest lies. Advantages of in vitro techniques are that they are relatively 
inexpensive, more sensitive and faster than in vivo methods. However, they do not 
give an accurate indication of the activity that a substance will exhibit when 
administered to an entire organism, when such factors as the difficulty of ensuring 
that the compound reaches its target site become much more significant. 
A large scale bioactivity directed screening programme has been initiated by 
the National Cancer Institute of the National Institute of Health in the United States of 
America, (NCI). This initiative comprises a global natural product selection 
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programme, including a major investigation of marine species as a source of 
potential new anticancer drugs. The screening programme utilises a wide variety of 
in vitro assays designed to identify compounds which show specific inhibition of 
particular tumour types; especially solid tumours13. 
In the past, commonly employed screening tests were based on mouse 
leukaemia models such as P388. This cell line is composed of rapidly dividing cells 
and has identified compounds of potential use against such tumours, but perhaps not 
surprisingly, such models are of little use in identifying agents which inhibit slow 
growing solid tumours such as lung and colon cancers13. 
The assays currently used by the NCI include newly developed techniques 
which involve the excision of actual human tumour cells and subsequent in vitro 
cloning14. As a single tumour is heterogeneous with respect to cell type arid further 
histological variation occurs between different tumours of the same type, this 
"disease-oriented" approach requires the use of a number of cell lines, representative 
of each type of tumour under investigation 14. 
The next testing stage, once the structure of an active compound is known is 
usually in vivo screening, which serves to define the potential of a compound for use 
as a drug. Factors such as undesirable side effects of a drug or deactivation by 
metabolic processes can be assessed. 
Drugs which show promise in in vivo screens go on to Phase I clinical trials 
where the maximum dose of the drug which is non-toxic to humans is determined. 
The optimum dose regime against a variety of human cancers is determined in Phase 
II trials. The first marine natural product to be tested in 11uman clinical trials is 
didemnin B (3), one of a series of cyclic depsipeptides (2-4) isolated from the 
Caribbean tunicate Trididemnum sp.13. These compounds show significant antiviral 
activity both in vitro and in vivo, in addition to the impressive antitumour activity of 
(3)5. It should be pOinted out that in spite of the thousands of extracts screened in 
these programmes, only a handful of compounds derived from these ever reach 
clinical trial. This has not deterred research in any way; in fact research into natural 
products of this type is flourishing, as scientists realise their potential as 
pharmaceutical leads. 
5 
(2) R = H 
0HN ° (3) R ~N):' 
o "I 1 0 
o (~" 0 SS£ A. /~, (4) R = OH ~ U . ~~ 
o 
The isolation and identification of a biologically active component is of 
course only the first step in obtaining a clinically useful agent. Structure-activity 
relationships are an integral part of the work, as not only is it important to identify the 
parts of the structure that are responsible for the activity of a compound, but often it is 
not the isolated compound itself which is the most effective drug, but an analogue of 
it. Synthetic modifications of a compound may serve to increase potency, reduce 
toxicity or side effects or improve solubility for example. If a compound is to be of use 
as a clinical agent, it is important to establish synthetic routes for its production, as it is 
unlikely that a sufficient supply can be obtained for this purpose from tl1e natural 
source. 
The Marine Chemistry group at the University of Canterbury is primarily 
concerned with the isolation and structural determination of potential antiviral and 
antitumour compounds. With this goal in mind, collections of organisms have been 
made from northern New Zealand to Antarctica. Work has mainly focused on the 
study of marine invertebrates such as sponges. Although a sponge is the most 
primitive of all multicellular animals3 , the phylum Porifera, like those of other marine 
invertebrates displays a high incidence of biological activity in screening procedures, 
probably for the reasons of chemical defence outlined earlier. Surveys have shown 
that the phyla which most frequently possess antiviral activity are also those most 
likely to contain cytotoxic compounds8, so a simultaneous search for these types of 
biological activities is justified. 
The search for antiviral agents is a difficult one. Viruses are the smallest 
biological structures known that carryall the genetic information required for 
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replication and unlike procaryotes and eucaryotes, contain only one type of nucleic 
acid8 . Viruses require host cells for reproduction, subverting the cell mechanisms for 
protein synthesis and nucleic acid replication to produce essential viral proteins and 
nucleic acids. Once formed, the new viral particles leave the host cell to invade 
others. As viruses normally invade specific cell types they are usually species 
specific8. An antiviral agent must inhibit some stage in the viral life cycle without 
damage to the host. The difficulty lies in the similarity between viral infected cells and 
normal ~ost cells and is the reason that few antiviral agents have been developed. 
The University of Canterbury Marine Chemistry group employs an in vitro antiviral 
assay in its screening of marine extracts, which also gives an indication of the 
cytotoxicity of a compound (see below). 
The terms antitumour or antineoplastic refer specifically to in vivo activity, 
while cytotoxicity refers to activity against cells cultured in vitro. Anticancer is a term 
exclusively used for results from clinical trials in humans8• The rationale behind the 
screening methods used by the NCI to evaluate potential antitumour agents has been 
outlined above. The range of facilities available at the NCI however is beyond the 
resources of many groups of researchers. Other simpler methods are often used to 
assess cytotoxicity, One example is the fertilised sea urchin egg assay. In this 
system the effects of a test compound on the mitotic division of a freshly fertilised egg 
are monitored. The test compound is added within five minutes of fertilisation. In a 
control, the first cleavage of the egg occurs after two hours. A substance is 
considered active if it causes 80-100% inhibition of cleavage at concentrations of 16 
).tg/ml or less8. Other simple tests used as biological activity screens are the brine 
shrimp and crown-gall potato disc assays. The brine shrimp assay gives a good 
indication of cytotoxicity. but is not specific for antitumour activity8. The crown-gall 
potato disc assay assesses the ability of a compound to inhibit crown-gall, a 
neoplastic disease induced in potato discs by inoculation with a bacterium, 
Agrobacterium tumefaciens15,16. Results show good correlation with in vivo P388 
activity, but the reliability of the test is a problem. However, a combination of the brine 
shrimp and crown-gall potato disc assays has been used successfully to minimise the 
need for extensive in vivo testing in the isolation of piceatannol, the antileukaemic 
principle from the seeds of Euphorbia Jagascae17, At the University of Canterbury. an 
in vitro P388 assay system is used to assess potential antitumour agents (See 
below). 
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1.2 BIOLOGICAL ASSAYS 
Three in vitro biological assay systems are employed in the majority of the 
work described in this thesis. An outline of the assay systems used follows. 
THE ANTIVIRAUCYTOTOXICITY ASSAY 
This assay determines any antiviral and/or cytotoxic properties of compounds 
present in a test solution and employs a BSC continuous cell line derived from 
African Green monkey kidney cells. Assay wells (13 rnm diameter), containing a 
cellular monolayer are infected with either a DNA virus, Herpes simplex Type 1 
(HSV1) or the Polio virus strain (PV1) which is an RNA virus. The cells are then 
overlaid with a methyl cellulose layer. Paper discs of diameter 6 mm are 
impregnated with the desired amount of test solution and air dried for twenty minutes 
at room temperature. The discs are pushed through the methyl cellulose overlay to 
sit directly on the virus infected cells. Virus and cell controls are included with each 
run. The cells are incubated for 24 hours at 35°C in a 5% C02 enriched atmosphere. 
Any biologically active compounds present can diffuse out of the paper disc and 
inhibit viral and/or cellular growth. 
After incubation, an inverted microscope is used to examine the wells for the 
size of the antiviral and/or cytotoxic zones. Antiviral assay results are tabulated as 
the excess radius from the disc at which virus inhibition is observed, as in Table 1.1. 
Cytotoxicity is estimated from the survival rate of the BSC cells and the designation 
system used is the same as that used to estimate virus inhibition. The appearance of 
the dead monolayer cells is also noted however, and listed as a "cytotoxicity type" 
which is scored subjectively as in Table 1.2. This "cytotoxicity type" is generally 
consistent for a particular test compound or extract. 
Unless otherwise stated, antiviral/cytotoxicity assay results are reported in 
this thesis in the form : HSV1 score, PV1 score, cytotoxicity plus the optional 
cytotoxicity type and the weight of sample impregnated onto the disc in micrograms. 
For example 2+ 2+ ww C7 20, indicates that for a sample of 20 J.Lg impregnated onto 
a disc, for both HSV1 and PV1, the antiviral/cytotoxic zone is 2-4 mm excess radius 
from the disc edge and the cytotoxicity is over the whole well and is of type C7. 
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Table 1.1: Interpretation of Antiviral/Cytotoxicity Results. 
? indeterminate activity. 
no discernible antiviral or cytotoxic effect. 
± minor effects located under the disc. 
1+ antiviral/cytotoxic zone 1-2 mm excess radius from disc edge. 
2+ antiviral/cytotoxic zone 2-4 mm excess radius from disc edge. 
3+ antiviral/cytotoxic zone 4-6 mm excess radius from disc edge. 
ww antiviral/cytotoxic zone over the whole well. 
Table 1.2: "CytotOXicity type" Designations. 
C1 Defined nuclei. 
C2 Cells are enlarged and "stringy", 
C3 Cells are a mixture of rounded and elongated types. "Scruffy", 
C4 Cells are rounded but separate from each other. 
C5 Cells are rounded and clumped together. 
C6 Cells are greatly increased in volume. 
C7 Cells appear granular. 
C7* Distinct cells but appear hazy. 
C8 Cells appear elongated with prominent nuclei. 
C9 Cells are rounded with ragged edges and prominent nuclei. 
C10 Cells are rounded and shrunken. 
C 11 Cells are enlarged with squared ends and form a mosaic pattern, 
THE P388 ASSAY 
The purpose of this assay is to determine the concentration of sample 
required to reduce P388 leukaemia cell growth by 50%, the ICso value. The test 
solution is added to wells containing the leukaemia cells in a series of eight two-fold 
dilutions. Media, solvent, cell and positive controls are included in each assay run 
and the cells are incubated at 35°C for three days. 
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To determine the number of viable leukaemia cells present in the assay 
wells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (5) is 
added to the wells and these are incubated for a further four hours. Healthy 
leukaemia cells reduce the yellow MTT to the purple formazan product (6) and the 
amount of formazan present in each well is determined spectrophotometrically, by 
measuring the absorbance at 540 nm. 
The absorbance is expressed as a percentage of the absorbance of the cell 
control which contains media, MTT and leukaemia cells but no test solution. A plot of 
the absorbances versus the logarithm of the sample concentrations is constructed, 
enabling the IGso value to be determined from the antilog of the 50% value. A typical 
IGso plot is shown in Figure 1.1. 
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Figure 1.1: A typical plot obtained from the P388 assay results, which is used to 
calculate an IGso value. 
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THE ANTIMICROBIAL ASSAY 
This assay determines if a test solution inhibits the growth of bacteria and/or 
fungi. The organisms used are two gram negative bacteria, (Pseudomonas 
aeruginosa and Escherichia coli), a gram positive bacterium (Bacillus subtilis) and 
three fungi; Candida a Ibicans , Trichophyton mentagrophytes and Cladisporum 
resinae. The organisms Trichophyton mentagrophytes and Cladisporum resinae 
only became available during the latter part of the work in this thesis. 
The bacteria or fungi are mixed with agar and poured into a petri dish so that 
a "lawn" of bacteria/fungi will grow over the dish on incubation. The desired amount 
of test solution is impregnated onto paper discs of 6 mm diameter, which are then air 
dried at room temperature for twenty minutes. Antibiotic and solvent control discs are 
placed on the surface of the seeded agar dishes along with the test discs and the 
dishes are incubated at 35°C. Incubation proceeds for 24 hours for all organisms 
except T. mentagrophytes and Cladisporum resinae where the required incubation 
period is 48 hours. 
After incubation, the dishes are inspected for growth inhibition caused by any 
antimicrobial compounds in the test solution. The size of any inhibition zone is 
measured as the excess radius from the edge of the paper disc in miliimetres. Other 
visual parameters are recorded as in Table 1.3. 
Table 1.3: Interpretation of the Antimicrobial Assay. 
No inhibition of bacterial growth. 
GE Growth enhancement of bacteria. 
GR Growth retardation of bacteria. 
x Size of inhibition zone in millimetres from disc edge. 
HM Hazy margin at inhibition zone edge. 
SM Sharp margin at inhibition zone edge. 
* Slight activity, <1 mm inhibition zone. 
11 
1.3 WORK IN THIS THESIS 
Work in this thesis has encompassed the major areas of interest of most 
natural products research; namely the isolation and characterisation of new 
compounds, both on a bioactivity-directed and chemistry-directed basis and the study 
of the components of an organism for taxonomic or ecological reasons. 
In keeping with the aims of the Canterbury Marine Chemistry group, the 
major focus of the work has been on the biological activity of marine organisms. 
Bioactivity-directed separations led to the isolation of a new ~-carboline 
alkaloid fron the bryozoan Cribricellina cribraria, as the major cytotoxic component of 
the extract. Several minor ~-carboline alkaloids were also isolated, of which one had 
a novel sulphone structure and some derivatives of the major alkaloid were prepared. 
Studies on the biological activity of the related bryozoan, Margaretta barbata were 
reinitiated and some known ~-carboline alkaloids isolated. 
To explore structure-activity relationships, a number of 1-substituted 
~-carboline alkaloids were synthesised. Nmr spectroscopic studies of these 
compounds and of the natural product alkaloids were performed. Attempts were 
made to account for the observed biological activities and to correlate these with 
physical parameters, so to this end, partition coefficients, Rf values and hplc retention 
indices were measured. 
Work on an extract of the sponge Axinella sp. 2 led to the isolation of two 
known biologically active components, girolline and hymenialdisine. Some 
discrepancies in the experimental and published data on hymenialdisine were noted 
and a previously unreported type of biological activity was detected for girolline. 
A new sterol sulphate was isolated from an extract of the sponge Sty/opus 
australis and two derivatives were syntheSised. The full assignment of the 1 H nmr 
spectrum of the sulphate was achieved. An extract of a related sponge, Hymedesmia 
sp. 1 was examined and an unusual amino acid found to be a major water soluble 
component of the sponge. The sterols of both Sty/opus australis and Hymedesmia 
sp. 1, along with those of Hymedesmia sp. 2 were examined for comparative 
purposes. 
A new furan fatty acid was isolated from an extract of the sponge 
Hymeniacidon hauraki. The isolation of the sterol corbisterol and the corresponding 
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sterol peroxide from one H. hauraki sample, led to an examination of infraspecific 
sterol variation in this sponge species. 
A screening procedure has been developed which examines the 
chromatographic behaviour of an extract coupled with its biological activity, to rapidly 
detect known biologically active compounds and to gain information on the best 
means of dealing with extracts containing unknown active components. A 
modification of this procedure is now used by the group to assess the suitability of an 
extract for further research. 
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CHAPTER TWO 
2.1 COMPOUNDS ISOLATED FROM BRYOZOANS-A REVIEW 
It is only within the last ten to fifteen years that researchers in marine natural 
products have begun to study the bryozoans, which are also called moss animals. A 
bryozoan is actually a sedentary colony of minute filter feeding individuals or zooids 
and these organisms are widespread throughout the marine environment18• They 
have proved to be worthy of attention as rich sources of biologically active 
compounds and/or compounds with novel structures. Their chemical components 
have been reviewed by Christophersen in 198518 and by Faulkner in his reviews in 
Natural Product Reports19. A more recent review, encompassing the information 
contained in these past reviews, while updating the groups of compounds isolated 
from bryozoans is presented here. 
o 
(7) 
Of the compounds isolated thus far, the bryostatins are perhaps the most 
interesting, possessing both novel structures and high antineoplastic activities. The 
structure of the first of these, bryostatin 1 (7) was confirmed by single crystal X-ray 
crystallography20 and to date nineteen related compounds, bryostatins 1-17 and 
bryostatins A and B have been reported20-29 . All of these compounds were isolated 
from the marine bryozoan Bugula neritina, with the exception of bryostatin 8 which 
was isolated from the Gulf of Mexico bryozoan Amathia convoluta24 and bryostatins A 
and B, isolated from the sponge Lissodendoryx isodictyalis29. It seems however that 
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in both these latter cases the samples had Bugula neritlna attached and some 
symbiotic relationship between the species has been suggested 29. All bryostatins 
possess the unusual 26-membered bryopyran ring system (8) and are typically 
present in the animal at an extremely low concentration, (- 10-6% by weight)8. These 
compounds are promising candidates for cancer chemotherapy on account of their 
very potent in vivo antitumour activity. 
Another species of Bugula, B. dentata was shown to contain an antimicrobial 
blue pigment (9). This tetrapyrrole was previously isolated from a tunicate and a 
bacterium30. 
o N 
H 
"Dogger Bank itch" is an allergic contact dermatitis, caused by contact with 
the bryozoan Alcyonidium gelatinosum. The compound responsible for this, 
(2-hydroxyethyl)dimethylsulphoxonium ion (10), has been isolated from the bryozoan 
by a combination of gel permeation and ion exchange chromatography. followed by 
precipitation as an iodo complex. The concentration of the sulphoxonium salt is 
estimated at 5 ppm of animal wet weight31 , Synthesis of this compound was 
achieved by base-catalysed condensation of formaldehyde with 
trimethylsulphoxonium chloride31 , 
R ~ (11) R = ~ 
Sr N ) . H CH3 (12) R = Sr 
"'f'" 
A series of brominated alkaloids has been isolated from the marine bryozoan 
Flustra foliacea. These are flustramines A-D (11-14)32-34, flustraminols A (15) and B 
(16)33, dihydroflustramine C (17)33,35 and its N-oxide (18)34, isoflustramine D (19) 
and flustramine D N-oxide (20)34, flustramides A (21 )36 and B (22)37, flustrabromine 
(23)38, 6-bromo-N-formyl-N-methyltryptamine (24)36, a bromoquinoline, 7-bromo-4(-
2-ethoxyethyl) quinoline (25)39 and flustrarine B (26)37, All the structures are 
15 
All the structures are formally derived from 6-bromotryptamine40 , with most 
possessing the skeleton of the alkaloid physostigimine (27). Flustramines A and B 
exhibit muscle relaxant activity both in vitro and in vivo41 , while dihydroflustramine C 
exhibits strong antimicrobial activity34,35. The crude petroleum ether extract of F. 
fofiacea shows strong inhibitory activity against influenza virus 18. 
Br 
R2 
R1 R2 
(17) H H ~ 
(19) H y~-
Br 
Br 
(21) R 
(22) R = 
(24) 
CHgNHCOO 
F,l 
(23a) R 
I N 
HgC ....... 'CHO 
Br 
CH3 
N r;J 
CHg-t CHg 
(27) 
Br 
OH 
Br N R ~ 
R1 2 CH3 
R1 ~R2 
(15) H ~ / ~_ 
(16) )=/~- H ~ 
R 
+ 
Br N 
H 0/1 
(18) R = H - CH3 
(20) R = )=/~-
F,l 
CH3- N ,,--f~ 
(23b) R ~ 0 
OCH2CH3 
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In earlier work on F. foliacea, the terpenoids cis- and trans- citral (28a-b), 
citronellol (29), nerol (30) and geraniol (31) were isolated42. This mixture displayed 
antifouling activity comparable to that of commercially available preparations1B• 
(26a) (26b) (31 ) 
The bromo-alkaloids, 2,5.6-tribromo-N-methylgramine {32} and its N-oxide 
(33) were isolated from the subtropical marine bryozoan Zoobotryon verticillatum43• 
Both alkaloids were synthesised from 3-dimethylaminomethyl indole {gramine)43. 
2,5,6-tribromo-N-methylgramine (32) inhibits cell division in the fertilized sea urchin 
egg assay with an ED50 of N 16 Ilg/ml. 
A series of bipyrroles, tambjamines A-D {34-37}, were isolated from the 
bryozoan Sessibugula translucens, but are so called because they were originally 
found in nudibranchs of the genus Tambje, a predator of the bryozoan. These 
compounds are potent inhibitors of cell division in the fertilsed sea urchin egg assay 
and also exhibit antimicrobial properties44. 
R2 ~:: 
R1 ~ N 
R1 R2 R3 R1 R2 
(34) H H H (36) H H 
(35) Br H H (37) H Br 
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Phidolopin (38), a purine derivative, was isolated from the bryozoan 
Phidolopora pacifica and the structure solved by X-ray crystallography45. It is both 
strongly antifungal and antialgal in vitro and a total synthesis has been 
accomplished46 . Two further nitrophenols. desmethylphidolopin (39) and 3-nitro-
4-hydroxybenzyl alcohol (40) were subsequently isolated from the same species and 
desmethylphidolopin was synthesised47. 
o 
RY'~yN> 
oANJ-N tH (38) R = CH3 
3 (39) R = H 
(40) 
R1 
(41) H 
(43) Br 
(45) Br 
R2 
H 
CH3 
H 
Another group of brominated alkaloids, the amathamides, have been 
isolated from the Tasmanian bryozoan Amathia wilsoni. Six amathamides. A-F 
(41-46)48,49 were reported and variations in alkaloid content between samples from 
different collection sites were noted49. 
R 
Br 
(42) R = H 
(46) R = Br 
OCH3 
Br 
o CH3 At::J (44) ~ , 
A bryozoan of the same family (Flustridae) as F. foliacea, Chartella 
papyracea, is the source of a series of unusual halogenated ~-Iactam alkaloids. 
Chartellines A-C (47-49)50,51 and chartellamides A (50) and B (51 )52 have been 
isolated, along with methoxydechlorochartelline A (52)51. The structure of chartelline 
A was solved by X-ray crystallography. Methoxydechlorochartelline A is thought to 
be an artefact of the isolation procedure and was synthesised from chartelline A. 
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0 
R1 Br H R3 N 
I ~Br 
Br N Br 
R1 R2 R3 H3C (50) R = H 
(47)CI Br Br (51) R = Br (48) H CI Br 
(49) CI H H 
(52) OCH3 Br Br 
An unusual tribrorninated alkaloid, hinckdentine A (53) was isolated from the 
marine bryozoan Hincksinoflustra denticulata, and the structure solved by X-ray 
crystallography53, 
o 
Br R (54) R = CH(OH)CH3 
(55) R = CH3 
(56) R =CH2CH3 
(57) R = CH=CH2 
The Tasmanian bryozoan, Costaticella hastata was the source of a group of 
~-carboline alkaloids, including the new compound (S)-1-(1-hydroxyethyl)-~­
carboline (54), 1-methyl-~-carboline, (harman) (55), 1-ethyl-~-carboline (56) and 
1-vinyl-~-carboline, (pavettine) (57)54, 
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2.2 STUDIES OF THE BRYOZOAN, CRIBRICELLINA CRIBRARIA. 
INTRODUCTION 
Although the simple ~-carboline alkaloids are well known from terrestrial 
plants55, reports of their occurrence in the marine environment are scarce. They were 
first reported from a marine animal when Inoue et a/. isolated harman (55) and 
~-carboline (norharman) (58) from the dinoflagellate, Noctiluca miliaris56. 
Later, Rinehart et a/. isolated the eudistomins (59-73), a series of potent 
antiviral compounds, from the Caribbean tunicate Eudistoma olivaceum57 and 
compounds of this type were subsequently isolated from a New Zealand ascidian 
Ritterella sigillinoides58• Three other eudistomins (74-76) have since been isolated 
from Eudistoma olivaceum59• 
R1 R2 
(59) OH Br NH 
(60) OH H ::::::::,.... 
R1 R2 R3 R4 
(61) H OH Br H 
(62) Br OH H H 
(63)H H Br H 
(64) H Br H H 
N 
H 
R1 R2 R3 
(65) Br OH H 
(66) H OH Br 
(67) H Br H 
(68) H H Br 
R1 R2 
(69) H Br 
(70) Br H 
(71) H H 
(72) OH Br 
(73) OH H 
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R1 R2 
(74) H Br 
(75) Br H 
(76) H H 
Jefford et al. isolated the compounds, manzamines A, 8 and G, (77-79) from the 
sponge Haliclona sp.60,61. The 1G50 of manzamine A against P388 was determined 
to be 0.07 Ilg/ml, while those of manzamines 8 and G were determined to be 6 and 3 
Ilg/ml respectively. At around the same time, Nakamura et al. reported the isolation of 
two ~-carboline alkaloids from the Okinawan sponge, Pellina sp., terming them 
keramamines A and 862. 80th exhibited antimicrobial activity with minimum inhibitory 
concentrations against Staphylococcus aureus of 6.3 and 25 Ilg/mlrespectively. 
Keramamine A is identical in structure to manzamine A. Further manzamines, E (80) 
and F (81) were isolated from an Okinawan sponge, Xestospongia sp., both with an 
IG50 of 5 Ilg/ml63. Through direct comparison of manzarnine F and keramamine 8 by 
tic, uv and ir spectroscopy, both compounds were shown to be identical and the 
structure of keramamine 8 revised63. It was postulated that the isolation of this class 
of compounds from three different sponge genera, implies that the producer of these 
is a symbiotic microorganism. 
(77) (78) (79) 
(80) R = H 
(81) R = OH 
R 
(54) R =: CH(OH)CH3 
(55) R == CH3 
(56) R ==CH2CH3 
(57) R = CH=CH2 
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As mentioned above, simple ~-carboline alkaloids (54-57) have been 
isolated from a marine bryozoan Costaticella hastata from Southern Tasmania54. 
This genus is considered to be analogous to CribricelJina64 . No mention of any 
biological activity of the extract or of the isolated compounds was made. 
A study of the marine bryozoan, Cribricellina cribraria was undertaken, as the 
crude extract was strongly cytotoxic against P388 and exhibited strong cytotoxicity on 
the antiviral/cytotoxicity assay. This led to the isolation of a new ~-carboline alkaloid, 
1-ethenyl-9H-pyrido[3,4-b]indol-8-01 (1-vinyl-8-hydroxy-~-carboline) (82), as the 
major cytotoxic component of the extract, along with a number of other minor 
~-carboline alkaloids. Several derivatives of compound (82) were also prepared. A 
novel ~-carboline alkaloid with a 4-methylsulphone substituent was isolated as a 
minor component of the extract. Homarine was isolated as the main water soluble 
component, while cholesterol, and cholest-4-en-3-one were the major components of 
the sterol mixture isolated from the bryozoan. 
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ISOLATION OF 1-VINYL-8-HYDROXY-~-CARSOLINE (82). 
A methanol/toluene extract of the orange bryozoan Cribricellina cribraria, 
showed strong P388 activity and cytotoxicity against a SSC cell line. Flash column 
chromatography on C18 reverse phase material led to the activity being concentrated 
in two fractions from the column. Recombination of these and further reverse phase 
column chromatography concentrated the activity into one fraction, from which further 
reverse phase column chromatography led to the isolation of the new compound 
1-vinyl-8-hydroxy-~-carboline (82) as a yellow oil and the major cytotoxic component 
of the extract. For the isolation scheme used refer to Figure A.1 in the Appendix. 
The structure of (82) was determined from the results of 1- and 
2-dimensional nmr spectroscopic experiments. The 1 H nmr spectrum of (82) in 
CD30D (Figure 2.1) showed signals for 8 protons, each in a different chemical 
environment. The 1 H nmr data for (82) are summarised in Table 2.1. The 13C nmr 
spectrum of (82) (Table 2.2) revealed the presence of twelve carbon resonances, of 
which seven were protonated carbons. Results of a COSY experiment showed three 
distinct proton spin systems, and a HETCOR experiment showed that two of the 
protons were attached to the same carbon. These results allowed the assembly of 
the structural fragments shown in Figure 2.2. 
n 
7.BO B.13 
nn 
.47 6.99 6.90 6.32 
H H 
115.66 I 1138.4B 
-~-~:::::::c-~-
H H H H 
112.71 I I 1114.47 133.71 1119.65 
-~-~:::::::~-~=~= -~-C:::::::C ~ 122.27 ~ ~ I I 
H H 
7.33 5.59 
U 
Figure 2.2: Structural fragments of compound (82), assembled from the results of 
COSY and HETCOR nmr experiments. 
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Figure 2.1: The 1 H nmr spectrum of 1-vinyl-8-hydroxy-~-carboline (82) in CD30D. 
Table 2.1: 1 H nmr data for compounds (57), (82) and (88-91). 
POSITION (57)a (82)b (88)a (89)b (90)b (91)b 
3 8.47 d (5.2) 8.13 d (5.3) 8.44 d (5.2) 8.14 d (5.5) 8.30 d (5.3) 8.08 d (5.5) 
4 7.87 d (5.2) 7.80 d (5.3) 7.84 d (5.2) 7.85 d (5.5) 8.01 d (5.3) 7.80 d (5.5) 
5 8.13 dd 7.47 dd 7.70 d (7.9) 7.61 d (7.8) 8.07 dd 7.63 d (7.6) 
(7.9,0.9) (7.7,0.9) (7.5, 1.8) 
6 7.29 m 6.99 t (7.7) 7.22 t (7.9) 7.06 t (7.8) 7.25 t (7.5) 7.10 t (7.6) 
7 7.52 m 6.90 dd 7.00 d (7.9) 6.94 d (7.8) 7.31 dd 6.99 d (7.6) 
(7.7,0.9) (7.5, 1.8) 
8 7.52 m 
9 8.9 br s 8.5 br sa 8.5 br s 8.5 br sa 
l' 7.22 dd 7.33 dd 7.22 dd 3.19 q (7.6) 7.47 dd 3.11q(7.6) 
(17.5,11.1) (17.5,11.1) (17.5,11.1) (17.2,11.0) 
2'a 6.39 dd 6.32 dd 6.41 dd 1.41t(7.6) 6.43 dd 1.31 t (7.6) 
(17.5, 1.3) (17.5,1.4) (17.5, 1.4) (17.2,1.8) 
2'b 5.67 dd 5.59 dd 5.71 5.66 dd 
(11.1, 1.3) (11.1,1.4) (11.1,1.4) (11.0, 1.8) 
8' 4.03s 2.45 s 3.97 s 
a Values in ppm for CDCI3 solutions. 
b Values in ppm for CD30D solutions. 
o coupling constants in Hz. 
!\) 
.p.. 
Table 2.2: 13Cnmr data for compounds (57), (82) and (88-91). 
CARBON (57)a (82)b (88)a (89)b (90)b (91)b 
139.84 141.23 140.12 149.11 141.56 148.32 
3 139.17 138.48 139.19 138.06 139.48 138.23 
4 114.07 115.66 114.32 114.48 115.82 114.48* 
4a 129.96 132.27 130.11 130.93 132.48 126.25 
4b coincident 124.12 122.77 124.65 122.40 120.62 
5 121.75 112.71 113.86 113.70 121.45 114.91* 
6 120.32 122.27 120.78 121.78 120.63 121.68 
7 128.54 114.47 107.95 113.46 122.54 109.25 
8 111.59 147.15 146.20 145.69 147.09 144.83 
8a 140.37 133.71 130.85 132.97 139.04 134.50 
8b 133.63 135.24 133.24 135.64 136.45 136.91 
l' 132.97 133.71 132.98 28.13 132.64 28.13 
2' 119.12 119.65 119.09 14.05 120.08 14.12 
8-0CH3 55.62 56.38 
8-0Ac 164.28 
21.26 
a Values in ppm for CDCI3 solutions. 
b Values in ppm for CD30D solutions. 
* Values in vertical columns may be interchanged. !\) 
()1 
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The chemical shift data, together with the results of an XCORFE experiment 
suggested a p-carboline nucleus with a vinyl substituent at C1 and a substituent, X, at 
either C5 or CB. Selected XCORFE nmr correlations are shown in Figure 2.3. 
Figure 2.3: Selected XCORFE correlations for compound (82). 
The position of substitution was determined by a series of nOe experiments. 
Irradiation of the H4 resonance led to enhancement of the H3 signal and the H5 
signal, while the reverse irradiation of the H5 resonance led to enhancement of the 
H6 and H4 resonances (Figure 2.4). This determined the site of substitution as CB. 
The two dimensional nmr spectroscopic data and nOe enhancements observed for 
compound (82) are listed in Table 2.3. 
Figure 2.4: nOe enhancements observed for compound (82). 
Table 2.3: COSY, HETCOR and XCORFE correlations and nOe 
enhancements observed for compound (82), 
7 
OH 9 CH=CH2 
l' 2' 
COSY H3 <-> H4 HETCOR H3 <-> C138.48 
H5 <-> H6 H4 <-> C115.66 
H5 <-> H7 H5 <-> C112.71 
H6 <-> H7 H6 <-> C122.27 
H1 ' <-> H2'a H7 <-> C114.47 
H1' <-> H2'b H1' <-> C133.71 
H2'a <-> H2'b H2'a <-> C119.65 
H2'b <-> C119.65 
XCORFE H3 <-> C4 H7 <-> C5 
<-> C4a <-> ca 
H4 <-> C3 <-> caa 
<-> cab H1' <-> C1 
H5 <-> C4a <-> C4a 
<-> C7 H2'a <-> C1 
<-> caa <-> C1' 
H6 <-> C4a H2'b <-> C1 
nOea H4 <-> H3,H5 
H5 <-> H4,H6 
H6 <-> H5 
H1' <-> H2'b 
a nOe experiments were performed under non-spinning conditions. 
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OCHa 
The presence of an oxygen substituent was suggested by comparison of 13C 
nmr data with those of 1-vinyl-4,S-dimethoxy-~-carboline (83)65. Evidence for a 
hydroxyl substituent was the observation of a bathochromic shift in the uv spectrum 
with base from 369, 296, 244, 230 nm to 386, 2S7, 262, 240 nm. A hydroxyl 
stretching band in the ir spectrum of (82) provided further support for the presence of 
a phenol. The high resolution EI mass spectrum confirmed the proposed structure, 
with an [M]+ of 210.0787, as appropriate for a molecular formula of C13H1 ON20. 
METHYLATION OF (82) 
To prove the nature of the oxygen substituent at CS and to investigate the 
effects of structural " modification on biological activity, methylation of (82) was carried 
out using diazomethane in ether. Methylation of compounds isolated from the tree, 
Picrasma javanica, originally identified as 1-vinyl-4-methoxy-5-hydroxy-~-carboline 
(84) and 1-ethyl-4-methoxy-5-hydroxy-~-carboline (85)66, but later proven to be 
1-vinyl-4-methoxy-8-hydroxy-~-carboline (86) and 1-ethyl-4-methoxy-S-hydroxy-p-
carboline (87)67, had resulted in a complex mixture of products66 . The reaction 
mixture from the methylation of (82) in diazomethane was also a complex mixture. 
The major component of the mixture however was 1-ethenyl-S-methoxy-9H-pyrido-
[3,4-b] indole (1-vinyl-S-methoxy-p-carboline) (88) and this was purified by reverse 
phase column chromatography. 
R1 
(84) CH=CH2 
(85) CH2CHS 
R1 
R2 R3 
OCHs OH 
OCHs OH 
Ra R1 
R1 R2 R3 
(86) CH=CH2 OCHs OH 
(87) CH2CHS OCHs OH 
The 1H and 13C nmr spectra of (88) in CDCI3 were consistent with the 
formation of a methoxyl at CS. In the 1 H nmr spectrum, a new singlet at 4.03 ppm was 
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assigned to the methoxyl protons. while appropriate changes in the chemical shifts of 
protons H5-7 were observed (Table 2.1). The 13C nmr spectrum was mainly 
assigned through the use of 2-dimensional nmr techniques. A signal at 55.62 ppm 
was assigned to the methoxyl carbon while a HETCOR experiment was used to 
assign the rest of the protonated carbon signals. A Heteronuclear Multiple-Bond 
Connectivity or HMBC experiment, facilitated the assignment of the quaternary 
carbon signals and confirmed the assignments of the protonated carbon resonances. 
(See Work Described in Chapter Two. p. 156). 
R2 
HYDROGENATION OF (82) 
R1 R2 
(88) CH=CH2 OCH3 
(89) CH2CH3 OH 
The dihydro derivative of (82). 1-ethyl-9H-pyrido-[3,4-b] indol-8-01 (1-ethyl-8-
hydroxy-~-carboline) (89) was prepared by hydrogenation over platinum dioxide 
. (Adam's catalyst). The 1H and 13C nmr spectra of (89) in CD30D were consistent 
with the formation of an ethyl group at C1. In the 1 H nmr spectrum, the vinyl proton 
signals were absent and replaced by a methylene quartet at 3.19 ppm and a methyl 
triplet at 1.41 ppm (Table 2.1). In the 13C nmr spectrum. new signals at 28.13 and 
14.05 ppm replaced the vinyl signals (Table 2.2). Full assignment of the 13C nmr 
spectrum was again achieved with the aid of the results of an HMBC nmr experiment. 
(See Work Described in Chapter Two, p. 157). 
ACETYLATION OF (82) 
The 8-acetoxy derivative of (82), 1-ethenyl-8-acetoxy-9H-pyrido-[3,4-b] 
indole (1-vinyl-8-acetoxy-~-carboline) (90), was prepared by acetylation of (82) in 
pyridine/acetic anhydride. 
The 1 Hand 13C nmr spectra of (90) were consistent with the formation of a 
monoacetate at position 8. A singlet in the 1 H nmr spectrum of (90) resonating at 
2.45 ppm was assigned to the methyl protons of the acetate group, while downfield 
shifts were observed for the H5, H6 and H7 resonances (Table 2.1). Overlap of the 
H5 and H7 resonances in both CDCI3 and CD300, made unambiguous assignment 
of these signals impossible. In the 13C nmr spectrum of (90), new signals at 164.28 
and 21.26 ppm were assigned to the acetate carbons (Table 2.2). Again overlap of 
signals in COCI3 was a problem, but a HETCOR spectrum of (90), obtained in 
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CD30D, facilitated unambiguous assignment of the protonated carbon signals. (See 
Work Described in Chapter Two. p. 157). 
R2 
HYDROGENATION OF (SS) 
R1 R2 
(90) CH=CH2 OAc 
(91) CH2CH3 OCH3 
The dihydro derivative of (SS). 1-ethyl-S-methoxy-9H-pyrido-[3,4-b] indole 
(1-ethyl-8-methoxy-f3-carboline) (91). was prepared by hydrogenation over platinum 
dioxide in order that its biological activity could be determined (see below). The 1 H 
. and 13C nmr spectra of (91) in C030D (Table 2.1) were consistent with the formation 
of an ethyl group at C1. The carbon signals were assigned by comparison with the 
13C nmr data for compounds (SS) and (S9). The structure of (91) was substantiated 
by comparison of the 1 H nmr and mass spectra with literature data68• 
ISOLATION OF 1-ETHYL-4-METHYL-SULPHONE-f3-CARBOLINE (92) 
During the course of isolation of (S2), the presence of another compound, 
fluorescent under ultraviolet light and of similar Rf to (S2) on tic. was noted. A 1 H nmr 
spectrum of the appropriate fraction revealed that this was also a f3-carboline 
alkaloid. Semi-preparative reverse phase hplc of fractions shown to contain this 
component by tic and 1 H nmr spectroscopy, led to the isolation of 4 mg of (92) as a 
pale green oil, which fluoresced blue-purple in alcoholic solution. 
CH3 I 
o=s=o 
The structure of (92) was proved by a combination of nmr spectroscopy and 
mass spectrometry. The 1 H nmr spectrum of (92) in CDCI3 (Figure 2.5). indicated the 
presence of a f3-carboline nucleus, with substitutents at either C1 and C3 or C1 and 
C4. Results of a COSY experiment showed a multiplet at 7.38 ppm was coupled to a 
doublet at 8.78 ppm (8.0 Hz) and a multiplet at 7.61 ppm (8.2 Hz). with signals in the 
ratio 1:1:2. 
-~ 'u J\i .. I ~~ .1 I J . w ,.... 
I d I ~ I j I J I J I A I • ~ I ~ PPM l I 
Figure 2.5: The 1 H nmr spectrum of 1-ethyl-4-methyl sulphone-~-carboljne (92) in CDC1s. 
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These data were consistent with an unsubstituted phenyl ring of a 
~-carboline nucleus, although the H5 signal was shifted downfield from the expected 
8.1 ppm69 to 8.78 ppm. Other features of the 1 H nmr spectrum were a one proton 
singlet at 8.98 ppm, a three proton singlet at 3.27 ppm, a three proton triplet and a two 
proton quartet assigned to an ethyl substituent and a broad one proton singlet at 8.7 
ppm assigned to the indolic proton (Table 2.4). 
The 13C nmr spectrum of (92) in CDCI3 (Table 2.4) revealed eight 
protonated carbon signals and six quaternary signals. The protonated carbon 
signals were assigned with the aid of a HETCOR experiment and the quaternary 
signals with the aid of an HMBC nmr experiment (Table 2.4). 
A high resolution EI mass spectrum of (92) showed an [M]+"ion of 274.0737 
with an [M+2J+ peak of the appropriate intensity for one sulphur atom. This data was 
suggestive of the molecular formula C'4H14N202S. A DCI mass spectrum obtained 
using methane as reagent gas showed an [MH]+ ion at 275, while that obtained using 
ND3 as reagent gas showed a peak at 277 [M-(H+D)D]+, confirming the presence of 
one exchangeable proton. The substitution pattern of the ~-carboline nucleus was 
confirmed by a series of nOe experiments. Irradiation of the H9 signal led to 
enhancement of the H8 and H l' signals, confirming the presence of an ethyl 
substituent at C1. As no enhancement of the 8.98 singlet was observed on irradiation 
of the H5 resonance, it was considered that this signal arose from a proton attached 
to C3 and therefore that the site of substitution was C4. T~lis left a fragment CH302S 
to be accounted for from the molecular formula which must be the C4 substituent. 
Fragmentations in the EI mass spectrum confirmed this grouping of atoms, with ions 
at 246 [M-CH2-CH2]+', 194 [M-H-CH3S02]+' and 167 [M-CH3S02-CH2CH3]+' The 
singlet at 3.27 ppm in the 1H nmr spectrum and a signal in the 13C nmr spectrum at 
43.24 ppm were consistent with a methyl group attached to a sulphur atom, in turn 
attached to one or more oxygen atoms. When the nOe experiments had been 
performed using CDCI3 as solvent, it was not possible to irradiate the S-methyl group 
resonance, as the ethyl methylene quartet signal was coincident. When C6D6 was 
used as solvent however, these signals were resolved and could be irradiated 
separately. Irradiation of the H5 signal produced enhancement of the S-methyl 
signal and vice versa (Table 2.4). 
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Table 2.4: Nmr spectroscopic data for compound (92). 
POSITION 
1 
3 
4 
4a 
4b 
5 
6 
7 
B 
Ba 
Bb 
9 
l' 
2' 
4' 
1 JCH correlations (HETCOR)a 
1JCH,2JCH,3JCH and 4JCH 
correlations (H MBC)a 
selected nOesb 
aFor CDCI3 solutions. 
bFor C6D6 solutions. 
B.9B s 
B.7B d (B.O) 
7.3B m 
7.61 m 
7.61 m 
B.7 br s 
3.22 q (7.6) 
1.50 t (7.6) 
3.27 s 
H3 <-> C139.88 
H5 <-> C125.86 
H6 <-> C121.67 
H7 <-> C129.77 
H3 <-> C 1, C4b, C4a 
H5 <-> CBa 
H6 <-> CB 
H7 <->CBa 
HB <-> CBa 
152.70 
139.BB 
119.22 
123.B4 
126.67 
125.B6 
121.67 
129.77 
111.B7 
140.57 
133.71 
27.54 
12.22 
43.24 
HB <-> C111.87 
H1' <-> C27.54 
H2' <-> C12.22 
H4' <-> C43.24 
H9 <-> CBa 
H1' <-> C1, C1' 
H2' <-> C1, C4a, 
CBb, C2' 
H4' <-> C4' 
H5 <-> H4', H6 (solvent obscured) 
H1' <-> H2' 
H4' <-> H5 
() coupling constants in Hz. 
OCH3 I 
0=8 
CH3 I 
0=8=0 
Figure 2.6: The three structural isomers possible for a 1-ethyl-~-carboline with a 
CH3S02- substituent at position 4. 
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Three structural isomers, differing in the arrangement of atoms in the C4 
substituent were possible (Figure 2.6). The isomer with a methoxyl group attached to 
the sulphur atom could be excluded on the basis of chemical shift data. Distinction of 
the two remaining possibilities was more difficult, with little or no difference expected 
in the chemical shifts of the methyl group, whether the compound was a methyl 
sulphone70,71 or a methyl sulphinate ester72,73. The 13C nmr chemical shift of C4 
should be useful in distinguishing between these two possibilities and definitive 
assignment of this carbon was achieved from the results of an HMBC nmr experiment 
and a 13C nmr experiment with a long pulse delay. One means of distinguishing 
between the two possibilities, using an HMBC nmr experiment, would be that in the 
case of a slJlphone, one would expect to observe a three bond correlation from the 
H4' proton signal to the C4 signal and possibly also a four bond correlation from the 
H4' proton Signal to the C3 signal and from the H3 proton Signal to the carbon signal 
at the 4' position. For a sulphinate ester, no correlations would be observed as the 
correlations involved would range over five bonds. However, the only correlation 
observed from the H4' protons was the one bond correlation to the C4' resonance 
and correlations observed for the H3 proton were to quaternary signals which were 
aSSigned to other carbon atoms in the structure (Table 2.4). 
This left a quaternary carbon signal at 119.22 ppm unassigned. Model 
compounds were, used to gain an indication of where the C4 resonance would be 
expected to be observed for each of the two possible structures. 1-ethyl-4-methoxy-
~-carboline (93) was used as a model for a compound with an oxygen attached 
directly to C4. For this compound, the C4 resonance was at 150.97 ppm and the C3 
Signal at 119.96 ppm65, quite different from the Observed 139.88 ppm shift for C3 of 
compound (92). Finding a suitable model for the sulphone possibility was more 
difficult. The difference in chemical shift of C3, C4 and C1 between toluene74 and 
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methyl 4-tolyl sulphone71 was compared with the difference in these resonances 
between 1-ethyl-~-carboline and compound (92). Using this model as a rough 
guide, for (92) one might expect a downfield shift of approximately 12 ppm in the C4 
resonance, from the 112.91 ppm shift observed for 1-ethyl-~-carboline (see Table 3.2 
below) and very little chemical shift difference for C3. A downfield shift of 
approximately 7 ppm would be expected for C1. This would mean that for (92), the 
C4 signal would be expected to be observed at approximately 125 ppm, although as 
the model is by no means ideal, some variation would be expected. The results of 
the model comparisons are summarised in Figure 2.7. 
CHa 
I 
O=S=o 
+12.2 
~"1.2 
CHa 
a) 
0.6 
CHa 
I O=S=O 
+6.4 
~ 1.0 
Figure 2.7: Differences in 13C nmr chemical shifts in CDCI3 on aromatic substitution 
a) for toluene to methyl 4-tolyl sulphone 
b) for 1-ethyl"~-carboline to 1-ethyl-4-methoxy-~-carboline (93) 
c) for 1 "ethyl-~-carboline to compound (92) 
To check that the signal at 119.22 ppm was real, and that no other weak 
resonances were present, a 13C nmr spectrum of compound (92) was obtained with a 
pulse delay of five seconds. No new signals were observed and that at 119.22 ppm 
was of similar intensity to the other assigned quaternary signals of the compound. 
This, combined with the better fit of the sui phone model compound to the observed 
data, supported the structure being assigned as the sulphone. 
Mass spectrometry should also have been helpful in distinguishing between 
the two possible structures. For a sulphone, one would expect to see a fragment ion 
resulting from loss of a methyl group and a fragment ion resulting from complete loss 
of the sidechain. For a sulphinate ester, fragment ions corresponding to the loss of 
CH2S0 to form a phenol, and loss of the sidechain would be expected72. Under EI, 
DCI and DEI conditions at a variety of ionising voltages, the fragmentation observed 
was inconclusive, with compound (92) showing fragment ions corresponding to the 
loss of the 1-ethyl grouping, the entire C4 grouping and both of these substituents, 
but none corresponding to the loss of a methyl grouping or formation of a phenol. 
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The ir spectrum of (92) had two strong bands at 1335 and 1160 cm-1, typical 
of a sulphone75 , while in the uv spectrum of (92) in methanol, some bands were 
shifted to longer wavelength than in 1-ethyl-~-carboline, in keeping with the extended 
conjugation offered by the sulphone grouping. 
Further evidence for a sulphone grouping rather than a sulphinate ester was 
given by the attempted acid hydrolysis of (92). Sulphinate esters are known to be 
very unstable and are easily hydrolysed under both acidic and basic conditions72. A 
sub-sample of (92) was dissolved in CDCI3, D20ITFA added to form a bi-phasic 
system and the reaction (if any), monitored by 1 H nmr spectroscopy. After two days, 
the only differences in the spectrum were the disappearance of the exchangeable 
indolic proton and the appearance of an H-O-D peak at 4.7 ppm. The absence of any 
hydrolysis reaction again strongly favoured the sulphone structure. 
This isolation of 1-ethyl-4-methyl sulphone-~-carboline, is the first report of a 
~-carboline alkaloid with a sulphur atom attached directly to the ring, either as a 
natural product or a synthetic compound. 
ISOLATION OF HARMAN (55) 
Tic analysis of reverse phase column chromatography fractions less polar 
than those containing (82), revealed the presence of another compound which was 
also fluorescent under ultraviolet light. Further chromatography on C18 reverse 
phase material led to the isolation of harman (55). Harman was identified by mass 
spectrometry and by comparison of its 1 Hand 13C nmr spectra with literature 
data76,65. 
(55) CH3 
IDENTIFICATION OF 1-ETHYL-~-CARBOLINE (56) 
Fractions containing harman by tic analysis also contained another 
component, fluorescent under ultraviolet light, at higher Rf on silica gel. A 1 H nmr 
spectrum of mixtures of this component and harman suggested that it was 1-ethyl-~­
carboline and this was confirmed by mass spectrometry and tic comparison with a 
synthetic sample, (see below). 
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ISOLATION OF PAVETTINE (57) 
1 H nmr analysis of reverse phase chromatography fractions slightly more 
non-polar than those containing (82) revealed the presence of another component 
containing a vinyl substituent. A preparative tic separation led to the isolation of less 
than 1 mg of a yellow-green oil, which was identified as pavettine (57). from its 1 H 
nmr and mass spectra77 and by tic comparison with an authentic sample. 
ISOLATION OF HOMARINE 
An early fraction from the initial reverse phase chromatography column on 
the extract contained a pale lemon precipitate, the 1 H nmr spectrum in D20 of which 
was suggestive of a 2-substituted N-methyl pyridinium compound, reminiscent of 
homarine (94). This identification was confirmed by 13C nmr spectroscopy78. This 
result is in accord with earlier findings, when homarine was identified as the major 
water soluble component of the bryozoan Margaretta barbata79 , and the results of 
Christophersen et al. who found homarine in addition to trigonelline (95) in each of 
four extracts of bryozoans investlgated8o. 
Q-7 cO2 
CH3 
(94 ) 
-~C02 
~tl) N 
I 
CH3 
(95) 
HO 
~ 
VVV' 
I a 
STEROLS 
R 
(96) 1a 
(97) 1b 
(98) 1j 
(99) 1e 
H 
2 3 
(100) 1d 
(101) 1c 
(102) 1 h 
(103) 19 
(104) 2c 
(105) 1f 
(106) 11 
(107) 3c 
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The sterols from the bryozoan were isolated by column chromatography on 
silica gel of a fraction from the initial reverse phase flash column on the extract. One 
fraction from the column contained a major component which was identified as the 
steroid, cholest-4-en-3-one (107) by comparison of its 13C nmr spectra in CDCI3 with 
literature data81 . Cholesterol (101) was identified as the major component of the two 
subsequent fractions by comparison of the nmr spectroscopic data with literature 
values81 . A sterol containing a 24-methylene group in the sidechain was also 
present in these fractions by 1 Hand 13C nmr spectroscopy, but in a lesser quantity. 
These three fractions were combined and sent to Professor Carl Djerassi for further 
analysis. The results of this analysis are summarised in Table 2.5 and confirm the 
presence of cholesterol and cholest-4-en-3-one as major components of the sterol 
mixture. 
Table 2.5: The sterol composition of Cribricellina cribraria. 
Sterols Present 
Percentage composition of the sterol mixture 
of the Crlbrlce/llna crlbraria sam pie. 
(96) 3 
(97) 9 
(98) + 
(99) 4 
(100) 18 
(101 ) 28 
(102) + 
(103) 4 
(104) 13 
(105) + 
(106) 6 
(107) 10 
unidentified 4 
+ denotes a trace amount, <1 %. 
2.3 STUDIES OF THE BRYOZOAN, MARGARETTA BARBATA 
PREVIOUS WORK ON MARGARE7TA BARBATA 
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Earlier, preliminary work on a bryozoan of the same family (Micronellidae) as 
Cribricellina cribraria, Margaretta barbata, had been undertaken by Colin Barrow in 
1987 as part of a Ph.D. thesis79. This work had been stimulated by the finding that 
the crude extract showed strong In vivo activity against P388. This earlier work had 
indicated that there were two biologically active components present in the extract, 
but with quite different polarities. After an initial reverse phase flash chromatography 
column on the crude extract, the more non-polar active material was concentrated 
into one fraction of 200 mg which eluted from the column with methano\. 1 Hand 13C 
nmr spectra of this fraction in CDCI3 were obtained, with no clearly obvious features, 
apart from signals reminiscent of unsaturated long chain fatty acid material. Tic 
40 
analysis of this fraction on silica gel revealed a number of spots which were 
fluorescent under uv light and well spread out on the plate. A preparative tic 
separation on a sub~sample of this fraction on silica was attempted but this led to very 
low recovery of both mass and activity. Further work on this fraction was then 
abandoned. 
ORGANIC SOLUBLE BIOLOGICAL ACTIVITY OF MARGARETTA BARBATA 
In light of the biological activity associated with this bryozoan and the 
presence of the fluorescent spots, reminiscent of the ~~carboline alkaloids isolated 
from Cribricellina cribraria, it was decided to investigate the appropriate fraction from 
Margaretta barbata more fully. The 1 Hand 13C nmr spectroscopy and assays were 
repeated to check the stability of the material. No significant differences were noted 
in the 1 Hand 13C nmr spectra or the tic from those obtained previously. The fraction 
had an IC50 of 9100 ng/ml in the P388 assay and exhibited cytotoxicity against a 
BSC cell line of type CG. 
Analytical reverse phase hplc was attempted and cuts taken and submitted 
for assay. Activity was spread throughout these cuts. A trial solvent partition 
between petroleum ether and ethanol/water (19:1), on a subsample of the material 
was attempted, to try and remove the fatty acid material. This was unsuccessful by 
both tic analysis and biological assay, so the partitions were recombined. 
Some of the sample had formed a dark brown solid, insoluble in methanol, 
dichloromethane or water, but a reverse phase flash chromatography column was 
run on the remaining 135 mg of sample. P388 assays on the column fractions 
showed significant activity in fractions 1 ~3 but the activity then dropped off markedly. 
Tic of these fractions revealed the presence of the fluorescent spots. The fractions 
were recombined and a further reverse phase column run. Assays of these fractions 
revealed that the activity was primarily concentrated into one fraction from this 
column, which by tic analysis, was not the fraction containing the fluorescent 
compounds. A 1 H nmr spectrum of the active fraction in CDCI3 contained very broad 
and unresolved resonances and was suggestive of the presence of fatty acid type 
material. A trial methylation of a sub-sample of this fraction, using diazomethane in 
ether did not significantly alter the activity, so the whole sample was methylated in 
the same manner, in the hope that this would facilitate purification by converting the 
major contaminants to less polar compounds. 
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The methylated material was re-submitted to reverse phase hplc and cuts 
taken. Activity was concentrated into two fractions, the 1 H nmr spectra of which were 
similar to those previously acquired. The two fractions were recombined but some 
material was insoluble in CDCI3 and remained on a filter when the nmr sample was 
prepared. This residue was dissolved in methanol and assayed separately from the 
CDCI3 soluble fraction. P388 assay results showed that the activity was 
concentrated in the CDCI3 soluble fraction which had been reduced in mass to 1.8 
mg and which now had an IC50 of 270 ng/rnl. A 1 H nmr spectrum of this fraction was 
obtained in CDCI3 with a drop of TFA added in an attempt to sharpen the signals. 
This was not successful. 
It was now obvious that the component responsible for the biological activity 
of the organic extract of the bryozoan was present at an extremely low level. 
Concentration of activity in the purification process was not accompanied by 
significant loss of mass and the remaining sample was still a complex mixture. Due 
to lack of material it was necessary to abandon work on this aspect of the active 
components from Margaretta barbata. The bioactivity ... directed separation is 
summarised in Figure A.2 of the Appendix. 
However, two known simple ~-carboline alkaloids were recovered and 
characterised from the fraction from the reverse phase column on the organic soluble 
active component of Margaretta barbata that had been shown to contain 
components, fluorescent under uv light on tic. The 1 H nmr spectrum of this fraction in 
CDCI3 revealed aromatic signals, reminiscent of a ~-carboline nucleus. Examination 
of the appropriate literature indicated that this was most likely, as some simple 
~-carboline alkaloids had been isolated from a Tasmanian bryozoan, Costaticella 
hastata, which is of the same family as M. barbata54. 
A singlet at 2.83 ppm in the 1 H nmr spectrum in CDCI3 of this fraction 
indicated that the major component of the fraction was most likely harman (55), the 
major alkaloid isolated from C. hastata. Semi-preparative reverse phase hplc led to 
the isolation of 2 mg of an oil, the 1 Hand 13C nmr, uv and mass spectra of which, 
were identical to those reported for harman 76,65. Tic analysis revealed that this was 
the major component of the fluorescent compounds seen previously by tic. 
Another fraction from the reverse phase hplc run of < 1 mg was shown by tic 
to contain both harman and another component, fluorescent under uv light, at higher 
Rf on silica gel. No signals were visible when a 1 H nmr spectrum was attempted, 
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even after many transients. An EI mass spectrum of the fraction showed peaks 
corresponding to those of harman, and another component with an M+ ion of 196. A 
peak at 168, corresponding to the loss of an ethyl grouping led to the component 
being tentatively identified as 1-ethyl-~-carboline. Comparison of the mass spectrum 
with that quoted for 1-ethyl-~-carboline confirmed this identification69 , as did tic 
comparison with an authentic sample. This compound had also been isolated from 
C. hastata along with harman, and in a lesser amount, which makes its occurrence 
here not surprising. 
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CHAPTER THREE 
3.1 FURTHER STUDIES OF f3-CARBOLINE ALKALOIDS 
INTRODUCTION 
The ~-carboline alkaloids isolated from the bryozoan Cribricellina cribraria 
and their derivatives constitute a series of structurally related compounds, amenable 
to further studies. Other structurally related compounds could be prepared relatively 
simply to further extend the series. Several of these alkaloids were therefore 
synthesised and an nmr spectroscopic study and studies of the biological activity and 
structure-activity relationships within this series carried out. 
The nmr spectroscopic study enabled the assignment of the 1 Hand 13C nmr 
spectra of the alkaloids, some of which had not been previously reported, while 
previously reported 13C nmr spectroscopic assignments for some of the alkaloids 
were shown to be in error. 
The main reason for synthesising further ~-carboline alkaloids however, was 
to study their biological activities. A wide range of biological activities has been 
described for various ~-carboline alkaloids. Many plants containing these alkaloids 
are used in traditional folk medicine to treat a variety of disorders. An example is the 
tropical forest tree of South America, Picrasma crenata, used in Southern Brazil to 
treat diabetes68 . 
Other reported activities of these alkaloids include enzyme inhibition against 
cyclic adenosine monophosphate (cAMP) phosphodiesterase82,83 and xanthine 
oxidase84, antiviral85,86 and antimicrobial62,85/antifungal87 properties. Some have 
been used therapeutically in traditional medicine. For example, several of the 
alkaloids (108-112) have been used in the treatment of gout, urinary and renal 
calculi84. 
R1 
R1 R2 R3 
(108)CHO H OH 
(109) C02CH3 H OH 
(110) CHO OH H 
(111) C~Ha H H 
(112) C02CH3 OAc H 
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The alkaloids isolated from Cribricellina cribraria exhibited biological activity 
to widely differing degrees. In particular, as the biological activities of pavettine 
versus 1-ethyl-~-carboline and harman were quite different (see below). it was 
decided to concentrate on the synthesis of 1-substituted ~-carbolines to see if any 
trends in their biological activities were apparent. In some cases, the identity and 
biological activity of the natural products could be checked against the synthetic 
samples. Attempts were made to relate the observed biological activities of the 
alkaloids to the factors considered most important in the study of structure-activity 
relationships. 
SYNTHESES OF 1-SUBSTITUTED-~-CARBOLINE ALKALOIDS 
A total of seven ~-carboline alkaloids were synthesised. These were 
norharman (58), harman (55). 1-ethyl-~-carboline (56), 1-propyl-~-carboline (113). 
1-isopropyl-~-carboline (114). 1-hexyl-~-carboline (115) and 1-phenyl-~-carboline 
(116). Most of the alkaloids were synthesised by condensation of L or DL-tryptophan 
and the appropriate aldehyde under acidic conditions, followed by an oxidative 
decarboxylation using potassium dichromate 77 ,88. In the cases of 1-hexyl-~­
carboline and 1-phenyl-~-carboline, the immiscibility of heptanal and benzaldehyde 
with water meant that the reaction had to be left to proceed for a much longer period 
of time with vigorous stirring. Yields in all cases were rather poor (of the order of 
1-20%). and it was generally found to be more convenient to purify the products by 
reverse phase flash column chromatography rather than by recrystallisation. 
f';J 
H 
(55) R CH3 R 
(56) R :::: CH2CH3 
(58) R H 
(113) R = CH2CH2CH3 
(114) R :::: CH(CH3b 
(115) R :::: (CH2)sCHS 
(116) R:::: C6HS 
(117) R:::: C02H 
(118) R = C02CH3 
R 
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Harman was prepared by an alternative method, in which tryptophan and 
acetaldehyde were condensed under physiological conditions of temperature and 
pH89. This allowed the isolation of the precursor of harman, 1-methyl-1,2,3,4-
tetrahydro-p-carboline-3-carboxylic acid (117), which was subsequently converted to 
harman. Although this method resulted in a greatly improved yield of compound 
(55-60%), it was more time-consuming than the other preparation. 
Methylation of the precursor with diazo methane to form methyl 1-met~yl-
1,2,3,4-tetrahydro-p-carboline-3-carboxylate (118) was also carried out to see if this 
had any effect on the biological activity. 
NMR SPECTROSCOPY OF P-CARBOLINE ALKALOIDS 
The 1 Hand 13C nmr spectra of the p-carboline alkaloids isolated from 
Cribricellina cribraria and their derivatives, an authentic sample of pavettine 
(obtained from Dr. B. Charles) and of the synthetic alkaloids, were recorded for 
comparative purposes. The means by which the spectra of the natural product 
alkaloids and their derivatives were assigned are outlined in Chapter Two of this 
thesis. For the 1 Hand 13C nmr spectral data of these alkaloids, refer also to Chapter 
Two, Tables 2.1-2.2 and 2.4. The 1 Hand 13C nmr assignments for the synthetic 
alkaloids are summarised in Tables 3.1-3.3. 
Table 3.1: 1 H nmr data for synthetic p-carboline alkaloids in ppm for CDCI3 solutions. 
COMPOUND 
POSITION (58) (55) (56) (113) (114) (115) (116) 
1 8.92 s 
3 8.47 d (5.3) 8.13 d (5.2) 8.43 d (5.3) 8.39 d (5.4) 8.42 d (5.3) 8.38 d (5.2) 8.57 d (5.0) 
4 7.96 d (5.3) 7.83 d (5.2) 7.83 d (5.3) 7.82 d (5.4) 7.82 d (5.3) 7.80 d (5.2) 7.92 d (5.0) 
5 8.14d (7.7) 8.12 d (7.3) 8.11 d (8.0) 8.11 d (7.8) 8.12 d (8.0) 8.11 d (7.8) 8.15 d (7.9) 
6 7.30m 7.30m 7.27m 7.28m 7.27 m 7.29m 7.31 t (7.9, 7.5) 
7 7.53 m 7.55m 7.49 m 7.51 m 7.49 m 7.53m 7.50 m 
8 7.53 m 7.55m 7.49 m 7.51 m 7.49 m 7.53m 7.50 m 
9 8.6 br s 11.0 br s 9.4 br s 8.5 br s 9.1 br s 8.5 br s 
l' 3.11 s 3.16q(7.6) 3.09 t (7.8) 3.54 d septets 3.10t(7.8) 
(6.9, 1.3) 
2' 1.41 t (7.6) 1.94 sx 1.48 d (6.9) 1.88 qt (7.8) 7.96 d (7.0) 
(7.8,7.4) 
3' 1.03 t (7.4) 1.39m 7.58 m 
4' 1.30 m 7.50 m 
5' 1.30 m 7.58 m 
6' 0.84t (7.1) 7.96 d (7.0) 
o coupling constants in Hz. 
.j:::>. 
(J) 
Table 3.2: 13C nmr data for synthetic ~-carboline alkaloids in ppm for CDCI3 solutions. 
COMPOUND 
CARBON (58) (55) (56) (113) (114) (115) (116) 
1 133.75 141.72 146.85 145.71 150.42 145.88 143.03 
3 139.38 138.86 138.84 138.80 138.52 138.62 139.61 
4 114.72 112.88 112.91 ) 112.79 112.78 112.78 113.77 
4a 121.55 121.77 121.96 122.10 122.03 122.09 121.92 
4b 128.96 128.32 128.63 128.59 128.76 128.66 129.84 
5 121.82 121.85 121.70 121.76 121.64 121.77 121.81 
6 120.20 120.20 119.92 120.06 119.92 120.09 120.27 
7 128.54 128.24 128.15 128.20 128.13 128.24 128.50* 
8 111.54 111.52 111.58 111.49 111.52 111.51 111.53 
8a 140.39 139.99 140.34 140.06 140.17 140.10 140.31 
8b 134.54 134.51 134.01 134.24 133.30 134.13 133.49 
1 ' 20.32 27.24 36.29 31.99 34.31 138.57 
2' 12.75 21.96 21.43 28.67 128.13 
3' 14.19 29.45 129.22 
4' 31.74 128.83* 
5' 22.56 129.22 
6' 14.04 128.13 
* Values in vertical columns may be interchanged. .j:::.. 
-.....J 
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Table 3.3: 1 Hand 13C nmr data for compounds (117) and (118). 
COMPOUND 
POSITION (117)a (118)b 
o1H O13C o1H O13C 
1 4.61 q (6.7) 49.07 4.27 dt 48.37 
3 3.71 dd 57.70 3.84 dd 52.20 
(4.8, 11.1) (4.5, 11.2) 
4 2.88 ddd 23.37 2.83 ddd 25.97 
(12.0, 16.1, 2.5) (11.2. 15.2.2.5) 
3.26 ddd 3.13 ddd 
(4.8. 16.1, 1.3) (4.5. 15.2. 1.9) 
4a 106.83 107.49 
4b 126.21 127.18 
5 7.55 d (8.6) 118.08 7.47d(7.1) 118.04 
6 7.12 t 118.89 7.13 m 119.62 
7 7.19 t (8.0) 121.39 7.13 m 121.78 
8 7.44 d (8.0) 111.29 7.31 d (7.5) 110.84 
8a 136.45 136.46 
8b 132.40 135.91 
9 11.20 s 7.8 br s 
l' 1.72 d (6.7) 17.08 1.51 d (6.7) 20.38 
3-C02H 169.49 173.63 
3-C02CH3 3.82 s 56.60 
a Values in ppm for DMSO solutions. 
b Values in ppm for CDCI3 solutions. 
() coupling constants in Hz. 
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A 13C nmr spectroscopy study of I)-carboline alkaloids has been reported 
previously in the Iiterature65• Nmr spectroscopic experiments on 1-ethyl-l)-carboline 
suggested that these previously published 13C nmr assignments should be revised. 
In the work reported here, the 1 Hand 13C nmr spectra of 1-ethyl-l)-carboline (Tables 
3.1 and 3.2), were assigned with the aid of COSY and HETCOR nmr experiments. 
Comparison of the experimental data with the literature values65 suggested that the 
literature assignments of C6 and C7 for many of these alkaloids were in error. 
The COSY spectrum of (56) obtained in CDCI3, showed that the H5 doublet 
at 8.11 ppm was coupled to both the multiplet at 7.27 ppm and to the two proton 
multiplet at 7.49 ppm, so these signals were assigned as H6 and H7, H8 respectively. 
In turn, the multiplet at 7.49 ppm showed coupling to the H6 resonance (Table 3.4). 
Proof for the assignment was given by a series of nOe experiments in 
DMSO-d6 (Table 3.4). Irradiation of the H5 resonance led to enhancement of the 
signal assigned as H6 and irradiation of this signal led to enhancement of the H5 
resonance and the H7, H8 multiplet. The H6 resonance was enhanced on irradiation 
of the multiplet, as was the H9 resonance. These results confirmed that the 
assignment of the 1 H nmr spectrum was correct. 
Table 3.4: Selected COSY and HETCOR correlations and nOe enhancements 
observed for 1-ethyl-l)-carboline (56). 
cosya H3 <-> H4 HETCORa H5 <-> C121.70 
H5 <-> H6 H6 <-> C119.92 
<-> H7 H7.8 <-> C128.15 
H6 <-> H7 <-> C111.58 
nOeb H3 <-> H4 H7,8 <-> H6,H9 
H4 <-> H3,H5 H9 <-> H8, H1' 
H5 <-> H4,H6 H1' <-> H9, H2' 
H6 <-> H5,H7 H2' <-> H1 ' 
a For CDCI3 solutions. 
b For DMSO-d6 solutions. 
The HETCOR nmr spectrum of (56) in CDCI3 showed that the H6 resonance 
was correlated to a 13C nmr signal at 119.92 ppm while the resonance arising from 
H7 and H8 was correlated to signals in the 13C nmr spectrum at 128.15 and 111.58 
ppm. This implied that the signal at 119.92 ppm arose from C6, while that at 128.15 
50 
ppm arose from C7, the reverse to the assignments given in the literature65 for 
analogous ~-carboline alkaloids such as harman. 
As the HETCOR spectrum of (56) was unambiguous, the assignment of C6 
and C7 had to be as given in Table 3.2. The analogous synthetiC ~-carboline 
alkaloids were therefore assigned as per these values. In cases where the 13C nmr 
data could not be assigned by direct comparison, HETCOR and/or XCORFE nmr 
experiments were used to aid in the assignments. 
The alkyl chain of 1-hexyl-~-carboline (115) was assigned in the following 
manner. A COSY nmr spectrum established the proton-proton connectivity 
throughout the chain, allowing assignment of the 1 H nmr spectrum. The 13C nmr data 
was then assigned with the aid of a HETCOR nmr experiment, but the assignment of 
C4' and C5' was ambiguous as both were correlated to the two proton multiplet at 
1.30 ppm. Unambiguous assignment of C4' and C5' was achieved by comparison of 
the 13C nmr data with that of chimyl alcohol90• 
The 1 H nmr spectrum of 1-phenyl-~-carboline (116) obtained in CDCI3 was 
difficult to assign, on account of some overlapping Signals. A 1H nmr spectrum of the 
compound was obtained at 50°C. The signals were better resolved through chemical 
shift difference at the higher temperature and this aided in the assignment of the 
spectrum at 23°C. A COSY nmr experiment confirmed the 1 H nmr spectral 
assignments. Although some of the Signals in the 13C nmr spectrum of (116) were 
over a very small chemical shift range, most could be unambiguously assigned with 
the aid of HETCOR and HMBC nmr experiments. For example. C1 and C1' were 
distinguished with the aid of an HMBC nmr experiment. Correlations from H3' to C1' 
and from H2' to C1, allowed the assignment as shown in Table 3.2. 
BIOLOGICAL ACTIVITY OF ~-CARBOLINE ALKALOIDS 
The alkaloids (55-58). (82). (88-92) and (113-118) were tested in the 
three biological assay systems as described in Chapter One of this thesis. For the 
antimicrobial/antifungal assays, compounds were submitted in a series of two-fold 
dilutions to determine the minimum inhibitory concentration (MIC) of the alkaloids 
against each organism. 
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1. P388/CYTOTOXICITY RESULTS 
The P388 and antiviral/cytotoxicity assay results of the ~-carboline alkaloids 
are summarised in Table 3.5. These results parallel each other, showing the same 
trends. 
R 
R2 CH3 
(55-58), (82), (117) R = C02H (113-116) (118) R = C02CH3 
For R1, R2, R3, see Table 3.5 
Table 3.5: P388 and antiviral/cytotoxicity assay results for ~-carboline alkaloids. 
COMPOUND P388 Antiviral/Cytotoxicity Results 
R1 R2 R3 1Cso(ng/ml) HSV1 PV1 Cyt. Type ~g/disc 
(58) H H H 25000 20 
(55) CHa H H 25000 20 
(56) CH2CHs H H 25000 20 
(113) (CH2hCHa H H 25000 20 
(114) CH{CHsh H H 13000 20 
(115) (CH2)sCHs H H 9000 ± ± C4 40 
± C6 10 
(116) CeHs H H 90000 20 
(57) CH=CH2 H H 100 ? ? ww C7 2 
± ± 2+ C7 0.5 
0.4 
(82) CH=CH2 OH H 100 ? ? ww C9 2 
± ± 2+ C9 0.5 
0.4 
(88) CH=CH2 OCHs H 100 ± ± 2+ C9 2 
± ± ± C9 0.5 
0.4 
(89) CH2CHa OH H >12500 20 
(90) CH=CH 2 OAc H 650 ? ? ww C7 20 
± ± 2+ C7 5 
1 
(91 ) CH2CHa OCHs H >12500 20 
(92) CH2CHs H S02CHS >12 500 20 
(117) >125000 20 
(118) 120 000 20 
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Table 3.5 clearly shows that for the P388 and antiviral/cytotoxicity assays, 
only those alkaloids with a vinyl sidechain at the 1-position exhibited any significant 
cytotoxicity or P388 activity. For these alkaloids, the presence or absence of a 
substituent at the 8-position had no effect on the cytotoxicity of the alkaloid, with 
pavettine (57) and 1-vinyl-8-hydroxy-~-carboline (82) having essentially the same 
activity. An exception to this is 1-vinyl-8-acetoxy-~-carboline (90) which was less 
active than the other alkaloids by a factor of six. All of the alkaloids with an 
unsaturated alkyl sidechain at position 1 exhibited no significant P388 activity or 
cytotoxicity, having IGso values greater than 12 500 ng/ml. An exception to this is 
1-hexyl-~-carboline, although the IGso value of this compound of 9 000 ng/ml is much 
higher than those of the vinyl alkaloids and the cytotoxicity is barely discernible at the 
concentrations tested. 
2. ANTIMICROBIAUANTIFUNGAL ASSAY RESULTS 
The results of the antimicrobial/antifungal assay are summarised in Table 
3.6. The antimicrobial/antifungal assay results are significantly different from those of 
the other assay systems. 
At the concentrations tested, none of the alkaloids tested showed any 
significant activity «60 Ilg/disc) against Pseudomonas aeruginosa and 1-phenyl-~­
carboline (116) and 1-methyl-1,2,3.4-tetrahydro-~-carboline-3-carboxylic acid (117) 
showed no activity against any of the microorganisms. Norharman (58) showed 
quite strong activity against E. coli. The only other alkaloids to show activity against 
this organism were pavettine (57), 1-ethyl-8-hydroxy-~-carboline (89) and harman 
(55). This activity was rather weak for the former two compounds and very weak for 
harman. The most active alkaloid against Bacillus subtilis was pavettine (57) with a 
MIG of 1.9-3.8 Ilg/disc. 1-Ethyl-8-methoxy-~-carbo line (91). 1-propyl- ~-carboline 
(113), 1-phenyl-~-carboline (116), 1-hexyl-~-carboline (115) and the tetrahydro-~­
carbo lines were all inactive against this organism. Most of the remaining alkaloids, 
namely norharman (58), harman (55), 1-ethyl-~-carboline (56), 1-isopropyl-~­
carboline (114). 1-vinyl-8-hydroxy-~-carboline, (82) 1-vinyl-8-methoxy-~-carboline 
(88) and 1-vinyl-8-acetoxy-~-carboline (90) exhibited a MIG of 7.5-15 Ilg/disc. 
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R 
R2 CH3 (117) R = C02H 
(118) R = C02CH3 
R1 R2 R3 R1 R2 R3 
(57) CH=CH2 H H (58) H H H 
(82) CH=CH2 OH H (55) CH3 H H 
(88) CH=CH2 OCH3 H (56) CH2CH3 H H 
(89) CH2CH3 OH H (113 ) (CH2hCH3 H H 
(90) CH=CH2 OAe H (114 ) CH(CH3h H H 
(91) CH2CH3 OCH3 H ( 115) (CH2}5CH3 H H 
(92) CH2CH3 H S02CH3 ( 116) CSH5 H H 
Table 3.6: Antimicrobial/antifungal activities of ~-carboline alkaloids, expressed as 
minimum inhibitory concentration (MIC) in Jlg/disc. 
COMPOUND Ec 8s Pa Ca Tm Cr 
(58) 3.7-7.5 7.5-15 >60 1.9-3.8 0.9-1.9 15-30 
(55) 60-120 7.5-15 >60 1.9-3.8 3.7-7.5 15-30 
(56) >120 7.5-15 >60 1.9-3.8 1.9-3.8 30-60 
(113) >120 >120 >60 >120 15-30 >120 
(114) >120 7.5-15 >60 1.9-3.8 0,45-0.9 15-30 
(115) >60 >60 >60 >60 1.9-3.8 7.5-15 
(116) >60 >60 >60 >60 >60 >60 
(57) 30-60 1.9-3.8 >60 1.9-3.8 0.1-0.2 0.9-1.9 
(82) >60 7.5-15 >60 15-30 0,45-0.9 3.7-7.5 
(88) >60 7.5-15 >60 7.5-15 0,45-0.9 15-30 
(89) 30-60 30-60 >60 30-60 30-60 >60 
(90) >60 7.5-15 >60 15-30 0.9-1.9 >60 
(91 ) >60 >60 >60 7.5-15 7.5-15 >60 
(92) >60 30-60 >60 >60 30-60 >60 
(117) >60 >60 >60 >60 >60 >60 
(118) >60 >60 >60 7.5-15 >60 >60 
Ec E. coli, Bs = B. subtilis, Pa = P. aeruginosa, Ca :: C. albicans, 
Tm = T. mentagrophytes and Cr = C. resinae. 
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Against the fungus Candida a/bicans, the lowest observed MIG was 1.9-3.8 
1J.9/disc and this was exhibited by norharman (58), harman (55), 1-ethyl-~-carboline 
(56), 1-isopropyl-~-carboline (114) and pavettine (57). All the vinyl alkaloids with 
aromatic substitution were less active. Again, 1-ethyl-8-hydroxy-~-carboline (89) 
exhibited only weak activity (30-60 1J.9/disc) and all other compounds were inactive, 
with the exception of methyl 1-methyl-1 ,2,3,4-tetrahydro-~-carboline-3-carboxylate 
(118), which had a MIG of 7.5-15 1J.9/disc. Candida albicans was the only organism 
which this compound exhibited any significant activity against. 
Pavettine (57) was the most active alkaloid against the dermatophyte, 
Trichophyton mentagrophytes, with a MIG of 0.1-0.2 1J.9/disc. This was the lowest MIG 
found for any of the alkaloids against any of the microorganisms tested. Again, the 
other vinyl alkaloids were less active, but these were still quite potent. Of the 
saturated 1-alkyl-~-carboline alkaloids, 1-isopropyl-~-carboline (114) was the most 
active, followed by norharman (58), 1-ethyl-~-carboline (56) and 1-hexyl-~-carboline 
(115), harman (55) and 1-propyl-~-carboline (113). This was the only 
microorganism against which 1-propyl-~-carboline exhibited any measurable activity. 
1-Ethyl-8-methoxy-~-carboline (91) had a MIG of 7.5-15 1J.9/disc, while both 1-ethyl-8-
hydroxy-~-carboline (89) and 1-ethyl-4-methylsulphone-~-carboline (92) had weak 
activity at 30-60 1J.9/disc. The other alkaloids were inactive at the concentrations 
tested. 
Many of the alkaloids showed either greatly reduced activity or no activity 
against Cladisporum resinae. Pavettine (57) was stili the most effective compound 
and 1-vinyl-8-hydroxy-~-carboline (82) was less active by a factor of four. The other 
8-substituted alkaloids however, were much less active again. 1-Hexyl-~-carboline 
(115) had a MIG of 7.5-15 jlg/disc but the growth of the fungus was only retarded to a 
very slight degree by this compound, rather than significantly affected. 
3. STRUCTURE/ACTIVITY RELATIONSHIPS 
Nowadays, the three factors which are considered most relevant in the study 
of structure-activity relationships are solubility, ionisation or electron distribution and 
shape or steric fit91. These three factors are now examined independently. 
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a) Shape. 
A 1 H nmr spectroscopy study of the binding mode and kinetics of antitumour 
drugs to DNA has shown that I)-carboline alkaloids bind to DNA by intercalation92. 
Intercalating compounds bind to DNA by sliding between the base pairs as shown in 
Figure 3.1. 
Figure 3.1: DNA, showing the secondary structure and intercalation of molecules 
between the base pairs. 
This binding causes the unwinding of the DNA helix. An intercalating molecule must 
possess a large, flat area of approximately 38 A2 to be able to fit between the base 
pairs of DNA93. A further requirement is a positive charge, as the space available for 
intercalation is negatively charged, due to the surrounding phosphate anions, purine 
and pyrimidine bases and oxygen atoms of deoxyribose93. The I)-carboline alkaloids 
are essentially planar, thus fulfilling the requirement of a large flat area. The 
requirement of positive charge is fulfilled by the indolic proton. The 1 H nmr 
spectroscopy study states that the "possession of three or more fused benzenoid 
rings virtually assures that the compound will bind primarily by intercalation of that 
chromophore, in the absence of bulky substituents that prevent intercalative 
binding"92. The I)-carboline alkaloids used in the study were norharman (58), 
methylnorharman (119), methyl harman (120) and methylharmine (121). For these 
compounds, intercalative binding was shown to be guanidine-cytosine base-pair 
specific and the compounds were also shown to be in fast exchange with the DNA, 
that is, the residence time of the compounds at any specific DNA binding site is short. 
R1 R2 R3 R4 
(119) H CH3 CH3 H 
(120) CH3 CH3 CH3 H 
(121) CH3 CH3 CH3 OCH3 
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The study concluded that ..... at least for the intercalating compounds. 
cytotoxicity and useful antitumour activity are associated with long drug/DNA 
residence times"92 . It is thought that the cytotoxicity of DNA drugs is a result of the 
induction of strand breaks in the DNA and of the blocking of polymerase enzymes 
during replication and transcription, therefore compounds with longer residence 
times at a DNA binding site may have higher cytotoxicity and antitumour activity92. 
The results of the study bear this out, showing that structural changes resulting in a 
slowing of the exchange kinetics generate antitumour activity. 
The structural features determining the kinetics of binding of a compound to 
DNA are not as well defined as those that determine if a compound binds by 
intercalation. As pointed out in the study, the attachment of cationic sidechains to an 
intercalating compound might increase residence time by providing additional 
electrostatic interactions between the compound and the DNA binding site, but the 
authors conclude that the effect also depends on the position, length and structure of 
the sidechain92 . 
The results of the current study appear to be in line with these findings. 
b) Electronic factors 
The lack of P388 activity for the 1-alkyl-~-carbolines cannot be on account of 
a decrease in flat area of the molecule, as in for example. replacing the vinyl 
substituent with an ethyl substituent, as the ~-carboline nucleus itself has enough flat 
area to bind by intercalation to DNA as was proven for norharman in the 1 H nmr 
study. Nor is it necessarily a result of the presence of a bulky alkyl group preventing 
intercalation by steric constraint. as methyl harman was also shown to bind by 
intercalation in the 1 H nmr study. yet it is not cytotoxic. It is more likely that the 
alkaloids lacking a vinyl sidechain still bind to DNA by intercalation but are in fast 
exchange, as was shown for compounds (58) and (119-121) in the study, and thus 
have no cytotoxic or antitumour properties. Changing the substituent at position 1 
from vinyl to alkyl had two effects, namely loss of conjugation and loss of planarity. 
As already stated, the loss of planarity would not be expected to affect intercalative 
binding in this case, so it would seem that the extension of conjugation in these 
compounds may be an important factor in determining activity. On this basis. 
1-phenyl-~-carboline might have been expected to exhibit similar cytotoxic and P388 
activity to the vinyl alkaloids, as there may be an extension of conjugation through the 
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phenyl ring. However, there is a steric constraint to the phenyl group being co-planar 
with the rest of the molecule94 which precludes this and accordingly 1-phenyl-~-
carboline is inactive in these assay systems. 
Another possible explanation as to why the 1-vinyl group is essential for 
antitumour/cytotoxic activity in the ~-carboline alkaloids, is on account of the reactivity 
it imparts to the alkaloids containing it. The 1-vinyl alkaloids are more susceptible to 
undergoing reaction with an electrophile as shown in Figure 3.2. 
Figure 3.2: Possible reaction of 1-vinyl-~-carboline alkaloids with an electrophile. 
This could conceivably occur during intercalation and may result in compounds with 
higher affinities for DNA and thus better antitumour/cytotoxic activity. It is noteworthy 
that for the antibiotic ravidomycin (122) a similar trend was observed, in that the vinyl 
group appeared to be necessary for antitumour activity. Replacing the vinyl group 
with an ethyl group significantly lowered the activity95. This was also the case for the 
related antibiotic, gilvocarcin V (123)96. Thus, for the antitumour and 
antiviral/cytotoxicity properties of these alkaloids, electronic effects would seem to be 
the most important factor. 
HO 
AcO 
CH3 0 
(122) 
HO 
o 
( 123) 
Trends in the antimicrobial and antifungal activities of the alkaloids are less 
evident, but they clearly do not fit this pattern. The observed trends vary depending 
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upon the organism tested against. However pavettine was generally the most active 
compound, except against E. coli where norharman was by far the most potent. 
Aromatic substitution resulted in decreased activity in almost all cases and replacing 
a vinyl group with an ethyl group generally decreased the activity. This finding is in 
agreement with that of a study of quasi-dimeric indole alkaloids which found that 
aromatic substitution decreased the antimicrobial/antifungal activity97. 1-Ethyl-8-
hydroxy-~-carboline (89), 1-ethyl-8-methoxy-~-carboline (91) and 1-ethyl-4-
methylsulphone-~-carboline (92) are therefore doubly deactivated with respect to 
pavettine and accordingly would be expected to have greatly reduced activity, as is 
indeed the case. 
For the 1-substituted alkaloids, activity dropped off dramatically between 
1-ethyl-p-carboline (56) and 1-propyl-~-carboline (113), although 1-isopropyl-~­
carboline (114) was at least as active as 1-ethyl-~-carboline. 1-Hexyl-p-carboline 
(115) might therefore have been expected to be very inactive and this was generally 
the case, but it exhibited reasonably strong activity against T. mentagrophytes and 
weak activity against C. resinae. 
As the p-carboline alkaloids are known DNA intercalators, it is not surprising 
that they generally exhibit good antimicrobial and antifungal activity. DNA in bacteria 
is present as a single chromosome which is often circular and laced through the 
plasma membrane98. The solitary chromosome is much more vulnerable than in 
higher organisms where DNA is membrane protected inside the cell nucleus98. Also, 
intercalating compounds are known to prefer circular DNA93 and in general, although 
bacterial DNA only constitutes 2-3% of the cell dry weight, it comprises approximately 
10% of the volume99, making it relatively accessible to potential reactant molecules. 
c) Solubility 
As shape and electronic effects would not seem to be the only determining 
factors in the observed antimicrobial/antifungal activities of the alkaloids; solubility. 
the third important factor in the study of structure-activity relationships may be of more 
significance here. Even if the solubility of a class of drugs is not the main factor 
responsible for their action, it still controls membrane penetration into cells. A 
favourable balance between lipophilic and hydrophilic properties may ensure that a 
drug reaches its site of action100. Bacteria generally have membranes which permit 
simple diffusion across them100• These membranes hinder the passage of ions and 
permit that of neutral molecules. Compounds with high oil/water partition coefficients 
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and thus high lipophilicity, diffuse the fastest. However. if the partition coefficient is 
too high, a compound may enter the membrane freely but be trapped there as its 
affinity is too great100• 
The standard method for measuring the partition coefficient of a compound 
uses octanol and water. The sUbstance is equilibrated between these two phases by 
rapid shaking, centrifuged to clear emulsions and the concentration of substance in 
each phase determined101 • The partition coefficient, P of a substance is defined as: 
P = [octanol] / [water] 
where [octanol] is the concentration of substance in the octanol layer and [water] is 
the concentration of substance in the water layer. Log P is the value usually quoted 
in the literature. 
Attempts were made to measure the partition coefficients of some of the 
~-carboline alkaloids by this shaking method, to see if any correlation between the 
partition coefficients and the observed antimicrobial/antifungal activities existed. The 
amount of compound in each phase was determined by uv spectroscopy. The limited 
supply of compounds available for use, combined with experimental difficulties meant 
that the measurements could not be accurately performed on most of the alkaloids. 
The major experimental difficulty was the low solubility of some of the alkaloids in one 
or both phases. For example, 1-phenyl-~-carboline was barely soluble in either 
phase and any compound that did dissolve formed an emulsion at the interface, 
which centrifugation and prolonged standing failed to clear. Also, when log P is 
greater than 4, the reliability of this method is a problem 1 00. It is possible to use a 
procedure defined by Hansch et al.1 01 to calculate partition coefficients of compounds 
in a series from that of a parent compound, using either the 1t values for a 
substituent101 or the fragmental constant, f102. The substituent constant, 1t, is derived 
from partition coefficient measurements of many compounds between octanol and 
water and is defined as : 1t = log P x- log PH. where P x is the partition coefficient of a 
derivative and PH is that of the parent compound. 1t Values do not take account of 
thermodynamic properties however, and thus 1tmethyl and 1Cmethylene for example, are 
assumed to be the same100• The hydrophobic fragmental constant. f, is similar to 1C, 
but attempts to overcome this error. The f values were calculated from published 
values of log P in octanollwater. For example fCH3 = log P toluene - fphenYl100. The 
partition coefficient of 1-propyl-~-carboline was able to be accurately measured by 
the rapid shaking method and log P was determined to be 2.50. This value was used 
60 
to calculate the partition coefficients for the homologous series of straight chain 
saturated 1-alkyl-~-carboline alkaloids, using both 1t values and f values for the 
sUbstituents (see Work Described in Chapter Three, p. 165). The results of these 
calculations are summarised in Table 3.7. 
Table 3.7: Calculated log P values for straight chain saturated 1-alkyl-~-carbollne 
alkaloids. 
log P calculated from: log P 
COMPOUND 1t values101 f values102 experimental 
(58) 1.00 0.52 2.26 ± 0.41 
(55) 1.50 1.18 2.33 ± 0.42 
(56) 2.00 1.84 2.57 ± 0.46 
(113) 2.50*± 0.23 2.50*± 0.23 2.50 ± 0.23 
(115) 4.00 4.48 not determined 
• value determined experimentally and used as the basis for calculations. 
From the results in Table 3.7, it is clear that the calculated values for log P 
differ somewhat, depending on the particular constants used, but the log P value 
increases with increasing chain length (Figure 3.3). 
10~----------------------------------~ 
D..1 
Cl 
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• 
a 
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log P (from f constants) 
log P (experimental) 
log P (from sub. constants) 
2 3 4 5 6 7 
alkyl chain length 
Figure 3.3: A plot of chain length in straight chain saturated 1-alkyl-~-carbollne 
alkaloids versus log P values (calculated and experimental). 
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However, this procedure cannot completely substitute for experimental 
measurements, as it assumes no group interactions take place102,103. This is 
evidenced by the fact that although no accurate values of log P were determined for 
the alkaloids, one-off experimental trials indicated that these log P values would fall 
between 2.0 and 3.0, a result inconsistent with that of calculation by either method. 
Alternative methods of assessing the relative solubilities were also 
investigated. The Rf values for the alkaloids on normal phase tic in two different 
solvent systems and the reverse phase hplc retention indices of the compounds were 
measured to see if any trends between these parameters and the observed 
antimicrobial/antifunga[ activities were evident. Both of these methods have been 
used by other workers to determine partition coefficients of compounds, where the 
rapid shaking method of measurement is impossible or impractical. Reverse phase 
tlc103-106 and hplc107-109 methods have been used. In the current study, normal 
phase tic and reverse phase hp[c were employed. It was concluded from the results 
of a previous study of the tIc properties of ~-carboline alkaloids 110, that 
chloroform/methanol (9:1) was a very good solvent system for these compounds. In 
the current work, ethyl acetate/acetone (1:1) had proven to be a useful solvent system 
for tic analysis of these alkaloids. Rf values for normal phase tic on silica gel were 
therefore determined for these two solvent systems. Reverse phase hplc retention 
indices for the alkaloids were determined using a PRP-1 column (analogous to C18) 
in methanol/water-TFA (3:1). Assuming that no absorption occurs, the Rf values and 
the hplc retention indices should be linearly related to the partition coefficient. The Rf 
values for the alkaloids and the hplc retention indices are summarised in Table 3.8. 
These values were determined from multiple measurements for each system. 
As can be seen from the data, the order of elution for some of the a[kaloids 
varies depending on the solvent system and type of chromatography employed. 
1-Ethyl-4-methylsu[phone-~-carboline (92) for example, has a retention time on hplc 
inconsistent with that expected from its Rf values on tic and with its observed place in 
the elution order of the natural product alkaloids on reverse phase flash column 
chromatography. This could indicate that the compound is being absorbed to the 
hplc column, or that it has unusual solubility properties, which might not be 
unexpected from its structure. Other compounds with somewhat varying elution 
orders between the systems are 1-methyl-1 ,2,3,4-tetrahydro-~-carboline-3-carboxylic 
acid (117), methyl 1-methyl-1 ,2,3,4-tetrahydro-~-carboline-3-carboxylate (118) and 
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1-hexyl-~-carboline (115). It is interesting to note that all of these compounds are 
relatively inactive. 
Table 3.8: Rf values and hplc retention indices for ~-carboline alkaloids. 
COMPOUND Rfa 
(58) 0.18 
{117} 0.20 
(55) 0.20 
(89) 0.31 
(56) 0.36 
(91) 0.37 
(118) 0.42 
(113) 0.43 
(82) 0.51 
(90) 0.51 
(57) 0.53 
(115) 0.53 
(92) 0.54 
(114) 0.54 
(88) 0.55 
(116) 0.58 
aEthyl acetate/acetone (1:1) on silica gel. 
bChloroform/methanol (9:1) on silica gel. 
Rfb Tc·To/Toc 
0.3 0.29 
0.27 0.61 
0.29 0.32 
0.23 0.43 
0.36 0.50 
0.34 0.65 
0.47 0.87 
0.40 0.71 
0.35 0.60 
0.37 0.62 
0.43 1.28 
0.47 0.78 
0.42 2.03 
0.44 0.80 
0.52 1.64 
0.56 1.94 
CMethanol/water-TFA (3:1). T c = retention time (seconds) for each alkaloid, 
To = retention time for a non-retained compound (methanol). 
The data for each of the systems was examined to see if any correlation 
existed between the partition coefficients for the alkaloids in these systems and the 
observed antimicrobial/antifungal activities. No general trend was observed between 
Rf or hplc retention index and activity for all the alkaloids taken as a series. This is 
perhaps not surprising, as if the alkaloids studied are simply ordered according to 
their partition coefficients, this represents the alteration of more than one feature of 
the structure at a time. 
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If the alkaloids were considered to be several smaller series however, some 
trends between partition coefficient and observed antimicrobial/antifungal activities 
were apparent. As previously stated, these trends were not always consistent for 
each organism tested against, but even so, some general trends could be inferred. 
For the series of straight chain saturated 1-alkyl-~-carboline alkaloids, an increase in 
Rf value or hplc retention index in the systems used (and thus an increase in partition 
coefficient) resulted in a decrease in antimicrobial/antifungal activity. A graph of the 
hplc retention indices of these alkaloids versus their minimum inhibitory 
concentrations against C. resinae in Ilg per disc (Figure 3.4) serves to illustate this 
trend. 
140~------------------------------------~ 
120 --a-- Cr MIC (alkyl series) 
100 
80 
60 
40 
20 
04-~--~--~~--~--~-r--~~--~--r-~ 
0.2 0.3 0.4 0.5 0.6 0.7 0.8 
Te-To/To 
Figure 3.4: Hplc retention indices versus MIC (1l9/disc) against C. resinae for 
straight chain saturated 1-alkyl-~-carboline alkaloids. 
For this series the activity did not increase until an optimum value was reached and 
then decline, but rather the lower members of the series generally exhibited the same 
or similar activities until a threshold was reached at 1-propyl-~-carboline, and then 
the activity dropped off dramatically. The activity of 1-hexyl-{3-carboline against T. 
mentagrophytes and C. resinae was an exception to this. The activity of 1-isopropyl-
~-carboline was of a similar level to that observed for the lower members of the 
straight chain series. Tic and hplc measurements indicated that this alkaloid should 
have a higher partition coefficient than 1-propyl-~-carboline, but experimental 
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measurements and calculation indicated that the partition coefficient is actuaHylower 
than that of 1-propyl-~-carboline, which is an interesting anomaly. 
If the 1-ethyl and 1-vinyl substituted alkaloids are considered as two separate 
series, it can be seen that for each, the optimum activity was reached at the 
unsubstituted compound. Activity declined with aromatic substitution, which resulted 
in an increase or decrease in partition coefficient. Examples of this parabolic 
relationship between solubility and antimicrobial activity have been previously 
reported 104. A typical example of this trend as it applies to the alkaloids here is 
shown in Figure 3.5. 
10~------------------------------------------------------------------------------------------------------------------------~ 
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Figure 3.5: Hplc retention index versus log MIC against C. albicans for the 1-ethyl 
and 1-vinyl ~-carboline alkaloid series. 
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Obviously aromatic substitution could affect other factors besides solubility, but in 
general, vinyl substituted alkaloids were at least as active as 1-ethyl-~-carboline and 
had higher partition coefficients, so solubility obviously plays some role in the 
antimicrobial/antifungal activities of these alkaloids. 
There is generally good correlation between the data obtained by the tic and 
hplc methods with that obtained by direct measurement of partition coefficients, 
indicating that these are indeed useful alternative methods of obtaining structure-
activity data. 
CONCLUDING REMARKS 
Some general conclusions can be drawn regarding the biological activity of 
the ~-carboline alkaloids, in light of the results obtained in the current study and those 
of other research workers. 
The mode of action of the ~-carboline alkaloids is DNA intercalation. The 
~-carboline nucleus contains the flat area of 38 A2, required for a compound to bind 
to DNA by intercalation and that intercalation is indeed the mode of binding of these 
alkaloids to DNA has been shown by a 1 H nmr spectroscopy study92. 
A vinyl group is necessary for good antitumour/cytotoxic activity of these 
alkaloids, either because of electronic effects or an increase in reactivity. The 
importance of the 1-vinyl group for antitumour/cytotoxic activity is most likely on 
account of the reactivity it imparts to the compounds containing it. If the activity was 
simply due to extended conjugation outside the ~-carboline nucleus, 1-phenyl-~­
carboline would be expected to exhibit good antitumour/cytotoxic activity and this is 
not the case. A terminal vinyl group is also essential for the antitumour/cytotoxic 
properties of the antibiotics ravidomycin95 and gilvocarcin V96. 
In the current study, the antimicrobial/antifungal activity of the straight chain 
saturated 1-alkyl-~-carboline alkaloids generally decreases with increasing chain 
length, Activities of the lower members of the series were of a similar level, but the 
activity declined sharply at 1-propyl-~-carboline. Results of a Japanese study of the 
antifungal activities of 1-alkyl-~-carbolines against Trichophyton interdigitale are in 
contrast to the current findings. Alkaloids with the 1-alkyl substituent varying from a 
hydrogen to a decyl chain were tested, along with some branched chain substituted 
alkaloids87, The study found that the branched chain alkaloids had the same MIC as 
the equivalent straight chain compounds, although this is clearly not the case here for 
1-propyl-p-carboline and 1-isopropyl-~-carboline, The study also found that harman, 
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1-ethyl-~-carboline and 1-propyl-~-carboline all had the same M IC and that this was 
twice as high as that of norharman. From that point down the series however, the 
longer the alkyl chain, the more active the alkaloid. For the Trichophyton species 
used at Canterbury, 1-propyl-~-carboline was considerably less active than 1-ethyl-~­
carboline and 1-hexyl-~-carboline had the same MIC as 1-ethyl-~-carboline. 
Aromatic subtitution of the ~-carboline alkaloids results in a decrease in 
antimicrobial/antifungal activity, as does replacing a vinyl with an ethyl group. This 
finding is in agreement with that of a study of quasi-dimeric alkaloids97. This previous 
study also tested the activity of harman against some of the same organisms used in 
the Canterbury Marine Chemistry group's assay system, namely B. subtilis, E. coli, P. 
aeruginosa and C. albicans and found it to be inactive against all of these organisms 
at the concentrations tested. In the current study however, harman exhibited good 
antimicrobial/antifungal activity and its antifungal properties have been reported 
elsewhere87.111, so clearly there is something inconsistent with the results of the 
study which found it to be inactive. 
Solubility is at least part of the reason for the observed 
antimicrobial/antifungal activities of these alkaloids. The results of the current study 
indicate that the antimicrobial/antifungal activity of the alkaloids is not entirely due to 
their solubility properties, but the observed results show some relationship between 
solubility and activity within the 1-alkyl-~-carboline, the 1-ethyl-~-carboline and the 
1-vinyl-~-carboline series. 
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CHAPTER FOUR 
4.1 BROMOPYRROLE COMPOUNDS FROM SPONGES 
~A REVIEW 
Over the past few years, a number of unusual bromopyrrole derivatives have 
been isolated from marine sponges. Many of the compounds were isolated almost 
simultaneously by different groups of workers and have been given different trivial 
names, rendering the literature somewhat confusing. Another point of confusion in 
the literature has been the taxonomy of the bromopyrrole-containing sponges. Figure 
4.1 shows the taxonomic relationships between sponges from which these 
compounds have been isolated. 
Subclass 
Tetractinomorpha 
Ceractinomorpha 
Class 
Demospongiae 
Order Family 
Axinellida Axinellidae 
Agelasidae 
Halichondrida Hymeniacidonidae 
Po eciloscle rida Myxillidae 
Genus 
Axinella 
Phakellia 
Acanthella 
Pseudaxinyssa 
Age/as 
Hymeniacidon 
Lissodendoryx 
Figure 4.1: Taxonomic relationships between bromopyrrole-containing sponges. 
Most of the compounds have been isolated from sponges of the order Axinellida and 
the majority of them from the family Agelasidae which contains only the genus 
Age/as. In their 1983 review on the chemotaxonomy of the Porifera, Bergquist and 
Wells state that all the species of Age/as examined to date have yielded 
bromopyrroles but that they are not widespread among the family Axinellidae112 . 
They also comment on the similar amino acid patterns in Age/as species and some 
Axinellidae. Some bromopyrrole compounds have been found in Hymeniacidon 
species and Bergquist and Wells note that some morphological characteristics of the 
Axinellidae parallel those of the Hymeniacidonidae and that there are some 
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similarities in sterol patterns such as the more unusual A-norstanols112• This raises 
the question of whether the isolation of bromopyrroles from two different orders is a 
case of mistaken identity or implies a closer relationship between the families 
Axinellidae and Hymeniacidonidae than their classification into the orders Axinellida 
and Halichondrida respectively imply. Considering the confusion which exists over 
these compounds, a chronological review of the isolation and chemistry of the 
bromopyrroles and related compounds is in order. Chevolot published a small 
review on oroidin and related compounds in 1981 113. This review encompasses the 
compounds discussed in Chevolot's review and includes other bromopyrrole 
compounds isolated since. 
The first report of the isolation of a bromopyrrole was from a Great Barrier 
Reef sponge, Phakel/ia f/abel/ata, (Axinellidae), when Sharma and Burkholder 
isolated dibromophakellin (124), and monobromophakellin (125), both with broad 
spectrum antimicrobial activity114. 115. Compound (124) was isolated as the 
enantiomer (-)-dibromophakellin and an X-ray crystal structure analysis of the 
monoacetate was obtained. 
H Br 
In 1971 Minale et al. reported the presence of 4,5-dibromo-pyrrole-2-
carboxylic acid (126), and its nitrile (127) and amide (128) in the sponge Agelas 
oroides116• The corresponding methyl ester (129) was also found but this was an 
artefact arising from the use of methanol in the isolation procedure. Refluxing of the 
nitrile, (127) under basic conditions, (20% KOH), yielded both (126) and (128) but 
only (126) after a longer period of time. They also found oroidin (130) and prepared 
the N-acetyl derivative and the dihydro equivalent of this, both of which on base 
hydrolysis yielded (126) and (128). Unfortunately their structural assignment was 
incorrect. The structure was later clarified by Garcia et al. who synthesised the 
dihydroacetate 117. Minale et al. subsequently found oroidin in two other species of 
Axinella : Axine/la verrucosa and Axinella damicornis 118, 
Sf 
·-n COH Sr~N'>- 2 
H 
Bf. (126) 
Br~Co.,CH3 
N 
H 
(129) 
Sr. 
7o-CN 
Br N 
H 
(127) 
Sf 
Sr 
Sr N 
H 
(128) 
o 
I/NH ~~.)-NH2 
N 
(130) 
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Chib et al. isolated the guanidine compound (131) from an unidentified 
species of Age/as and found it to have antimicrobial and antibiotic properties 119. 
Later they synthesised some thiophene and furan guanidine compounds, some of 
which showed moderate antimicrobial activity, but not to the same extent as that of a 
series of synthetic pyrrole derivatives120. 
Sr. ~~yNH' 
H 0 NH 
(131 ) 
The compound midpacamide (132), isolated by Scheuer et at. from an 
unidentified sponge from the Marshall Islands, differs slightly from others of its class 
in that it contains a 3-methylhydantoyl moiety. 1-Methyl-4,5-dibromopyrrole-2-
carboxylic acid (133), was also isolated from the sponge and synthesised as proof of 
structure. Base hydrolysis of midpacamide yielded (133)121. 
Sr. 
7o-C02H Sr N 
I 
CHa 
(133) 
In 1977 Sharma and Magdoff-Fairchild gave a much fuller account of the 
isolation and structural determination of (124) and (125) and suggested that the 
reason for their low basicity in comparison to other guanidines is on account of 
inhibition of resonance in the resulting cations, due to the twisted conformation of the 
imidazoline ring122. For guanidines, strong basicity is a result of resonance 
stabilisation of the guanidinium ion formed (Figure 4.2). 
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+ I 
,",N ... 
H"" .. 
Figure 4.2: Guanidine and the guanidinium cation, showing the resonance 
stabilisation of the cation. 
To achieve this, the three guanidine nitrogen atoms must be coplanar. In compounds 
(124) and (125) the nitrogens are not coplanar, as the imidazoline ring is twisted 
and if coplanarity were to be achieved, strong ring strain of the central six-membered 
ring would occur122. Oxidation of (124) with dilute nitric acid and treatment with 
dilute hydrochloric acid gave respectively compounds (134) and (135) which were 
prepared to substantiate this hypothesis 122. 
HN 2~H 
NO; ~:'N 
N 
(134 ) 
Br Br Br 
(135) 
Sharma et al. then outlined the partial structure of another compound from 
Phakellia flabellata123 and later published the full structure124. Like the phakellins 
(124) and (125). the compound occurs naturally as a hydrochloride, which on 
treatment with sodium carbonate yields the free base form, (136). The diacetyl 
derivative was prepared and oxidation of (136) with potassium permanganate 
yielded guanidine and the pyrrololactam (137), which was reduced to the alcohol 
with sodium borohydride124. 
o 
(136) 
o 
o 
(137) 
NH 
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Faulkner et al . isolated sceptrin (138), the monobromo dimer of oroidin, from 
Agelas sceptrum, along with oroidin itself. Sceptrin was found to be the major 
antimicrobial constituent of the sponge and an X-ray crystal structure of the 
compound was obtained125. Sceptrin could result from a head-to-head cycloaddition 
reaction of monobromo-oroidin and since this is an allowed photochemical reaction, 
a number of photodimerization reactions of oroidin were attempted, but all proved 
unsuccessful. 
Brh .H " ()-l~' 
N 0 H 
(138) 
In 1982 Buchi and Foley reported a biomimetic synthesis of (124). This was 
achieved by synthesis of dihydrooroidin from (+)-citrulline. followed by oxidative 
cyclization to give racemic dibromophakellin 126. 
In 1982 also, Cimino et al. reported the isolation of (139) from two marine 
sponges: Axinella verrucosa and Acanthel/a aurantiaca. This compound was found 
to be moderately cytotoxic in vitro but inactive in vivo against P388 leukaemia 
cells127. An X-ray crystal structure was obtained 128 and the diacetate derivative was 
prepared. The following year, Kitagawa et al. reported compounds (139) and (136) 
from Hymeniacidon aldis. (Hymeniacidonidae). naming (139) hymenialdisine and 
repeating the X-ray analysis 129. 
o 
Br 
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Keramidine (140), an antagonist of serotonergic receptors, was isolated 
from the Okinawan sponge Age/as sp. by Nakamura et al.in 198413°. This compound 
is similar to oroidin but is monobrominated in the three position of the pyrrole ring and 
N-methylated on one of the guanidine nitrogens. 
In 1984 Maksimov et al. isolated the pyrrololactam (137) from the 
Madagascan sponge Acanthella carteri. This compound had previously been 
prepared 122 but this was the first reported isolation from a natural source. 
Compounds (136) and (139) were also isolated, along with the unusual amino acid 
taurine (141) 131. The same group of workers isolated compound (137) from a 
Tanzanian Axinellid, along with compounds (136), (124), (139) and (126)132. 
Br 
(141 ) 
BrD-C02CH, N 
H 
(143) 
In the same year, Schmitz et al. reported the isolation of (137) which he 
called aldisin, and a monobromopyrrololactam (142) from Hymeniacidon aldis and 
also from an unidentified Fijian sponge. Compound (137) was also isolated from the 
Fijian sponge, and it is likely that compounds (137) and (142) are actually 
degradation products of compounds (136) and (139). 2-Bromoaldisin, (142) was 
isolated from a Sri Lankan Lissodendoryx species, (Myxillidae), Order-
Poecilosclerida, along with 5-bromo and 4,5-dibromopyrrole-1-carboxylic acid methyl 
esters (143) and (129)133. These were probably artefacts of work-up however as 
found by Minale 116, Clearly the taxonomy of the so-called Lissodendoryx species 
requires further investigation in light of what is known of the distribution of 
bromopyrroles among the Porifera. 
Br Br 
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In 1985 also, Ahond and Poupat isolated nine pyrrolic metabolites from the 
New Caledonian sponge Pseudaxinyssa cantharella, (Axinellidae)134. These 
included the new compounds dibromocantharelline (144) and odiline (145) and 
oroidin, hymenialdisine, compounds (137), (136), (142) and (+)-dibromophakellin, 
the enantiomer of (124). The structures of (144) and (+)-dibromophakellin were 
confirmed by X-ray analysis. The structure of the most polar metabolite (146), was 
not fully determined. Acetylation, debromination and hydrogenation reactions were 
carried out on some of these compounds. Dibromocantharelline underwent 
enolisation in basic media and was then methylated and acetylated to yield 
compounds (147-149). A large quantity of taurine was also isolated from the 
sponge. 
srKx H 
sr-~'N~N~R1Br 
H 0 (146) R2 
Sr 
R1 
(147) H 
(148) COCH3 
OCH3 (149) COCH3 
R2 
H 
H 
COCH3 
At around the same time, Faulkner also reported the isolation of (145) which 
he called stevensine, and sceptrin from an unidentified Micronesian sponge 135. 
The enantiomer of dibromocantharelline was isolated by Maksimov et at from 
Acanthella carteri in 1986 and an X-ray crystal structure analysis obtained. This was 
named dibromoisophakellin. Debromination occurred under catalytic hydrogenation 
conditions136. 
Sr. 
In ~~}-NH2 Sr ~N~ N 
H 0 (150) H 
Kobayashi et al isolated two more bromopyrroles from Hymeniacidon sp .• 
hymenidin (150). the monomer of sceptrin and an antagonist of serotonergic 
receptors 137 and hymenin (151) which was found to be both antibacterial and an 
a-adrenoceptor blocking agent138 . Hymenin is thought to arise from an 
intramolecular cyclization of oroidin. 
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In 1986 Ahond and Poupat reported a synthesis of oroidin by two different 
routes, both starting with 4(5)-hydroxymethylimidazole (152). Yields in both cases 
were very low139. 
(iCH20H 
N 
H 
OH 
N H2N--( /; 
HN CI 
(152) ( 153) 
Perhaps the most promising metabolite of this type in terms of biological 
activity which has been isolated thus far, is girolline (153), isolated from 
Pseudaxinyssa cantharella by Ahond and Poupat. This compound is active against 
P388 leukaemia cells, both in vitro and in vivo. The bromopyrrole group is absent 
and girolline contains an unusual chlorohydrin functionality140. Girolline could 
conceivably be formed in the sponge through hydrolysis of oroidin, followed by 
addition across the double bond to form the chlorohydrin. Again, girolline occurs 
naturally as a hydrochloride. A total synthesis of girolline has recently been 
achieved, using 4(5)-hydroxymethylimidazole (152) hydrochloride as the starting 
material, as for the synthesis of oroidin 141. The threo- isomer had the same activity 
and spectral characteristics as the natural product. 
Table 4.1 summarises the bromopyrrole compounds isolated to date, with the 
sources they were obtained from. 
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Table 4.1 Summary of Bromopyrrole Compounds. 
Structure Name Source Reference Comment 
{124} dibromophakellin Phakellia 114 H-dibromophakellin. 
flabel/ata 
115 
122 Low basicity reported. 
Oxidation and acid 
treatment. X-ray of 
monoacetate 
126 Biomimetic synthesis. 
Tanzanian 132 Isolation. 
Axinellid 
Pseudaxinyssa 134 (+ )-dibromophakellin. 
cantharel/a X-ray structure. 
{12S} monobromo- Phakellia 114 
phakellin flabel/ata 
115 
122 
{126} 4,5-dibromo- Age/as oroides 116 Isolation and as a 
pyrrole-2- reaction product. 
carboxylic acid 
Tanzanian 132 Isolation. 
Axinellid 
(127) 2-cyano-4,5- Age/as oroides 116 Isolation and 
dibromopyrrole hydrolysis 
(128) 2-amino-4,5- Age/as oro ides 116 Isolation and as a 
dibromopyrrole reaction product. 
(129) 4,5-dibromo- Age/as oro ides 116 Artefact of isolation. 
pyrrole-2- procedure. 
carboxylic acid 
methyl ester 
Lissodendoryx 133 
species 
(130) oroidin Age/as oroides 116 Isolation. Incorrect 
structure. 
Derivatisation. 
117 Correct structure. 
Synthesis of 
monoacetate. 
Axinella 118 Isolation. 
verrucosa 
Axinel/a 
damicornis 
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Table 4.1 continued 
Age/as 125 X-ray not reported. 
sceptrum 
Pseudaxinyssa 134 Isolation. 
cantharella Derivatisation. 
139 Synthesis. 
(131 ) Age/as sp. 119 Isolation. 
(132) midpacamide unidentified 121 Isolation and base 
sponge hydrolysis. 
(133) 1-methyl-4,5- unidentified 121 Isolation. Product of 
dibromopyrrole sponge hydrolysis of (132). 
-2-carboxylic acid 
(136) Phakellia 123 Partial structure. 
flabel/ata 
124 Full structure. 
Acetylation and 
oxidation. 
Hymeniacidon 129 Isolation. 
a/dis 
Acanthella 131 Isolation. 
carteri 
Tanzanian 132 Isolation. 
Axinellid 
unidentified 133 Isolation. 
sponge 
Pseudaxinyssa 134 Isolation. 
cantharella 
(137) 122 Oxidation product of 
(125). 
Acanthel/a 131 Isolation. 
carteri 
Tanzanian 132 Isolation. 
Axinellid 
aldisin Hymeniacidon 133 Isolation. 
a/dis and 
unidentified sponge 
Pseudaxinyssa 134 Isolation. 
cantharella 
(138) sceptrin Age/as 125 Isolation and X-ray 
sceptrum structure. 
un identified 135 Isolation. 
sponge 
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Table 4.1 continued. 
(139) Axinella 127 Isolation, X-ray and 
verrucosa acetylation. 
Acanthella 
a urantiaca 
hymeniald isine Hymeniacidon 129 Isolation and X-ray 
a/dis structure. 
Acanthella 131 Isolation. 
carteri 
Pseudaxinyssa 134 Isolation. 
cantharella 
(140) keramidine Age/as sp. 130 Isolation. 
(141 ) taurine Acanthella 131 Isolation. 
carteri 
Pseudaxinyssa 134 Isolation. 
cantharella 
(142) 2-bromoaldisin H. a/dis 133 Isolation. 
unidentified 
sponge 
Lissodendoryx 
species 
P. cantharella 134 Isolation. 
(143) 5-bromo- Lissodendoryx 133 Artefact. 
carboxylic acid species 
methyl ester 
(144) dibromo- P. cantharella 134 Isolation, X-ray 
cantharelline structure and reactions. 
dibromo- A. carteri 136 Isolation and X-ray 
isophakellin structure. 
Enantiomer of (145). 
(145) odiline P. cantharella 134 Isolation. 
stevensine unidentified 135 Isolation. 
sponge 
{146} P. cantharella 134 Structure not fully 
determined. 
(150) hymenidin Hymeniacidon 137 Isolation. 
species 
(151 ) hymenin Hymeniacidon 138 Isolation. 
species 
153) girolline P. cantharella 140 Isolation and 
derivatisati on. 
141 Synthesis. 
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4.2 STUDIES OF THE SPONGE AX/NELLA SP. 2 
INTRODUCTION 
A crude extract of the sponge, Axinella sp. 2 in the collection of the University 
of Canterbury Marine Chemistry group, exhibited strong cytotoxicity in the P388 
assay and strong antiviral activity in the antiviral/cytotoxicity assay. Preliminary work 
on an extract of this sponge by a member of the group, Dr. Nigel Perry, indicated that 
the compound responsible for this activity was probably girolline (153), previously 
isolated from the New Caledonian sponge, Pseudaxinyssa cantharella140• Dr. Perry 
also noted the presence of oroidin (130), taurine (141) and some ring-contracted 
norsterols in the sponge extract. 
Further work on the sponge was undertaken for several reasons. It was 
considered necessary to prove that girolline was the compound responsible for the 
observed biological activity, so isolation and purification of this compound had to be 
achieved. Also, if sufficient quantity of oroidin could be isolated from the sponge 
extract, it was hoped to carry out reactions of this compound as shown in Scheme 4.1 
to synthesise girolline and its structural and stereoisomers and to assay them for 
biological activity. 
Scheme 4.1: Proposed reaction scheme for the conversion of oroidin to girolline. 
Br 
N 
H 
Br ~C02H 
Br N 
H 
OH 
20 % KOH 
HOCI 
via chloramine T 
HO NH 
r ~H, 
N 
CI 
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The first of these objectives proved to be a difficult task in itself, due to the 
problems of separating small water soluble molecules from other similarly sized 
compounds and salts. However, a combination of reverse phase column 
chromatography and gel permeation chromatography led to the isolation of girolline 
as the antiviral and major cytotoxic component of the extract. 
In addition to girolline, the known compound hymenialdisine was isolated as 
a major cytotoxic sponge component and an X-ray crystal structure analysis 
performed. Several discrepancies between the experimental data obtained on 
hymenialdisine and the published data were noted. 
The quantity of oroidin in the sponge extract was not as great as first 
supposed and the poor solubility of this compound rendered It difficult to work with. A 
tic survey of all other sponge extracts of the family Axinellidae in the Marine 
Chemistry group's collection was undertaken, in an effort to find other sponges 
containing oroidin which could be extracted to gain sufficient compound for the 
proposed reaction chemistry to be performed. Unfortunately, oroidin was not 
detected in any other extracts. 
The sterol composition of Axinella sp. 2 was found to consist exclusively of 
A-norstanols, a feature characteristic of many Axinellidae sponges. 
ISOLATION OF GIROLUNE (153) 
Reverse phase flash column chromatography of the crude sponge extract, 
led to the antiviral activity being concentrated in the first three fractions from the 
column. These were combined and partially desalted by dissolving in 
methanol/water (4:1) and filtering. Gel permeation chromatography of the methanol 
soluble material led to the biological activity being retained. Subsequent elution with 
0.25 M acetic acid yielded crude girolline acetate which was converted to girolline 
hydrochloride by the addition of concentrated hydrochloric acid. The sample was 
again desalted by dissolving it in methanol and filtering. The methanol soluble 
material was subjected to reverse pllase hplc to yield a fraction, the 1 H nmr spectrum 
of which, contained only signals arising from girolline (153). Elemental analysis of 
this fraction revealed only 1.5% carbon, indicating the presence of a large amount of 
inorganic salts. Further gel permeation chromatography led to the isolation of 
girolline as an opaque oil, again pure by nmr analysis. Elemental analysis now 
revealed 10% carbon, which, with the theoretical value being 27.4%, indicated that 
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attempts to remove the inorganic salts had not been entirely successful. However, as 
this was not a new compound and had already been extensively studied by another 
group of researchers 140, 141 and the amount of material that would be obtained from 
further purification would not be sufficient to examine the reaction chemistry of 
girolline, efforts to remove the remaining inorganic material were discontinued. 
OH 
N 
H2N-( /; CI NH, 
HN (153) 
The 1 H nmr spectrum of girolline in 020 was consistent with the published 
data, as was the 13C nmr spectrum 140. The FAB mass spectrum showed ions at 367 
[M + matrix + NaJ+'and 331 [M + matrix + Na - HCI]+~ The ir spectrum of the isolated 
girolline contained O-H and N-H stretching bands at 3500 and 3310 cm-1 and a 
strong C-CI stretching band at 610 cm-1. The ORO curve of girolline was negative, 
confirming that the stereochemistry of the isolated compound is identical to that of the 
previously reported compound. The isolated girolline had an IC50 of 100 ngiml in the 
P388 assay and showed antiviral activity against both Polio and Herpes viruses at a 
dose age of 0.5 ~g per disc, with cytotoxicity type C7*. As the elemental analysis 
results would seem to indicate that the isolated girolline is only 33% pure by mass, 
the activity of the pure compound is probably much higher. The antiviral activity of 
girolline has not previously been reported. Girolline shows significant antitumour 
activity against both human and murine cell lines and is in Phase 1 of clinical 
study142. 
TAURINE (141) 
A fraction from the first gel permeation column of the water soluble partition of 
the extract was shown to contain a major component by 1 Hand 13C nmr 
spectroscopy in 020. On standing, a white precipitate settled out, the 1 Hand 13C nmr 
spectra of which were consistent with those reported for taurine143,144. 
(141 ) 
Q ~+ I 
N CO -I 2 
CHs 
(94 ) 
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HOMARINE (94) 
Fractions from the gel permeation columns of the water soluble material from 
the extract were analysed by 1 H nmr spectroscopy in D20. Homarine was identified 
in several fractions by comparison of the 13C nmr data with literature values78. 
ISOLATION OF HYMENIALDISINE (139) 
A later fraction from the initial chromatography column on the extract showed 
antimicrobial activity against Bacillus subtilis. Over time a pale yellow powder settled 
out of this fraction. Recrystallisation from methanol yielded a small quantity of good 
quality cubic crystals. A better yield was obtained by recrystallisation from aqueous 
methanol using trifluoroacetic acid fumes to aid dissolution and triethanolamine 
fumes to neutralise the solution, to give pale yellow needles. 
The crystals were insoluble in chloroform, but a 1 H nmr spectrum of a sub-
sample of these crystals was obtained in deuterated chloroform/trifluoroacetic acid 
(9:1). The spectrum (Table 4.2) contained two sharp two proton multiplets at 3.59 and 
3.61 ppm, a sharp one proton doublet (2.6 Hz) at 6.57 ppm and three broad singlets 
at 8.18,9.2 and 10.49 ppm, which each integrated as one proton. 
Table 4.2: 1 H nmr data for Hymenialdisine (139) 
POSITION CDCI3J'TFA DMSO-d6 DMSO-d6 
(9:1 ) + TFA or HCI 
1 10.49 br s 12.95 br s 13.0 br s 
3 6.57 d 6.71 s 6.60 d 
(2.6) (2.3) 
7 8.18 br s 8.19 br s 8.21 br s 
8 3.59 ma 3.37 br s 3.36 s 
9 3.61 ma 3.37 br s 3.36 s 
15 9.2 br s 8.8 br s 8.9 br s * 
14' not seen not seen 9.6 br s' 
aAssignments as per reference 133 
'Assignments in vertical columns may be interchanged. 
The 1 H nmr spectrum obtained in DMSO-d6 was less well defined, with a 
broad four proton singlet at 3.37 ppm, one proton singlets at 6.71, 8.19, and 12.95 
ppm and a very broad singlet at 8.8 ppm. The addition of a drop of trifluoroacetic acid 
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to the sample moved the signal at 6.71 ppm to 6.60 ppm and sharpened it to a 
doublet (2.3 Hz) and another broad singlet at 9.6 ppm was evident. A 13C nmr 
spectrum (Table 4.3) was obtained in this solvent system. Ten carbon resonances 
were evident, with that at 32.41 ppm being of low intensity. 
o 
Br 
Table 4.3: 13C nmr data for Hymenialdisine (139) 
CARBON DMSO-d6ffFA DMSO-d6/HCI DMSO-d6 
2 105.12 106.23 103.48 
3 1.11.24 112.05 115.36 
4 121.60" 122.29' 124.16' 
5 128.51 128.65 126.90* 
6 162.44 163.08* 162.60 
8 solvent obscured 39.39 solvent obscured 
9 32.41 32.89 29.42 
10 128.80 129.50 126.32 * 
11 121.22" 121.17* 124.10* 
12 163.44 163.41 * 171.65 
14 154.52 154.95 155.97 
* Assignments in vertical columns may be interchanged. 
A HETCOR nmr experiment showed only three correlations. The proton 
resonance at 6.60 ppm was correlated to a carbon resonance at 111.24 ppm and the 
proton resonance at 3.36 ppm showed correlations to the carbon resonance at 32.41 
ppm and the solvent peak. The latter correlation was at first assumed not to be real, 
but was later realised to be a true correlation to a carbon resonance, obscured by the 
solvent signal. 
At this stage, the literature was checked for other compounds isolated from 
the Axinellida. The data was most consistent with that published for hymenialdisine 
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(139), first isolated by Cimino et al. from Axinella verrucosa and Acanthella 
aurantiaca127 and later by Kitagawa et al. from Hymeniacidon a Idis 1 29 . The 
experimental nmr data however was not entirely consistent with that reported by 
either of these two groups of workers, with the most notable differences being for the 
imidazole ring. A negative ion DCI mass spectrum obtained using methane as 
reagent gas, clearly showed an appropriate isotope pattern for one bromine atom 
and established the molecular formula as Cll H lOBrNs02, with parent ions at 
325/323, as for hymenialdisine. The compound decomposed at 220°C (turning a 
deep red), while the reported melting point for hymenialdisine was 160-164°C 
(decomposition)129. Uv and ir spectroscopic data obtained were similar to reported 
values but not identical. 
A single crystal X-ray structure analysis was performed to attempt to clarify 
the discrepancies between published and observed data. The study established that 
the compound was indeed hymenialdisine. As for the two previously published X-ray 
crystal structure analyses of this compound 128,129, the structure was solved by the 
heavy atom method and a molecule of methanol was incorporated into the crystal 
lattice per molecule of hymenialdisine. No significant differences were observed 
between the X-ray data and that previously reported. Figure 4.3 shows the structure 
of hymenialdisine as determined by single crystal X-ray analysis. 
Figure 4.3: The X-ray crystal structure of hymenialdisine (139). 
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This did not explain the differences in nmr data or melting point. As the 
differences probably arose from the previously reported data being recorded for the 
free base and the experimental data for the protonated form, the sample from which 
the crystals for the X-ray analysis were selected was dissolved in DMSO-dS with a 
drop of TFA added and the 1 Hand 13C nmr spectra recorded. The spectra were 
identical to those obtained prior to the X-ray analysis and the crystals used in the 
X-ray study again decomposed at 215-220°C. The same sample was then flushed 
down a r.everse phase column to remove the DMSO and the 1 Hand 13C nmr spectra 
of the sample obtained in just DMSO-dS. The spectra were this time in accord with 
those reported by Cimin0127, although the assignments of CS and C14 were reversed 
(Table 4.3). The nmr data reported by Kitagawa was obtained in DMSO-dS with two 
drops of 2M hydrochloric acid added129. This experiment was repeated and the data 
did not agree with that of Kitagawa. Not surprisingly, it was consistent with that of the 
protonated form (Table 4.3). 
Table 4.4: HETCOR, XCORFE and HMBC correlations observed for hymenialdisine 
(139) in DMSO-dS/TFA. 
HETCOR 
HMBC 
H3 <-> C111.24 
H8, 9 <-> C32.41 
<-> solvent 
Hi 
OR 
<-> C121.22 
<-> C121.60 
XCORFE H3 
HS,9 
<-> C105.12 
<-> C121.60 
<-> C128.51 
<-> C121.22 
<-> C121.60 
<-> C128.80 
The 13C nmr spectrum of the protonated form (Table 4.3) was assigned with 
the aid of XCORFE and HMBC nmr experiments (Table 4.4) and by reference to 
published data for the protonated form of the debromo compound (136)124. An 
XCORFE nmr experiment showed correlations from HS, 9 to carbon signals at 121.22, 
121.S0 and 128.S0 ppm. The signal at S.SO ppm assigned to H3, showed 
correlations to carbon resonances at 121.S0 and 12S.51 ppm. The correlation to the 
resonance at 12S.51 ppm was a three bond correlation, no matter whether the 
resonance at 128.51 ppm arose from C5 or C10. If this resonance arose from C5 
however, correlations from HS, 9 to it would be over four bonds and no such 
correlations were observed. The observed correlation from HS, 9 was to the carbon 
signal resonating at 12S.S0 ppm and if this was assigned as C1 0, these correlations 
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would be over two and three bonds, which is more likely. The signal at 128.51 ppm 
was therefore assig ned as C5 and that at 128.80 ppm assigned as C 10. H3 showed 
a correlation by XCORFE to a carbon signal resonating at 121.60 ppm, which would 
be a two bond correlation if this signal was assigned as C4 and a four bond 
correlation if assigned as C11. An HMBC nmr experiment on hymenialdisine 
revealed one further correlation. The proton signal at 13.0 ppm assigned to H 1, 
showed a correlation to either the carbon resonance at 121.22 ppm or that at 121.60 
ppm, but it could not be determined to which. As it is probably more likely that the 
observed XCORFE correlation from H3 would be over two rather than four bonds, the 
signal at 121.22 ppm was assigned as C11 and that at 121.60 ppm as C4. These 
assignments however, could be interconverted (Table 4.3). The 13C nmr spectrum of 
hymenialdisine in DMSO-d6/HCI was assigned by analogy to that obtained in 
DMSO-d6/TFA, while that obtained in DMSO-d6 alone was assigned in a similar 
manner, and by reference to previously published assignments for hymenialdisine 
and compound (136)124,129,133. 
A situation similar to this is reported in the literature for the debrominated 
compound133. A large difference in melting point from previously published data was 
observed, so the free base of the compound was prepared and melting point, nmr 
and mass spectra obtained. It is interesting to note that in this case, "The nmr spectra 
were virtually the same as those obtained" for the protonated form 133. This was not 
so in the present case. Since discrepancies such as those discussed here can be 
confusing or misleading to other researchers, besides sometimes leading to 
inaccuracies in the literature, it is obviously important when dealing with compounds 
of this type to determine if one has a free base or a salt, and to carefully monitor and 
record the experimental conditions used when measuring the physical properties of 
such a compound. 
Cimino found hymenialdisine to be "moderately cytotoxic" in vitro127. In our 
assay systems, hymenialdisine was found to show cytotoxicity of type C11 in the 
antiviral/cytotoxicity assay and a 1 mm inhibitory zone against Bacillus subtilis at 200 
Ilg per disc in the antimicrobial assay. The ICso of hymenialdisine was determined to 
be 700 ng/ml in the P388 assay. 
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Or. Perry found that a 13C nmr spectrum in DMSO-d6 of fraction 5 from the 
initial ch romatography column of the extract revealed the presence of oroidin (130), 
the data corresponding well with literature values134. Dr. Perry was also able to 
assign the 1 H nmr spectrum in DMSO by comparison with that published for 
keramidine (140)130. Using a solvent system of ethyl acetate, acetone, formic acid 
and water, known to put oroidin at an Rf of approximately 0.7 134, Dr. Perry analysed 
the fractions from the column and detected oroidin as weak spots under ultraviolet 
light in fractions four to seven. A small sample of oroidin was purified and the 1 Hand 
13C nmr spectra obtained in DMSO-d6. The previous assignment was found to be in 
error, and the spectra were reassigned with the aid of difference decoupling and 
HETCOR nmr experiments. Dr. Perry ceased work on the extract at this stage. 
After a period of time, the column fractions were examined by 1 Hand 13C 
nmr spectroscopy in DMSO-d6, to check for the presence of oroidin. No signals 
characteristic of this compound were present and it was decided to re-extract the 
sponge. 
A further extraction of Axinella sp. 2 was carried out and reverse phase flash 
column chromatography performed as previously. Tic and nmr spectroscopic 
analysis showed fraction seven to contain oroidin. Isolation of oroidin was attempted 
by various combinations of medium pressure and high pressure liquid 
chromatography. This resulted in the isolation of only 3 mg of oroidin. 
Many problems were encountered in working with this compound. Its low 
solubility made separation from other components difficult, as rather than be eluted 
cleanly from a column, it tended to leach off slowly throughout the course of the 
isolation or adhere to the column. Various amounts of DMSO were added to samples 
in an attempt to overcome this problem, but the difficulty of removing this solvent from 
fractions for analysis presented a further problem. 
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Also, the quantity of oroidin present in the sponge extract was not as great as 
first supposed, so utilising it to synthesise girolline was no longer feasible. As 
Axinel/a sp. 2 is a very rare sponge, only known from the sponge garden at Goat 
Island, Leigh64, the acquisition of a large collection of sponge was also impractical. It 
was at this stage that it was decided to survey all other samples of the order 
Axinellida in the Marine Chemistry group's collection to try and find other Porifera 
species rich in oroidin. 
TLC SURVEY OFAXINELLIDA 
All other samples in the collection identified as belonging to the order 
Axinellida were screened by tic to check for the presence of oroidin. Where more 
than one extract of the same species existed, the sample most recently extracted was 
used. Crude methanol/toluene extracts which had been stored frozen, were spotted 
onto silica gel plates at very high loadings. The solvent system used previously was 
employed and samples of crude Axinel/a sp. 2 extract and pure hymenialdisine and 
oroidin were used as references. Plates were examined under ultraviolet light and by 
dipping in Sakaguchi reagent145. 
The samples surveyed and the initial biological assay results for each are 
summarised in Table 4.5. Of the thirty six extracts surveyed, twenty seven showed 
any detectable biological activity. Of these active extracts. only two exhibited any 
antimicrobial activity and this was against B. subtilis. Twenty three of the twenty 
seven active extracts showed some antiviral/cytotoxic activity and eleven extracts 
showed this type of activity only. A variety of cytotoxicity types was observed. Fifteen 
extracts exhibited some P388 activity and in ten of these, the activity was strong (3+ 
or 4+). Four extracts exhibited P388 activity only. The only extract with activity in all 
three assay systems was that of Axinella sp. 2, although those of Axinel/a sp. 3, 
Axinella sp., Pseudaxinella sp. 1, Raspai/ia agminata and Raspailia sp. 5 all showed 
strong activity in both the antiviral/cytotoxicity and P388 assay systems. No common 
spots were seen in the active extracts, except those of Raspailia sp. 5. Oroidin was 
not detected in any of the extracts, except that of Axinel/a sp. 2. 
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Table 4.5: Axinellida samples surveyed by thin later chromatography. 
HSV1 PV1 CYT. TYPE P388 AM 
Acanthoclada prostrata (84L02-30) NO NO 
Acanthoclada sp. (86K05-02) 2+ 2+ NO 
Axinella sp. A (86L01-04) ? ? 4+ C1 
Axinella sp. 1 (87PH01-02) 
Axinella sp. 2 (86L01-02) ? ? 4+ C1 4+ BS1 
Axinel/a sp. 3 (87MA02-17) 4+ ? + C7 4+ 
Axinella sp. 4 (83T417-06) ± ± ± NO NO 
Axinella tricalyciformis (87GS01-05) ? ? + C4 BS1 
Axinella sp. (87MA03-11 ) 1+ 
Axinella sp. (87MS02-02) ? ? 2+ C6 4+ 
Axinella sp. (87SI03-03) 
Eurypon sp. (85K02-15) ? ? 3+ C4 
Eurypon sp.1 (831129-27) ? ? 3+ C4 NO NO 
Flame Axinellid (87K12-02) ± C6 NO 
Flame Axinellid (87MS03-03) 3+ 
Homaxinella sp. 2 (87 ANT01-06) 
Homaxine/la sp. 3 (87 ANT04-02) 
Homaxinella sp. (85NP03-07) 3+ C2 NO NO 
Homaxinella sp. (87 ANTO 1-04) 1+ 
Pararhaphoxya pulchra (87SI02-03) 
Phakellia dendyi (86L01-05) ? ? 2+ C1 NO NO 
Phakellia sp. 1 (831130-38) ? ? ± C6 NO NO 
Pseudaxinella australis (87SI02-04) 
Pseudaxine/la sp. 1 (87SE02-05) ? ? 4+ C11 4+ 
Pseudaxinella sp. (85NP01-09) NO NO 
Raspailia agminata (87CR01-05) ? ? 4+ C11 4+ 
Raspailia topsenti (87CR01-07) ? ? 3+ C4 4+ NO 
Raspai/ia topsenti (87TP01-05) ? ? + C3 1+ 
Raspailia sp. 2 (87FR01-12) 
Raspai/ia sp. 2 (flat) (87S 101-17) ± C11 NO 
Raspai/ia sp. 3 (87SI02-05)) + C7 1+ 
Raspailia sp.5 (87MS03-13) ? ? 4+ C3 3+ 
Raspailia sp. 5 (87MS02-04) ? ? 4+ C11 4+ 
Raspailia sp. (87BG03-05) 3+ 
Raspailia sp. (87K11-05) ? ? 2+ C4 NO NO 
Raspailia sp. (87TS01-15) ? ? 2+ C3 1+ 
For an explanation of the assay systems used, see Section 1.2, p. 7. 
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A compound of identical Rf to hymenialdisine was detected in both extracts of 
Raspailia sp. 5. The biological assay results of both extracts were also consistent 
with the presence of this compound, with strong cytotoxicity of type C11 in the 
antiviral/cytotoxicity assay and strong P388 activity also. Unfortunately there was no 
more supply of sponge so it was decided to attempt to identify the compound 
definitively by using the screening method outlined in Chapter Seven of this thesis on 
sub-samples of the crude reference extracts. Samples were made up for assay in the 
three biological assay systems and small scale columns, employing C18 reverse 
phase and phenyl reverse phase materials and silica gel were run as outlined in 
Chapter Seven of this thesis. The results are summarised in Figure 7.11 of Chapter 
Seven, p. 144. These results are consistent with those expected for hymenialdisine, 
(see Chapter Seven), with the majority of the biological activity concentrated in the 
final fraction of each column. 
The fractions thought to contain hymenialdisine, namely fraction 3 from the 
C18 and phenyl reverse phase columns and fraction 4 from the silica column, were 
examined by 1 H nmr spectroscopy in CDCI3ITFA (9:1). No signals characteristic of 
hymenialdisine were observed. This could be due to the level of hymenialdisine 
being too low to be seen by nmr spectroscopy, but the P388 assay results indicate 
that if the biologically active component is hymenialdisine, resonances arising from it 
should be visible in the 1 H nmr spectra of the column fractions. Therefore it is likely 
that in spite of the similar biological activity, chromatographic profile and Rf on tic, the 
biologically active component of Raspailia sp. 5 is not hymenialdisine. A bulk 
extraction of sponge would have confirmed this but at the time of writing, no bulk 
extract was available. 
STEROLS 
Dr. Perry had examined the sterol composition of Axinella sp. 2 and found it 
to consist mainly of the ring-contracted A-norstanols. He identified the major sponge 
sterol as the fully saturated sterol, 3~-(hydroxymethyl)-A-nor-5a-cholestane (154) by 
13C nmr spectroscopy146. 
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(154 ) 
The sterol mixture from the second extraction of Axinella sp. 2 was isolated 
by column chromatography on silica gel. Both the 1 Hand 13C nmr spectra were 
consistent with (154) being the major sterol. Characteristic signals in the 1 H nmr 
spectrum in CDCIs were two one proton doublets of doublets at 3.46 ppm (10.3, 10.3 
Hz), and 3.71 ppm (10.3, 6.3 Hz) for the C4 protons146. 
The sterol mixture was sent to Professor Carl Djerassi for analysis by gcms. 
Results of this analysis are summarised in Table 4.6 and show that the entire sterol 
composition of the sponge consists of ring-contracted A norstanols. 
R 
1 
HOH2C ~ ~ ~ """" """" I I I b c a 
~ """" I 
(154) 1d 
(155) 1a 
(156) 1c 
(157) 1b 
(158) 1f 
(159) 1e 
(160) 1h 
(161) 19 
(162)11 
(163) 2d 
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Table 4.6: The sterol composition of Axine/la sp. 2. 
Percentage composition of the sterol mIxture 
Sterols Present of the Axinella sp. 2 sample. 
(155) 1 
(156) 2 
(157) 7 
(158) 2 
(159) 19 
(154) 32 
(160) 4 
(161 ) 15 
(162) 16 
(163) 2 
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CHAPTER FIVE 
5.1 STUDIES OF THE SPONGE, STYLOPUS AUSTRALIS 
INTRODUCTION 
As part of the investigation of extracts from New Zealand marine 
invertebrates, an extract from the sponge Stylopus australis (Hymedesmiidae) was 
examined. This extract was chosen as it showed biological activity and because a 
search of the literature revealed that no work had been carried out previ0usly on 
sponges of this family. It was therefore a possible potential source of novel 
metabolites. The investigation led to the isolation of the new steroidal sulphate, 
3PAP-dihydroxy-pregn-5-en-20-one-3-sulphate (164), a major component of the 
18 
19 o 
OH (164) 
extract. Although the occurrence of steroidal sulphates in a wide variety of 
echinoderms is well known147-150,190, their occurrence in sponges is less well 
documented. The first report of the isolation of a steroidal sulphate from a sponge 
was in 1981 when Fusetani et al. isolated 24~,25-dimethylcholestan-2p,3a,6a-triol-
2,3,6-trisulphate (halistanol sulphate) (165). as an antimicrobial constituent of the 
Okinawan sponge, Halichondria cf. moorei Bergquist151 . Hemolytic and icthyotoxic 
activities were also observed for sulphate (165). Two similar compounds. (166) and 
(167). were subsequently isolated from the sponges Halichondria sp. and 
Trachyopsis halichondrioides respectively by a group of Russian workers152-153,190. 
Three steroidal sulphates (168-170). were isolated from the sponge Toxadocia zumi 
by Faulkner et a~54, and these exhibited a range of biological activities, notably 
strong antimicrobial activity against Staphylococcus aureus and Bacillus subtilis. Of 
the steroidal sulphates isolated to date, those with structural features most similar to 
(164) are 3p.6a-dihydroxy-5a-pregn-9(11 )-en-20-one-3-sulphate (171). isolated 
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from the starfish Asterias amurensis147 and cholest-5-en-3a.4I3,21-triol-3-sulphate 
(172) isolated from the brittle star Ophiura sars/149. The isolation of (164) is the first 
report of a naturally occurring 313.4I3-dioxygenated 5-pregnene. 
R R 
(165) R = (166) R= 
..tVV' 
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( 167) 080a-
0 
(168) 
HO (169) 
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OH (172) 
ISOLATION AND STRUCTURE OF STEROL SULPHATE {164} 
Frozen Sty/opus australis sponge was extracted by blending with 
methanol/toluene and the resulting extract partitioned between ethyl acetate and 
water. Reverse phase column c~lromatography of the aqueous phase and 
subsequent silica gel column chromatography yielded the sterol sulphate (164). The 
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1 H nmr spectrum of (164) (Figure 5.1) revealed the presence of a double bond 
proton, two protons attached to oxygenated carbons and three methyl groups, while 
the 13C nmr spectrum was consistent with the presence of 21 carbon atoms, a single 
double bond, a ketone functionality and two other oxygenated carbons. These data 
were suggestive of a steroid nucleus and the structure of (164) was further 
elucidated from comparisons of its 13C nmr chemical shifts (Table 5.1), with those 
reported for compounds containing the 17p-acetyl function on the one hand, and the 
A5 3P.4P-diol system on the other hand81 . A Distortionless Enhancement by 
Polarisation Transfer (DEPT) nmr experiment was used to distinguish between 
signals of similar chemical shift but different multiplicity; C7 and C8 for example. 
The presence of a sulphate group was suggested by mass spectrometry. 
The negative ion liquid chromatography (Ic) mass spectrum exhibited a molecular ion 
species at m/z 411 [M-H]-, and fragment ions at 331 [M-HS03J- and 313 [M-H-
H2S04]-, The molecular formula for (164), C21 H3206S, was obtained from a high 
resolution fab mass spectrum. Strong ir absorption bands at 1215 and 1255 cm-1 
supported the presence of a sulphate ester148. 
The stereochemistry of sterol (164) was established as 3p,4P from a 
consideration of H-H coupling constants. Values of 11.1, 3.3 and 3.3 Hz for the H3 
coupling constants, corresponding to couplings to the 2P, 2a and 4a protons 
respectively155, implied that H3 was in an axial. and therefore a orientation. The 
observation of large nOe interactions between H4a and H6 and between H3a and 
H2a and H4a confirmed the stereochemical aSSignment. The assignment of the 1 H 
nmr spectra of steroids is not a trivial matter, on account of the complex envelope of 
overlapping signals between 1.2 and 2.2 ppm. The full assignment of the 1 H nmr 
spectrum of (164). (Table 5.2), was achieved with the aid of a COSY nmr experiment. 
selected nOe experiments, HETCOR and XCORFE experiments and comparison of 
the 1 H nmr data of (164) with that of other steroids assigned by a combination of the 
above techniques 156-158. 
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Figure 5.1: The 1 H nmr spectrum of compound (164) in CD30D. 
2.0 1.5 1.0 PPM 
c.o 
01 
96 
Table 5.1: 13C nmr spectral data for compounds (164). (173) and (174). 
COMPOUND 
CARBON (164)a (173)b (174)a 
1 38.98 38.68 39.03 
2 25.76 24.44 25.87 
3 81.64 77.37 81.68 
4 77.15 76.74 77.24 
5 143.84 141.67 143.82 
6 129.46 126.91 129.66 
7 33.45 31.57 33.58 
8 33.35 31.61 33.39 
9 51.99 50.06 52.34 
10 37.65 36.07 37.68 
11 21.98 21.75 21.73 
12 40.09 36.97 41.02 
13 45.42 43.95 43.79 
14 58.49 56.90 58.13 
15 24.03" 23.56 24.05 
16 24.10" 22.83 27.12 
17 64.94 63.60 59.63 
18 13.88 13.20 12.87 
19 21.73 20.51 21.79 
20 212.80 209.14 71.16 
21 31.98 31.86 24.12 
22 170.13 
23 20.56 
a Values in ppm for CD30D solution. 
b Values in ppm for CDCI3 solution . 
• Assignments in vertical columns may be interchanged. 
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Table 5.2: 1H nmr spectral data for compounds (164). (173) and (174). 
COMPOUND 
POSITION (164)a (173)b (174)a 
1 1.17 (x, 1.91 ~ 1.17 (x, 2.08 ~ 1.17 (x, 1.91 ~ 
2 1.79 (x, 2.07 ~ 1.69 (x, 2.08 ~ 1.79 (x, 2.07 ~ 
3 4.18 dt (11.1, 3.3, 3.3) 4.43 dt 4.18 dt 
4 4.38 d (3.3) 5.72 d (3.0) 4.38 d 
6 5.67 dd (5.3, 3.1) 5.81 dd (5.3,3.4) 5.67 
7 1.65 (x, 2.1 0 ~ 1.65 (x, 2.10 ~ 1 .65 (x, 2.1 0 ~ 
8 1.52 1.56 1.52 
9 0.98 0.92 0.94 
11 1 .59 (x, 1.4 7 ~ 1.59 (x, 1.47 ~ 1.59 (x, 1.47 ~ 
12 1.49 (x, 2.05 ~ 1.46 (x, 2.08 ~ 1 .49 (x, 2.05 ~ 
14 1.15 (3.0) 1.18 1.13 
15 1 .72 (x, 1.26 ~ 1.62 (x, 1.26 ~ 1.72 (x, 1.26 ~ 
16 1.66 (x, 2.14 ~ 1.66 (x, 2.07 ~ 1 .66 (x, 2.13 ~ 
17 2.64 t (9.0) 2.53 t 2.17 m 
18 0.62 0.62 0.77 
19 1.20 1.11 1.20 
20 3.61 m 
21 2.11 2.00 1.09 d (6.1) 
23 2.13 
a Values in ppm for CD30D solution. 
b Values in ppm for CDCI3 solution. 
o coupling constants in Hz. 
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A summary of the way in which the assignment was achieved is shown in 
Figure 5.2. There were several signals in the 1 H nmr spectrum of (164) which could 
be unequivocally assigned on the basis of chemical shift and coupling data. These 
signals were then used as points from which to build up the rest of the assignment. 
For example, a doublet of doublets in the 1 H nmr spectrum at 5.67 ppm, characteristic 
of a double bond proton of a ~5 steroid, was assigned to H6. Irradiation of this proton 
signal produced a significant nOe enhancement of a signal at 4.38 ppm which could 
be assigned to H4«. This signal in turn showed both a COSY correlation to, and nOe 
enhancement of the signal at 4.18 ppm, allowing assignment of this as H3«. COSY 
correlations from this proton to signals at 1.79 and 2.07 ppm established these as 
arising from the protons attached to C2. The observation of an nOe enhancement of 
the Signal at 1.79 ppm on irradiation of the H3« Signal determined that this resonance 
was from H2« and that therefore the 2.07 ppm Signal was due to H2~. 
In turn, the H2« Signal showed a COSY correlation to a Signal at 1 .17 ppm 
and a HETCOR correlation from the C1 resonance to a Signal at 1.91 ppm 
established that these two Signals were due to the C1 hydrogens. Tables from 
Schneider et al 157 were used to calculate the effects of various substituents on the 
chemical shifts of steroid C1 protons. Using the values given for a ~5 double bond 
and a 3~-OH, (assuming the effect of a 3~-S04 is similar), chemical shift values of 
1.11 ppm for H1« and 1.93 ppm for H1 ~ were calculated. Although no account could 
be made for the effect of the 4~-OH from these tables, the calculated shifts fit the 
observed values well, supporting the assignments. 
The H6 resonance also showed COSY correlations to signals at 1.65 and 
2.10 ppm, in addition to nOe enhancements. These Signals therefore must be from 
H7« and H7~. Calculated values suggested 1.61 ppm for the H7« signal and 1.99 
ppm for the H7~ signal157, which allowed assignment of the 1.65 ppm Signal as 
arising from H7« and the 2.10 ppm signal from H7~. Both these proton resonances 
showed COSY correlations to a signal at 1.52 ppm, establishing this signal as arising 
from H8, an assignment confirmed by a HETCOR correlation from the C8 resonance. 
The sequence could be extended further, as this proton resonance was also 
correlated by the COSY experiment to the signal at 1.15 ppm which was therefore 
assigned as H14. A HETCOR correlation from the C14 resonance, an XCORFE 
correlation from the C18 resonance and comparison with the chemical shift of the 
equivalent proton in progesterone 156 confirmed the assignment. 
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Figure 5.2: nmr correlation diagram for compound (164) 
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The H14 signal showed a COSY correlation to a signal at 1.72 ppm, which 
must therefore arise from a proton attached to C 15. This was in turn correlated to a 
signal at 1.26 ppm. In progesterone, the H15a signal was aSSigned as 1.72 ppm and 
the H15~ signal as 1.27 ppm156, so these assignments are appropriate here. 
A signal at 0.62 ppm is established as arising from the H18 protons from its 
chemical shift and a HETCOR correlation from the C18 resonance. This signal also 
shows an XCORFE correlation to the C17 resonance, which in turn shows a HETCOR 
correlation to a signal at 2.64 ppm, assigned to H17. 
The H 17 signal is correlated to signals at 1.66 and 2.14 ppm from the COSY 
spectrum, which also shows these signals are correlated to each other. They 
therefore arise from the protons attached at C16, and comparison with the equivalent 
proton signals in progesterone established the signal at 1.66 ppm as arising from 
H16a and that at 2.14 ppm as arising from H16~156. 
A one proton Signal at 0.98 ppm was established as arising from H9 from 
chemical shift data and the observation of a HETCOR correlation from the C9 
resonance. The H9 signal is coupled to signals at 1.59 and 1.47 ppm from a COSY 
spectrum which showed these were also coupled to each other. Comparison with 
progesterone data determined the 1.59 ppm signal to be from H11 a and the signal at 
1.4 7 ppm to be from H 11~. The H 11 a resonance is coupled to signals at 1.49 and 
2.05 ppm, also coupled to each other from a COSY spectrum. Again using 
progesterone as a model, the 1.49 ppm signal was assigned to H12a and that at 2.05 
ppm to H12~156. 
A H ETCOR correlation from the C 19 resonance to a signal at 1.20 ppm and 
chemical shift data, established this signal as arising from the H19 methyl protons, as 
did the observation of an XCORFE correlation to the C1 resonance. Chemical shift 
data and a HETCOR correlation again were used to assign the H21 methyl protons 
as the signal at 2.11 ppm, thus completing the assignment of the 1 H nmr spectrum. 
PREPARATION OF ACETATE (173) 
Confirmation of the structure was afforded by the acetylation of sterol (164) 
to give the mono-acetylated product (173). The 1 Hand 13C nmr spectra of the 
acetate (173) were consistent with the formation of a monoacetate at position 4. 
Changes in the 1 H nmr spectrum indicative of this were the downfield shifts of the 
signals for H3, H4 and H6. The H4 resonance exhibited the largest downfield shift, 
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from 4.38 to 5.72 ppm, while smaller shifts were observed for the H3 and H6 
resonances (Table 5.2). A new signal in the spectrum of acetate (173) at 2.13 ppm 
corresponded to the methyl protons of the acetyl group. In the 13C nmr spectrum, two 
new signals at 170.13 and 20.56 ppm evidenced the formation of the acetate, as did 
the upfield shift of the C3 signal from 81.64 to 77.37 ppm (Table 5.1). The Ic mass 
spectrum showed m/z 453 [M-H]- and 395 [M-C2H302]-' 
H 
OAc (173) OH (174) 
PREPARATION OF DIOl (174) 
The pure sterol sulphate was inactive in the antiviral/cytotoxicity, P388 and 
antimicrobial assay systems. Through preparation of a number of derivatives of the 
three biologically active sterol sulphates (168-170) from the sponge Toxadocia 
zumi, it was found that both the 313-slJlphate and the 19-carboxylic acid functionalities 
were required for antimicrobial activity154. Since (164) was inactive in the 
antimicrobial assay at 200 1l9/disc, it was decided to explore the effect on activity, if 
any, by introducing a more polar group elsewhere in the molecule. 
The 3/3.4/3,20/3-trihYdroxy-pregn-5-en-3-sulphate (174) was prepared by 
sodium borohydride reduction of sulphate (164) in ethanol. After preparative tic, the 
major reduction product (174) was isolated in good yield. 
The 1 Hand 13C nmr spectra of (174) were similar to those for sterol (164) 
with no changes in the signals in the spectra corresponding to the sulphate region of 
the molecule. In the 1 H nmr spectrum of (174), a new multiplet at 3.61 ppm 
corresponded to the C20 proton and an upfield shift of the H17 signal from a triplet at 
2.63 ppm to a multiplet at 2.17 ppm was observed. The 21-methyl singlet shifted 
upfield from 2.11 to 1.09 ppm and appeared as a doublet (6.1 Hz) due to coupling to 
the hydrogen introduced at C20. A slight shift in the H 18 methyl signal from 0.62 to 
0.77 ppm was apparent (Table 5.2). 
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The 13C nmr spectrum of (174) before preparative tic showed evidence for 
formation of both diastereoisomers, with major and minor signals in a ratio of 
approximately 6:1 for the carbons in the region of the molecule around C20. After 
preparative tic however, only the major diastereoisomer was detected. A new signal 
at 71.16 ppm confirmed the formation of the alcohol at C20, with a corresponding loss 
of the ketone signal at 212.80 ppm. Other changes in the spectrum were the C17 
resonance from 64.94 to 59.63 ppm, the C21 resonance from 31.98 to 24.12 ppm, the 
C18 resonance from 13.88 to 12.87 ppm and the C16 resonance from 24.10 to 27.12 
ppm (Table 5.1). 
The stereochemistry of sterol (174) was established as 20P on the following 
evidence. An earlier study of the reduction of 20-ketosteroids, both with sodium 
borohydride and lithium aluminium hydride, found that the major reduction product 
was the 20P epimer159. For reduction with sodium borohydride, the epimeric ratio of 
20P/20a. was 7.2:1 159, similar to the approximate 6:1 ratio found here. Further, 
although the spectra were obtained in different solvents, and in the current work only 
one epimer was isolated for comparison with literature data, the observed 1 H nmr 
chemical shifts of Hi8 and H21 for compound (174) were more consistent with those 
reported for 20p-hydroxysteroids than for the 200: epimers159-161. Thus, the 
stereochemistry of compound (174) was inferred to be 20p. 
The antimicrobial assay of diol (174) showed slight activity «1 mm zone) 
against B. subtilis at 200 119/disc, indicating that the presence of a polar group at C20 
only marginally improves the antimicrobial activity of (164). Possibly the mechanism 
of antimicrobial action of (168-170) involves a blocking action through the binding of 
the molecule to some substrate and with polar groups at C3 and Ci9, the molecule 
has the right geometry for efficient binding. 
HYDROLYSIS ATTEMPTS ON STEROL SULPHATE (164) 
All attempts to hydrolyse the sulphate (164) to the parent diol were 
unsuccessful, despite a wide variety of standard methods such as base hydrolysis in 
pyridine/dioxane and acid hydrolysis in acetic acid being attempted. Either no 
reaction occurred or complex mixtures of unidentifiable products resulted. Although 
the presence of a 8 5 double bond should enhance the rate of solvolysis under acidic 
conditions, the presence of a 4p-oxygen functionality retards the rate by a similar 
order of magnitude 162. If reaction does occur, the conditions required for hydrolysis 
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of the sulphate lead to elimination from the 4~ allylic alcohol, as found for 4~-hydroxy-
3~-p-tolylsulphonyloxyandrost-5-en-17 -one 162. Under basic conditions, a complex 
product mixture was formed, while if hydrolysis of the 20-alcohol (174) was 
attempted, reaction failed to occur. 
Reduction of sulphate (164) using lithium aluminium hydride gave a mixture 
of products which was not characterised. None of the products gave a positive 
sulphate test on tic with methylene blue dip 163, so it is possible that the products are 
similar to those formed in the anomalous reduction of 3~-p-tolylsulphonyloxycholest-
5-en-4~-0j164. A 1 H nmr spectrum of the reaction mixture in CDCI3 however, showed 
no recognisable signals. 
BIOLOGICAL ACTIVITY OF SPONGE 
The organic phase of the sponge extract showed strong antiviral activity 
against a BSC cell line at 100 J.l.9/disc. Partitioning of this phase by normal phase 
column chromatography on silica gel, led to the activity being concentrated in one 
fraction from this column. Further column chromatography on silica gel reduced the 
mass and spread the activity over four fractions, the most active of which only 
contained 1 mg of material. A comparison of the 1 H nmr spectra of these four 
fractions showed few similarities and indicated that each fraction was probably still a 
complex mixture. Pursuit of the activity was not continued, due to the extremely low 
level of the active component and limited supply of the sponge. A sample of crude 
sponge extract was screened by the procedure outlined in Chapter Seven of this 
thesis. For the results of this screening, refer to Chapter Seven, p. 144. 
GLYCERYL ETHER (CHIMYL ALCOHOL) (175) 
During the investigation of the active component of the extract, 5 mg of a 
yellow oil was isolated as one fraction from a silica gel column. A 1 H nmr spectrum in 
CDCI3 of this fraction showed signals at 3.46, 3.50, 3.71 and 3.86 ppm, indicative of 
those reported for glyceryl ethers165. The 13C nmr spectrum of this fraction confirmed 
this, with signals at 64.33, 70.41. 72.54 and 71.88 ppm for the backbone of the 
glyceryl ether165. This led to the assembly of the basic skeleton of the glyceryl ether 
(175) with the R group being an alkyl chain of unknown length. The length of the 
chain was determined by mass spectrometry. The CI mass spectrum obtained using 
N H3 as reagent gas, was consistent with the molecular formula C19H4003 and a 
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molecular weight of 316, showing ions at 334.1987 [MH + NH3]+ and 317.3051 [MH]+. 
This allowed assignment of the R group as C16H33. That the R group was an 
unbranched alkyl chain was determined from a DEPT nmr experiment, with the 
observation of only one methyl group signal in the 13C nmr spectrum. This confirmed 
that the oil was the known compound, 2,3-dihydroxy-1-hexadecyl-oxypropane or 
chimyl alcohol (175)165.90. 
TLC SURVEY OF HYMEDESMIIDAE 
All other samples in the Canterbury Marine Chemistry group's collection of 
the family Hymedesmiidae were screened by tic and 1 H nmr spectroscopy to check 
for the presence of sulphate (164). The samples surveyed were Sty/opus sp. 1, 
Sty/opus australis, Sty/opus sp., Hymedesmia sp. 1, Hymedesmia sp. 2 and three 
other samples identified as Hymedesmia sp. Sulphate (164) was found to be 
present in Sty/opus sp. 1 in addition to Sty/opus australis, but not in any 
Hymedesmia species, the only other genus in the family Hymedesmiidae, indicating 
perhaps that this compound is genus specific. 
STEROLS. 
Overall, the sterol sulphate (164) was found to be present in the sponge at a 
level comparable to that of the co-occurring sterols. It was desirable to investigate the 
sterol composition of Sty/opus australis to see if other pregnane sterols were present 
and to give an indication as to possible precursors to (164). A comparison of the 
sterol composition with that of sponges which did not contain sulphate (164), was 
also considered useful. The sterol mixtures of Sty/opus australis, Hymedesmia sp. 1 
and Hymedesmia sp. 2 were examined for this purpose. 
Sterol mixtures were isolated by silica gel column chromatography of 
chloroform extracts of the sponges. Analysis of the sterol mixtures was performed by 
gas-chromatography-mass spectrometry (gcms) of the trimethylsilyl (TMS) ethers of 
the sterols of each sponge. 
HO H ~ ~ VVV' I a 
~ ~ 
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(99) 1 9 
(100) 1f 
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(102) 1] 
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The range of sterols encountered in this study and their gcms properties are 
summarised in Table 5.3. Three different sterol nuclei and twelve different sidechains 
were observed. The sterols are listed in order of increasing retention time on the gc 
capillary column. An analysis of the relative retention times and the mass spectral 
fragmentation patterns of each sterol enabled the assignment of molecular size, ring 
stnJcture and position of double bonds166,167. For example, for sterols (97) and 
(176), the M+' ion at 456 indicated that the parent sterol had a molecular formula of 
C27H440. The base peak at m/e 111 was typical of a CSH15 sidechain with a 6 22 
double bond167. Prominent ions at m/e 129 and [M-129]+ are characteristic of a 
6 5 -3p-trimethylsilyloxysteroid and arise from the fragmentations shown in Figure 
5.316S. The two sterols were differentiated by comparison of the relative retention 
times with literatu re values 166,167. Side-chain epimeric sterols exhibit almost 
identical gcms data, so the relative configuration of the asymmetric centres of the side 
chain could not be determined166. 
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Figure 5.3: Typical mass spectral fragmentations of a A5-3~-trimethylsilyloxysteroid. 
R R 
-lor .+~ (CH3hSIO 
R m/e 129 
(CH3bSiO + [M-129t 
Table 5.3: GeMS Data of Sterol TMS Ethers 
Sterol M+' Relative Typical MS Fragments 166,167 
Structure Retention Time of TMS ethers. 
(cholesterol =1.000) 
(96) 442 0.870 313.255.129.97. 
(176) 456 0.960 351,255,327.129,111. 
(97) 456 0.970 351,255,327,129,111. 
(101 ) 458 1.000 353,329,247, 129. 
(104) 460 1.003 305.230,215. 
(177) 456 1.020 343,327,253,213,129. 
(100) 470 1.030 341,255.129,125. 
(178) 470 1.060 343,255, 129, 125. 
(99) 470 1.068 386,343,341,296,257, 
129. 
(105) 472 1.071 367,343,261, 129. 
(103) 484 1.090 484,355,351,255,139, 
129. 
(106) 486 1.130 381,357,275,129. 
. (1 02) 484 1.140 386,355,296,257,129. 
( 179) 498 1.190 386,296,369, 129. 
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Table 5.4 summarises the sterols present in each species, listing them as 
percentage composition. 
The same sterols are present in each of the two Hymedesmia species, but 
there are differences in sterol composition between Stylopus australis and the two 
Hymedesmia species. 
Table 5.4: The sterol composition of Hymedesmiidae sponges. 
Percentage Composition In Each Species 
Sterols 
Present Stylopus australis Hymedesmia sp. 1 Hymedesmia sp. 2 
(96) 2 5 6 
(176) 6 2 3 
(97) 10 7 11 
(101 ) 24 13 15 
(104) + 
(177) 13 6 
(100) 23 20 19 
(178) 2 
(99) 12 35 35 
(105) 3 
(103) 3 1 + 
(106) 12 3 2 
(102) 2 3 3 
(179) 1 
+ indicates a trace amount of a particular sterol, <1 %. 
Stylopus australis contains 13 sterols of which most contain nucleus 1. As 
for many sponges, the major sterol is cholesterol (101) with 24-methylene 
cholesterol (99) being the next most abundant. Minor quantities of both the 
completely saturated sterol, cholestanol (104), and a /17 sterol (178) were present. 
The sterol compositions of both the Hymedesmia species are very similar, 
with each possessing the same ten sterols. Relative quantities of each sterol differ 
between the two species but only for minor sterols. For each, 24-methylene 
cholesterol is the major sterol, followed by (100). Sterols in the two Hymedesmia 
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species are exclusively Ll5. Both contain relatively large quantities of desmosterol 
(177). which is not present in Stylopus australis. 
There is however. no major difference in the sterol composition of S. australis 
and the two Hymedesmia species which would give an indication as to precursors of 
(164) as hoped. It was thought that S. australis could contain other sterols with a 
pregnane sidechain which might be precursors to (164). but since this is not the case 
and as (164) is a major component of the sponge, it would seem that all SUCll sterols 
are converted to (164). In light of the lack of biological activity of (164). it seems 
unlikely that it is an anti-fouling agent as postulated for compounds of this type in 
other sponge species154. 
ACTIVITY OF (164) AS NEUROSTEROID. 
y-Aminobutyric acid (GABA) inhibits nerve transmission in the mammalian 
brain169 . Pregnenolone (180) and its sulphate ester (181) are thought to be 
synthesised locally in the mammalian brain where they have been characterised and 
are known to modulate contractions mediated by GABAA receptors in the isolated 
guinea-pig ileum170. As sulphate (164) only differs from pregnenolone sulphate in 
the presence of a 4P-hydroxyl group. a sample of (164) was sent to Professor 
Graham Johnston at the Department of Pharmacology. University of Sydney, 
Australia for testing in the isolated guinea-pig ileum assay. 
o o 
HO (180) - 0 380 (181 ) 
(164) was considerably less potent than pregnenolone sulphate in 
enhancing the action of GABA. Sulphate (164) enhanced GABA-induced 
contractions of the gUinea-pig isolated ileum by 10% at both 10-7 and 10-a M. Under 
the same conditions, pregnenolone sulphate has been found to enhance these 
contractions by 100% at 10-7 and 90% at 10-8 MHO. Thus the presence of a 4P-
hydroxyl group significantly reduces the activity of pregnenolone sulphate as a 
neurosteroid. 
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5.2 STUDIES OF THE SPONGE, HYMEDESMIA SPECIES 1 
INTRODUCTION 
There are only two genera in the sponge taxonomic family Hymedesmiidae: 
Sty/opus and Hymedesmia. An investigation of an extract of the sponge 
Hymedesmia sp. 1 was undertaken for much the same reasons as outlined for 
Sty/opus australis: the extract showed biological activity, and since no work on this 
genus had been reported in the literature, it was a potential source of new 
metabolites. In addition, any similarities in chemical composition between the genera 
Sty/opus and Hymedesmia could be examined. 
The investigation led to the isolation of N-(1-carboxyethyl)taurine (D-rhodoic 
acid) (182), as the major water soluble component of the extract. The ubiquitous 
marine metabolite homarine (94) was also isolated from the water soluble fraction of 
the extract, along with the amino acid taurine. 
Cl N CO2-I 
HaC, 
/"-... SOaH 
HOOC ~~ 
( 182) 
CHa 
(94 ) 
The biological activity of the extract was investigated, but pursuit of this was 
abandoned as the activity could not be well localised, despite the variety of 
chromatographic techniques attempted. 
The sterol composition of the extract was examined for comparative 
purposes, and the results of this study are outlined in Section 5.1. 
ISOLATION .OF D-RHODOIC ACID (182) 
The aqueous phase of a chloroform/water partition of a crude extract of 
Hymedesmia sp. 1 was further partitioned by reverse phase flash column 
chromatography. A 1 H nmr spectrum of the first fraction from this column showed the 
presence of several major components. 
Gel permeation chromatography followed by reverse phase hplc, led to the 
isolation of (182) as the major water soluble component of the extract. (182) gave a 
red-pink spot when treated with ninhydrin spray. The structure of (182) was 
determined as follows. The 1 H nmr spectrum of (182) in D20 (Figure 5.4) was very 
simple. A three proton doublet at 1.48-1.51 ppm was coupled to a one proton quartet 
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Figure 5.4: The 1 H nmr spectrum of compound (182) in D20. 
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(7.1 Hz), which depending on pH, was centred between 3.84-4.00 ppm. The only 
other signals in the 1 H nmr spectrum were two methylene triplets at 3.23 and 3.42 
ppm (6.8 Hz). The 13C nmr spectrum in D20 showed a quaternary signal at 173.16 
ppm, a tertiary signal at 57.25 ppm, two secondary signals at 47.40 and 42.34 ppm 
and a primary signal at 14.82 ppm. A HETCOR nmr experiment was used to 
determine that the methylene triplet at 3.23 ppm was attached to the carbon 
resonating at 47.40 ppm and that at 3.42 ppm, attached to the carbon signal at 42.34 
ppm. Results of an XCORFE nmr experiment showed that the methine group 
resonating at 3.78 ppm was long range coupled to the secondary carbon at 42.34 
ppm. This led to the proposal of the structural fragments shown in Figure 5.5. 
H1.48 H 3.84 H3.42 H3.23 
173.16 
H--C,4.B2 t.25 X--C42.34 C47.40~ ~-C-~ 
H H H o 
Figure 5.5: Structural fragments of rhodoic acid (182). 
The chemical shift of the methine proton suggested that it was attached to a 
nitrogen atom. Comparison of the data with the 1 Hand 13C nmr data of 
alanine 171,172 and N-methyl taurine 173 inferred the stucture (182). The molecular 
formula of CsH 10NOSS was confirmed by mass spectrometry. A negative ion 
Secondary Ion Mass Spectrometry (SIMS) mass spectrum of (182) using a matrix of 
triethanolamine showed an [M]- of 196 and other ions at 234 [M-3H+K]- and 218 [M-
2H+Na]-. 
The observation of strong bands in the ir spectrum of (182) at 1730 and 
1200 cm-1 evidenced the presence of carbonyl and sulphinic acid functionalities 
respectively, while the obseNation of a negative ORD curve confirmed the chirality as 
D-, through comparison with that obtained previously174. 
Previous 1 H nmr spectroscopy of (182) isolated from abalone muscle, used 
the solvent trifluoroacetic acid (TFA). In this solvent, the methylene protons were not 
resolved into two well defined triplets, but appeared as a broad four proton singlet at 
3.63 ppm174. 
Few reports of the isolation of rhodoic acid exist and its taxonomic 
distribution appears to be rather limited. The first report was in 1961 when it was 
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isolated by ion-exchange chromatography from three species of red algae, Chondrus 
ocellatus, Neodelsea yendoana and Iridaea cornucopiae. Permanganate oxidation 
of (182) yielded taurine, alanine and propionic acid175. Rhodoic acid, also known as 
tauropine, has since been found to have a very limited distribution among 
Rhodophyta and some species biosynthesise O-rhodoic acid, employing the enzyme 
rhodoic acid dehydrogenase to catalyze the reaction: 
taurine + pyruvate + NAOH ,.. O-rhodoic acid + NAO+ + H20176. 
The abalone Haliotis discus hannai was also found to biosynthesise O-rhodoic acid 
by the same mechanism 177. The enzyme responsible for the catalysis was isolated 
from muscle of ormers of the genus Haliotis by two groups of workers 178,179 and later 
from the pedicles of a brachiopod, Glottidea pyramidata. Taurine and pyruvate were 
shown to be the preferred substrates through kinetic studies 180. 
Experiments involving anoxia in two different muscular tissues of H. 
tamel/osa, showed that O-rhodoic acid was accumulated in the shell adductor 
muscle, used for lowering the shell for protection and righting the animal, while 
O-Iactate was the glycolysis product in the foot muscle 181. Thus O-rhodoic acid was 
the product of anaerobic metabolism in a specific muscle of the mollusk. 
The isolation of O-rhodoic acid from Hymedesmia sp. 1 would appear to be 
the first report of this compound from a sponge. Whether it is a product of anaerobic 
metabolism in the sponge is not known, but it was the major water soluble component 
of the extract. A 1 H nmr spectrum of the water soluble fraction of an extract of 
Hymedesmia sp. 2, clearly showed the presence of this component also. 
Rhodoic acid was inactive in the antiviral/cytotoxicity, P388 and antimicrobial 
assay systems. 
ISOLATION OF HOMARINE 
Fractions from the gel permeation chromatography column on the 
Hymedesmia sp. 1 water soluble partition, which eluted later than those containing 
rhodoic acid (182), contained mainly salt and one other major component. This 
component was identified as homarine (94) from its 13C nmr spectra in 02078. 
Although homarine is a common marine metabolite found in many organisms, 
including bryozoans79,80, tunicates182, and nudibranchs183, its isolation from Axinel/a 
sp. 2 (see Chapter Four) and Hymedesmia sp. 1 appear to be the first reports of its 
isolation from sponges. 
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ISOLATION OF TAURINE (141) 
Taurine was identified in one of the hplc fractions in the isolation of rhodoic 
acid, by comparison of the 1H and 13C nmr data with literature values143,144. Taurine 
also gave a pink spot on tic with ninhydrin spray. 
(141 ) 
BIOLOGICAL ACTIVITY OF SPONGE 
The crude extract of Hymedesmia sp. 1 showed cytotoxicity (type C4) in the 
antiviral/cytotoxicity assay. Various combinations of normal and reverse phase 
column chromatography and gel permeation chromatography were attempted on this 
material, but all resulted in the spread of activity throughout the column fractions. A 
1 H nmr spectrum of one of these active fractions in CD30D, was most uninformative, 
containing many broad unresolved signals. 
An extract of Hymedesmia species 1 was screened by the procedure 
outlined in Chapter Seven of this thesis, and the results of this work are also outlined 
in Chapter Seven, p. 145. 
As no suitable means of concentrating the biological activity could be found, 
and as no structural clues could be obtained from 1 H nmr spectroscopy of various 
fractions, work on the biological activity of the sponge was discontinued. 
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CHAPTER SIX 
6.1 STUDIES OF THE SPONGE HYMENIACIDON HAURAKI 
INTRODUCTION 
As part of the investigation of extracts from New Zealand marine 
invertebrates, an extract from the sponge, Hymeniacidon hauraki was examined. A 
literature search revealed that terpenoid isocyanides, some of which showed 
antimicrobial activity, had previously been reported from this genus 184. Furthermore, 
as a number of novel sesquiterpenes exhibiting cytotoxiC properties had been 
isolated from a sponge assigned to the genus Hymeniacidon79, there was the definite 
possibility that H. hauraki might contain similar compounds. However, the 
sesquiterpene-containing sponge has subsequently been renamed as a Eurypon 
. species64. 
The investigation led to the isolation of the new compound, (8Z, 11 Z, 14Z, 
17 Z )-3,6-epoxyeicos-3,5,8, 11,14, 17-hexenoiq acid {183}, a furan fatty acid, which 
was responsible for the biological activity of the extract. The instability of the 
compound prevented full characterisation being achieved at first. However full 
characterisation was eventually achieved by conversion of a sub-sample of the fatty 
acid to the methyl ester (184). 
(183) R = H 
(184) R = CH3 
5 4 
Saturated furan fatty acids of the general type (185) have been isolated 
previously from several marine organisms including soft corals185, ascidians186 and 
scallops186, but have been most commonly isolated from fish Iipids186,187. The 
unsaturated furanoid fatty acid isolated from H. hauraki presumably arises through 
oxidation of the corresponding straight chain C20 fatty acid. 
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In the course of the investigation, the 6 5,7 sterol, (22E)-stigmasta-5,7,22-
trien-3~-01 (corbisterol) (186) was isolated, along with its peroxide, 5a,8a-epidioxy-
24~-methylcholesta-6,22-dien-3~-01 (187). This led to an examination of infra-
specific sterol variation in H. hauraki, as the reported sterol composition of the 
species was quite different from that found in this work. 
HO 
(186) 
ISOLATION OF FURAN FATTY ACID (183) 
Frozen H. hauraki sponge was extracted by blending with methanol/toluene 
and the resulting extract partitioned between chloroform and water. The organic 
phase was subjected to normal phase column chromatography on silica gel to yield a 
fraction, the tic and 1H nmr spectrum in CDCI3 of which, revealed the presence of one 
major component. Further nmr spectroscopy, involving 13C nmr, COSY, DEPT, 
HETCOR and decoupling experiments, led to the proposal of a compound with a 
disubstituted furan ring, (183). 
The structure was proposed on the following evidence. The 1 H nmr 
spectrum of (183) (Figure 6.1) exhibited two mutually coupled one proton doublets at 
5.93 and 6.13 ppm (3.2 Hz). These chemical shifts and coupling constant were 
appropriate for the protons on a furan ring, disubstituted as in compound (183)188 
and each of these signals showed a HETCOR correlation to carbon signals at 105.99 
and 108.99 ppm respectively. The H4 doublet showed a COSY correlation to a 
broadened two proton singlet at 3.66 ppm (Figure 6.2) which in turn was correlated 
by a HETCOR experiment to a carbon signal at 33.80 ppm. That these signals arose 
from a methylene group was confirmed from tile results of a DEPT nmr experiment, 
and the singlet in the 1 H nmr spectrum was thus assigned as arising from the H2 
protons. 
The H5 signal was further split into a doublet of doublets and showed a 
COSY correlation to a doublet at 3.39 ppm, assigned to the H7 protons. These 
protons exhibited a HETCOR correlation to a resonance at 26.28 ppm in the 13C nmr 
spectrum and again a DEPT experiment verified the methylene grouping. 
-'--r--;-'---'--'l 
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Figure 6.1: The 1 H nmr spectrum of compound (183) in CDCI3_ 
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Figure 6.2: The COSY nmr spectrum of compound (183) in CDCI3. 
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Results of a COSY experiment revealed that the H7 protons were coupled to 
a two proton multiplet at 5.54 ppm, one of which was attached to a carbon resonating 
at 124.64 ppm. The multiplet at 5.54 ppm, assigned to H8 and H9 was coupled to a 
complex multiplet at 2.82 ppm, again from the results of a COSY experiment. The 
integral of the multiplet indicated that six protons gave rise to the signal. This 
multiplet was coupled to another multiplet at 5.37 ppm which also integrated as six 
protons. Further correlation from this signal to a two proton multiplet at 2.06 ppm and 
a correlation from this multiplet to a triplet at 0.96 ppm, established the connectivity 
throughout the left hand side of the molecule. 
The presence of a carboxylic acid functionality was suggested by the 
observation of a quaternary carbon signal in the 13C nmr spectrum of (183) at 174.84 
ppm and the observation of a strong band in the ir spectrum at 1710 cm-1, in addition 
to a broad band at 3420 cm-1. Other sharp bands .in the ir spectrum at 990, 790 and 
720 cm-1 were consistent with the strong 0 C-H out of plane bending bands, 
characteristic of a furan189. Since the H2 protons were not coupled to any protons on 
an adjacent carbon, the carboxylic acid grouping must be attached to C2 and the 
carbonyl carbon was thus assigned as C1. Hence the structure of (183) was 
assembled. The 1 Hand 13C nmr spectral data for compound (183) are summarised 
in Table 6.1. 
The stereochemistry of the double bond between C8 and C9 was determined 
to be Z from the magnitude of the coupling constant (7.3 Hz). The stereochemistry of 
the other double bonds in the chain could not be determined directly, due to lack of 
resolution in the 1 H nmr spectrum of (183). However, the 1 H nmr data of the alkyl 
chain of (183) fitted well with that of the alkyl chains of (6Z, 9Z, 12Z, 15Z, 182, 21 Z)-
2-tetracosa-6,9,12, 15, 18,21-hexaenylpenta-2,4-dien-4-0Iide (188) 190 and 
laurencenyne (189)191. 
o 
( 188) 
(189) 
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Table 6.1: Nmr spectroscopic data for compound (183) in CDCI3. 
POSITION o1H o 13C 
174.84 
2 3.66 s 33.80 
3 ( 154.12 
4 6.13 d (3.2) 108.99 
5 5.93 dd (3.2, 1.1) 105.99 
6 155.66 
7 3.39 d (6.3) 26.28 
8 5.54 m(6.3, 7.3) 130.07 
9 5.54m 124.64 
10 2.82 m 25.59 
11 5.37m 127.70" 
12 5.37 m 127.78" 
13 2.82 m 25.59 
14 5.37 m 128.57· 
15 5.37 m 128.47" 
16 2.82m 25.50 
17 5.37 m 126.97 
18 5.37 m 132.01 
19 2.06 m (7.0, 7.6) 20.52 
20 0.96 t (7.6) 14.14 
o coupling constants in Hz. 
*sequential values may be interchanged. 
1JCH correlations (HETCOR) H2 <-> C33.80 H4 <-> C108.99 
H5 <-> C10S.99 H7 <-> C26.28 
H8 <-> C130.07 H9 <-> C124.64 
H 10<-> C2S.S9 
H13 
H16 
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Comparison of the 13C nmr data of (183) with that of 9Z. 12Z, 15Z 
octadecatrienoic acid (linolenic acid) (190}192 and methyl 5Z. 8Z, 11Z. 14Z, 17Z-
eicosapentaenoate (191)192, facilitated the assignment of the double bond protons 
and confirmed the stereochemistry of each of them as Z-, as expected for a fatty acid 
derivative. The 13C nmr resonance for the methylene groups between the double 
bonds was at 25.59 ppm, whereas if the double bonds were E- the methylene group 
resonances would be expected to be at lower field as in 9E, 12E-octadecadienoic 
acid methyl ester (192), where the signal for the methylene group between the 
double bonds resonates at 35.70 ppm193. 
(190) 
(191 ) 
(192) 
Methylation of a sub-sample of (183) was attempted, using diazomethane in 
ether. Tic analysis of the reaction mixture versus starting material revealed two 
distinct spots at low Rf in the starting material and a similar two spots. but at much 
higher Rf in the reaction mixture. Analysis of starting material and reaction mixture by 
nmr spectroscopy could not be performed immediately due to an instrumental 
malfunction, so both samples were dried under nitrogen, wrapped to exclude light 
and stored frozen until such time as further analyses were possible. 
After a period of ten days, the 1 H nmr spectrum in CDCI3 of each sample was 
obtained. In the spectrum of the starting material, all the signals were present, but the 
signal to noise ratio was much worse than that of the original spectrum obtained. For 
the methylated sample there was a new singlet at 3.73 ppm, indicating that 
methylation had occurred, but the signal to noise ratio was worse than that In the 
spectrum of the starting material, and the H4 and H5 resonances of the furan ring had 
virtually disappeared. The tic evidence suggested that the compound had begun to 
undergo rearrangement or decomposition prior to methylation. It had been hoped to 
carry out nOe experiments to confirm the structural predictions made, but the entire 
sample decomposed before this could be achieved. 
Prior to the attempted methylation of the nearly pure compound, (183) was 
shown to have moderate cytotoxicity (2+) at 20 I1g per disc and weak cytotoxicity (±) 
at 5 I1g per disc of type C3 in the antivlraJ!cytotoxlclty assay. 
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RE-EXTRACTION OF SPONGE 
The decomposition of furans in light and air in the presence of a sensitiser is 
well known and has been the subject of many studies194-196. Singlet oxygen reacts 
with the furan ring to form a peroxide, which can then undergo further reaction to form 
a variety of products depending on reaction conditions 197.198 (Scheme 6.1). It was 
therefore decided to attempt to reisolate sufficient of the furan compound to complete 
characterisation, by using an extraction procedure designed to exclude light and 
oxygen as much as possible. 
Scheme 6.1: Reaction of 2,5-disubstituted furans with singlet oxygen195,196. 
R2-ZJ-R1 
o 
hv/sens .. 
O2 
A further sample of H. hauraki was extracted by blending with 
methanol/dichloromethane as previously, but the blender was flushed with nitrogen 
and an anti-oxidant, ~-carotene was added to the extract prior to blending, in an 
attempt to halt decomposition of the furan. The extract was partitioned by reverse 
phase flash column chromatography and care was taken to exclude light from the 
fractions. Fractions shown to contain the furan compound by tic and 1 H nmr analysis 
were recombined for further chromatography. As the compound could be lost 
through the carboxylic acid group causing irreversible absorption to silica gel, it was 
decided to use the less retentive DIOl phase instead. The fractions were therefore 
subjected to normal phase chromatography using DIOl as stationary phase. This led 
to the isolation of 1.5 mg of the desired compound, for further characterisation. 
Difficulty was encountered in obtaining a mass spectrum of the acid, so a small 
sample was converted to the methyl ester with diazo methane in ether. An EI mass 
spectrum of this material showed an M+' ion at 328.2033, as appropriate for a 
molecular formula of C21 H2803. 
The pure compounds were submitted for assay in the antiviral/cytotoxicity and 
P388 assay systems. This time, the acid (183) exhibited the cytotoxicity type C9 in 
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the antiviral/cytotoxicity assay while the methyl ester (184) was inactive. In the P388 
assay, compound (183) had an ICso of approximately 13400 ng/ml, while the methyl 
ester again was inactive, implying that the carboxylic acid functionality is required for 
this compound to exhibit any cytotoxicity. 
ISOLATION OF CORBISTEROL (186) AND ITS PEROXIDE (187) 
Frozen Hymeniacidon hauraki sponge was extracted by blending with 
methano,l/toluene, and the resulting extract further partitioned by reverse phase flash 
column chromatography. Tic and 1 H nmr spectroscopy of two fractions from this 
column revealed sterols to be present and we"-resolved peaks in the 1 H nmr spectra 
in the 2.0-2.5 and 5.0-5.4 ppm regions prompted further investigation. These two 
fractions were recombined and partitioned by column chromatography on silica gel. 
Information gained from 13C, DEPT and COSY nmr spectra of one of the subsequent 
fractions was used to ascertain that a ",,5,7 sterol had been isolated and comparison 
of 13C nmr data with literature values provided a good match for the sterol nucleus 197. 
The 1 H nmr spectral data indicated that the sidechain contained a single 
double bond in a trans configuration, with a doublet of doublets at 5.10 ppm (J = 15.3, 
8.2 Hz) 198. That both olefinic carbons had one attached proton each was 
established from the results of a DEPT nmr experiment. Comparison of the data with 
those of the ergosterol (193) nucleus 197 and of the sidechain of chondri"asterol 
(194)198,199 led to the structure being assigned as (22E)-stigmasta-5,7,22-trien-3p-ol 
(corbisterol) (186). 
HO ( 193) H (194 ) 
This assignment was confirmed by mass spectrometry. A high resolution CI 
mass spectrum of (186) using ammonia as reagent gas, showed an [MH]+ ion at 
411.3621, consistent with a molecular formula of C29H460. A DEI mass spectrum 
showed an [M]+ ion at 410 and fragment ions at 351 [M-C3H70]+ and 253 [C19H2S]+ 
(Scheme 6.2)200. 
Scheme 6.2: Some typical mass spectral fragmentations of !l5,7 sterols and 
peroxldes200. 
HO 
I allylic Cleava:e 
m/z 253 
HO 
m/z 251 
.CH2 
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The 1 H nmr spectral data of another column fraction suggested that the 
peroxide of corbisterol, 5a,8a-epidioxy-241;-methylcholesta-6,22-dien-3~-01 (187) 
was present, with characteristic doublets at 6.23 and 6.50 ppm (J ::: 8.5 Hz) arising 
from the H6 and H7 protons of (187)200, 
Again mass spectrometry confirmed this. A DCI mass spectrum obtained 
using ammonia as reagent gas, showed an ion at 460 [M+NH4+]+, while a DCI mass 
spectrum obtained using methane as reagent gas showed ions at 443 [MH]+, 425 
[MH-H20]+, 411 [MH-02]+, 377 [M-H20-02-CH3]+, 331 [MH-CsH16]+ and 303 [M-
C10H19]+. A DEI mass spectrum showed an ion at 410, [M]+ for (186), due to loss of 
oxygen from the molecular ion, probably by a retro-Diels Alder type fragmentation 
(Scheme 6.2)200. 
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(96) 18 (101) 1e (106) 1k (193) 41 (197) 1 n (201) 2k 
(97) 1 b (103) 1i (176) 1c (194) 31 (198) 2b (202) 3e 
(99) 19 (104) 2e (177) 1d (195) 1j (199) 2g (203) 3h 
(100) 11 (105) 1h (186) 4i (196) 1m (200) 2j 
INFRA-SPECIFIC STEROL VARIATION IN HYMENIACIDON HAURAKI 
The sterol composition of Hymeniacidon hauraki had been examined twice 
previously166.201 and no /:.5,7 sterols were reported. The taxonomic identification of 
the sample was rechecked and confirmed as H. hauraki. This sample was collected 
from Takatu Point. Another extraction of the same sponge, but a different sample, this 
time collected from Leigh Reef, was therefore undertaken to check the sterol 
composition. The extract was partitioned between chloroform and water and then 
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further partitioned by normal phase column chromatography on silica gel. This 
extract again showed no signs of the 1.15,7 sterols isolated previously. At this stage, 
the taxonomic identification of the two samples was again examined by two different 
taxonomists, one of whom was Professor Bergquist, and it was verified that both 
samples were the same species, H. hauraki. 
It was therefore desirable to analyse the sterol composition of each of the 
samples and to compare them with each other and with the previously reported data. 
Sterol mixtures were isolated by column chromatography on silica gel and the 
analyses were performed by gcms of the TMS ethers of the sterol mixtures of each 
sponge. 
The range of sterols encountered and their gcms properties are summarised 
in Table 6.2. 
Sterol 
Structure 
(96) 
(176) 
(97) 
unidentified 
(101 ) 
(104) 
(177) 
(100) 
(193) 
(99) 
(105) 
unidentified 
(103) 
47 
(186) 
(106) 
(195) 
Table 6.2: GeMS Data of H. hauraki Sterol TMS Ethers. 
M+' 
442 
456 
456 
454 
458 
460 
456 
470 
468 
470 
472 
482 
484 
484 
482 
486 
484 
Relative 
Retention Time 
(cholesterol =1.000) 
0.870 
0.960 
0.970 
0.990 
1.000 
1.003 
1.020 
1.030 
1.060 
1.070 
1.073 
1.090 
1.095 
1.110 
1.130 
1.140 
1.150 
Typical MS Fragments 
of TMS ethers166 
313,255,129,97. 
351,255,327,129,111. 
351,255,327,129,111. 
353,329,247,129. 
305,230,215. 
343,327,253,213,129. 
341,255,129,125. 
378,363,337,253,211, 
131,81,74. 
386,343,341,296,257, 
129. 
367,343,261,129. 
484,355,351,255,139, 
129. 
381,357,275, 129. 
386,355,296,257,129. 
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Table 6.3 summarises the sterols present in each sample and the 
percentage composition of each, as determined by gas chromatography. The same 
information reported for each of the two samples examined in the literature is also 
summarised in Table 6.3 for comparative purposes. 
Table 6.3: Percentage Composition of the Sterol Mixtures of H. hauraki samples. 
Percentage composition of sterol mixture 
Sterols Present of Hymenlaeldon haurakl sam pies 
Leigh Takatu Bergquist166 Bergquist201 
Reef Point et al., 1980 et al., 1986 
(193) 10 
(186) 24 
(96) + + 
(97) 5 4 4 2 
(176) + + 
(177) 4 
(101 ) 46 20 21 15 
(100) 9 6 5 
(99) 4 8 14 
(105) 4 8 9 
(103) 4 6 9 2 
(195) 3 
(106) 25 10 19 19 
(196) 8 
(197) 2 
(198) + 
(104 ) 2 + 5 3 
(199) + 
(200) + 
(201) 10 
(202) + 
(203) 6 
(194) 10 20 
+17 + 
+ unidentified + 
+ unidentified + 
+ (-C310) + 
+ unidentified C28 and C31 + 
+ denotes a trace amount, <1%. 
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As expected, the gcms data confirms the observation of markedly different 
sterol compositions of the two H. hauraki samples. 
The Leigh Reef sample of H. hauraki contained ten different sterols and had 
a sterol composition simi lar to that reported for the species by Bergquist et a~ 66,201 
with cholesterol (101) as the major sterol and (106) as the next most abundant. 
Bergquist reported a relatively high percentage of A? and ring-saturated sterols in her 
samples however, and in the sample studied no b) sterols were observed and the 
only saturated sterol present, (104) was a minor component of the mixture. This 
aside, the compositions are reasonably similar. 
The sterol composition of the sample from Takatu Point which contained 
corbisterol (186) was quite different from that of the Leigh Reef sample and the 
compositions reported in the literature. Here there were sixteen different sterols and 
significant amounts of /).5,7 sterols. Corbisterol was the major sterol of the sponge 
and ergosterol (193) was present as well. Other unidentified sterols present 
exhibited fragmentations in accord with those expected for /).5,7 sterols200 . 
Considerable quantities of cholesterol (101), 24-methylenecholesterol (99) and 
(106) were components of this sample as of the sample from Leigh Reef, and 
desmosterol (177) was present, in contrast to the Leigh Reef sample. 
In the same study where the sterol composition of H. hauraki was first 
reported, Bergquist compares her findings of the sterol compositions of some 
sponges with the results of other workers on the same sponge species but from very 
different geographical locations, and finds "that sterol pattern is species-specific and 
that feeding regime does not influence the components of the pattern within a 
species"166. In other words, marked infra-specific sterol composition of sponges is 
not expected and has not been widely observed. In her later study however, 
Bergquist stated that although a re-examination of the sterol composition of H. 
hauraki confirmed the previous finding of mainly /).5 and /).7 sterols, the second 
sample "showed considerable variation in the levels of individual sterols present. 
Seasonal variation cannot be ruled out as a cause for this inconsistency"201. 
So although levels of anyone sterol were somewhat variable, overall 
composition was relatively constant and no /).5,7 sterols were observed. 
Environmental differences were not thought to be a significant factor in sterol 
composition and it is interesting to note that one of the samples studied by Bergquist 
was collected from an almost identical location to the sample containing /).5,7 sterols. 
As corbisterol was the major sterol of the Takatu Point sample and not merely present 
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in a trace amount, contamination from other sponges is not a plausible explanation 
for its presence. It has been suggested that 1.1 5,7 sterols in sponges may be of 
symbiotic origin, as these sterols are known components of marine yeasts166. 
Verification of this would require examination of the sponge by electron microscopy, 
using special techniques to prepare the sample and this facility and the required 
expertise were not available. 
It has also been demonstrated by a series of double labelling experiments 
that sponges are capable of converting 1.15 sterols into 1.15,7 sterols. That this function 
is performed by the sponge itself and not by symbiotic algae or fungi was inferred 
from an examination of the sponge by electron microscopy202. Thus it is possible, 
since a "typical" H. hauraki sample contains predominantly 1.15 sterols, that these are 
sometimes converted to 1.15,7 sterols by the sponge. 
A number of samples of H. hauraki from a limited variety of geographical 
locations, consisting of several individuals per sample were available in the 
University of Canterbury Marine Chemistry group's collection. Each of these samples 
was separated into individuals by the group's taxonomist and the individuals were 
stored separately. A small scale chloroform extraction of each individual was 
performed and the 1 Hand 13C nmr spectra of the extract obtained to check for the 
presence of 1.15,7 sterols. In every case, signals characteristic of these sterols were 
noted in the nmr spectra of the extract (Figures 6.3 and 6A) and in some of the 
extracts the presence of peroxides was noted also, confirming that the isolation of 
1.15,7 sterols from the Takatu Point sample was not an exceptional case. 
For a detailed study of the infra-specific sterol variation in H. hauraki in the 
future, a carefully designed sampling programme would need to be carried out. 
Individual sponges from varying geographical locations and depths would need to be 
collected during different seasons to cover as wide a range of environmental 
conditions as possible. Care would have to be taken that each sample was indeed 
an individual and that no contamination occurred before examining each sample by 
electron microscopy, extracting it and examining the sterol composition by gcms. 
Such a study was beyond the facilities and expertise available, so at the time of 
writing, has not been carried out. 
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Figure 6.3: The 1H nmr spectrum of corbisterol (186) in CDCI3. 
Figure 6.4: The 13C nmr spectrum of corbisterol (186) in CDCI3. with characteristic 
signals indicated. 
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ORIGIN OF STEROL PEROXIDES. 
A number of theories have been advanced to explain the isolation of sterol 
peroxides from sponges. Djerassi et al. found several sponges to contain almost 
exclusively sterol peroxides and concluded that these were actual sponge 
components200, Later however, Djerassi et aL found that a re-examination of freshly 
Iyophilised samples of these sponges showed only the presence of 1::.5 ,7 sterols and 
no peroxides were detected202 . Therefore the isolation of sterol peroxides from 
sponges is most probably the result of oxidation of the conjugated diene system of 
sterols containing nucleus 4 during work-up or on storage. This is substantiated by 
the present study, in which 1::. 5 ,7 sterols only were detected in some samples 
investigated, and peroxides in addition to 1::.5,7 sterols, detected in others. 
A recent study, in which sterol peroxides were isolated from the Cnidarian 
Actinia equina, concluded that A. equina transforms dietary sterols into peroxides on 
the basis of a carbon-14 incorporation experiment203 . The sterols of the mussel 
Mytilus edulis, the chief prey of A. equina were examined and found to be exclusively 
1::..5 , but with an almost complete coincidence of sidechains with the peroxides isolated 
from A. equina. That these peroxides did not arise from the sterols of A. equina was 
concluded after an examination of the sterol composition of A. equina did not reveal 
the presence of most of the sidechains observed in the peroxides. 4-[14C]-cholesterol 
was injected into A. equina specimens and the sterol and peroxide fractions later 
isolated. Most of the 14C label was still present in the sterol fraction, but some 
radioactivity was detected in the peroxide fraction and the authors concluded that the 
in vivo transformation of sterols to peroxides was occurring. Contrary to the authors' 
statement, this in vivo transformation was not proven but only one possible 
explanation for the isolation of the sterol peroxides and not the most plausible, It is 
the opinion of this author that in light of the results of other workers202, it is more likely 
that A. equina converts dietary 1::..5 sterols to 1::.5 ,7 sterols and that the isolated 
peroxides arise through the oxidation of these sterols on work-up. Experiments 
involving injection of labelled 1::.. 5,7 sterols into A. equina should either prove or 
disprove this assertion. 
CHAPTER SEVEN 
7.1 "FINGERPRINTING" OF MARINE NATURAL PRODUCT 
EXTRACTS 
INTRODUCTION 
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During the course of searching for biologically active compounds from marine 
invertebrates, the Marine Chemistry Research group at the University of Canterbury 
has experienced problems that are common to all branches of natural products 
chemistry, viz the re-isolation of known compounds and therefore the duplication of 
effort between research groups, A case in point was the isolation of prianosin A 
(204) from the sponge Prianos me/an os by Kobayashi and co-workers204, This 
o o 
Br 
(204) (205) 
o 
(208) Br 
compound had previously been isolated by the Canterbury group as one of a series 
of biologically active compounds (204-208) from sponges of the genus 
Latrunculia 205-207, Another example is the isolation of the eudistomins (59-76) by 
Rinehart et al from the ascidian Eudistoma ofivaceum57 , Some compounds of this 
series (61), (63) and (209) which were antiviral, were subsequently isolated by the 
Canterbury group from the ascidian, Ritterella sigillinoides58, This problem has been 
encountered by most natural products research groups at some stage, and many 
other such examples exist. 
R1 
(61) OH 
(63) H 
(209) H 
~ 
R2 H3N 
Br 
Br 
H 
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The isolation and identification of a biologically active compound from a 
marine organism is an exercise that involves considerable time and effort. More often 
than not, the compound is present at a low level in the extract of an organism, and 
therefore many purification steps are required to obtain a pure compound. If the 
compound responsible for the biological activity of the organism has been isolated 
previously, the effort involved in the isolation duplicates the previous input. Although 
the isolation of known biologically active compounds from organisms not previously 
known to contain that class of metabolites is of value from a chemotaxonomic or 
ecological perspective, the major aim of this and some other groups is to isolate and 
identify new biologically active marine metabolites which might have potential as 
future pharmaceutical agents. This problem of duplication of effort can potentially 
hinder progress in the fight against cancers and other diseases, and does nothing to 
enhance the morale of the hapless researcher, who may have spent hours of 
painstaking work on the isolation of a known metabolite. It Is therefore desirable to 
identify known active components of an extract at as early a stage as possible, to 
minimise both effort and disappointment. We have coined the phrase "fingerprinting" 
to describe this overall process of dereplication of extracts. This overall process 
includes various phases, but undoubtably the most important is "chemical screening", 
the chemical equivalent of screening extracts for biological activity. This procedure, 
along with taxonomy, is critical in the dereplication process. A flow sheet, (Figure 7.1) 
describes the general approach our group takes towards the process of 
dereplication. 
Taxonomy is the starting point in this approach, as closely related organisms 
often contain similar components. If the taxonomic classification of an organism is 
known, this can be used to search the literature for related organisms, to give some 
idea of the types of compounds which may have been found In earlier extracts of the 
organism under consideration. In some cases however, the same compound has 
been found in organisms that are unrelated taxonomically, and chemical components 
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may vary even within a species, depending on such factors as habitat (diet) and 
season. Obtaining reliable taxonomic identifications of organisms is no simple 
matter, as marine invertebrate taxonomy is a complex field and even experts in the 
area do not always agree. Taxonomic relationships are therefore not a totally reliable 
guide in this type of work and should be treated with caution. 
I 
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Antiviral 
I 
Antitumour 
I I 
Actiyity? 
~es 
Antimicrobial 
I 
Physical properties 
I 
Polarity 
I I 
Ionic? Molecular weight range. 
Antifungal 
I 
Figure 7.1: The general approach to the dereplication of extracts taken by the 
Canterbury Marine Chemistry group. 
The question of which methods to employ in the isolation of the biologically 
active component of an extract presents further difficulties to the research worker. 
The biologically active component may be polar or non-polar, of high or low 
molecular weight, acidic or basic and the best method of approach to the isolation will 
vary with both the nature of the biologically active component and the nature of the 
other components of the extract in question. For example, if it is known that the 
compound responsible for the biological activity of the organism is non-polar, a good 
initial approach may be to partition the extract between water and a relatively 
non-polar solvent such as dichloromethane, thereby removing much mass quickly in 
the initial step of purification. 
In an effort to address the problems of dereplication, a chemical screening 
procedure has been developed. The aims of the procedure are to aid in the prompt 
identification of known biologically active compounds, and to give information on the 
properties of unknown active components of an extract. Based primarily on 
chromatographic behaviour, the procedure utilises a variety of small scale 
chromatographic separations on the crude extract, monitored by bioassay, to 
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generate an activity/chromatography profile for a given extract. Valuable information 
is obtained on the chromatographic properties of the active component, thus defining 
the best approach to its isolation. This profile can then be compared with those 
known for active marine metabolites and if a match is found, the presence, (or 
absence) of the known compound can be checked quickly. The value of this is 
amplified greatly if taken in conjunction with the marine literature and taxonomic data. 
The three assay methods outlined in Chapter One of this thesis were used in this 
work. 
THE SCREENING PROCEDURE 
In the screening procedure, taxonomy was used initially to identify the 
organism, providing one means of differentiation between extracts. A small scale 
extraction was then performed and sub-samples of the crude extract assayed for 
biological activity in antimicrobial, antiviral/cytotoxicity and P388 assay systems to 
furnish another means of extract differentiation. Stability of the biological activity was 
checked by reassay of the crude extract one week later. 
The extract was sub-divided for chromatography. Small scale column 
chromatography was carried out, using silica gel. C18 reverse phase and phenyl 
reverse phase material as stationary phases. and taking crude fractions of a standard 
volume and solvent composition. The crude extract was adsorbed on to a neutral 
solid support, celite, (diatomaceous earth), and dry loaded onto the columns. This 
approach facilitates handling of the extract, increases the surface area and avoids 
solubility problems or solvent effects. Fractions were assayed for activity and the 
results used to construct an activity/chromatography profile for each extract. 
Extracts for which the active components were known were used as 
standards. They were selected to represent a wide range of polarities of the active 
components. Standard organisms were seven sponges: Latrunculia brevis205 , 
Mycale sp. 1208 , Strongylacidon sp. 1209 , Ircinia novaezelandiae210 • Tedania 
diversirhaphidiophora211 , Axinella sp. 2 (see Chapter Four of this thesis), Petrosia 
hebes212, and an ascidian. Ritterella sigillinoides58. "Unknown" extracts were of two 
different types. The first type were extracts for which the identity of the extract and of 
the biologically active component were known, (but not by the experimentalist), while 
the second type were extracts which had been identified taxonomically, but the 
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source of the biological activity had not been determined. Extracts of this type studied 
were those of Raspai/ia sp. 5, Sty/opus australis, and Hymedesmia sp. 1. 
The results were collated as an activity/chromatography profile for each 
extract (Figures 7.2-7.13) as follows. For each crude extract, typical results in all 
three biological assay systems are shown. Antiviral/cytotoxicity results are expressed 
in the manner outlined in Chapter One of this thesis. Antimicrobial assay results are 
expressed in the form, E. coli score, B. subtilis score, P. aeruginosa score, C. 
albicans score and the weight of sample impregnated onto the disc in micrograms. 
Using the P388 assay data, the percentage activity in each fraction is calculated 
using the formula: % activity = alb x c/d x 100 
where a = mass of column fraction (mg). 
b = mass loaded onto column (mg). 
c = P388 assay result of crude extract (ng/ml). 
d = P388 assay result of column fraction (ng/ml). 
This method of expressing the results was adopted preferentially for the reasons of 
clarity of presentation, better quantitation of activity recovery and as it is the assay of 
choice in the Canterbury group for determining the potential of an extract for further 
work. 
The graphs are therefore compiled using the P388 assay data, except in the 
cases of Sty/opus australis and Hymedesmia sp. 1, where, as no P388 activity could 
be detected, the graph is compiled from the antiviral/cytotoxicity data in the following 
manner. Activity levels were expressed as a value representing the concentration of 
activity with respect to the crude extract. For example, if the minimum active dose of 
crude extract was 100 jlg per disc, and the minimum active dose of a certain fraction 
was 20 jlg per disc, the activity of this fraction was expressed as 5. This method 
shows the concentration of activity, and its loss in some cases, where the activity of a 
fraction was less than that of the same dose of the crude extract. For the Sty/opus 
australis extract, the crude extract exhibited no activity, so the activity was 
standardised against the most active fraction. 
DISCUSSION OF RESULTS 
The activity profiles of the standard extracts (Figures 7.2-7.13) correspond 
well to the expected chromatographic behaviour of the appropriate active 
compounds. Each different active component was clearly distinguishable by its 
activity profile and the two standard extracts containing the same active component 
had very similar profiles. 
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Figure 7.2: Activity/chromatography profile of Latrunculia brevis. 
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The compound responsible for tl1e biological activity of Latrunculia brevis is 
(204), one of a series of compounds found in Latrunculia species, all of which are 
biologically active. This compound has medium polarity, as its chromatographic 
behaviour shows, with activity concentrated in fractions 2 and 3 of C18 reverse phase 
and phenyl reverse phase columns, and the recovered activity in fraction 4 of the 
silica column. Recovery of the activity from silica is poor, partly as solvents used are 
not polar enough to elute all of this compound and partly as the compound adheres 
to silica gel. 
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The biologically active compounds in Mycale species I are the mycalamides, 
(210-211), compounds of mid-range polarity, but slightly less polar than (204). The 
chromatographic behaviour reflects this, with activity concentrated mainly in fraction 3 
of the G18 reverse phase column, 'fractions 2 and 3 of the phenyl reverse phase 
column and in fractions 3 and 4 of the silica column. These compounds are very 
potent with an IGso of 0.5 ng/ml for (210) and 0.1 ng/ml for (211). 
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Figure 7.4: Activity/chromatography profile of Strongylacidon sp. I. 
Strongylacidon species I contains the same active components as Mycale 
species I, but at a much lower level (- 1 %). The assay results for the crude extracts 
indicate this, with IGso values of 7576 and 160 ng/ml respectively. The activity profiles 
for the two extracts however are very similar, as would be hoped if the screening 
procedure is to be of use. This is a good example of the same compounds occurring 
in species which are not particularly closely related taxonomically. Both Mycale and 
Strongylacidon species are of the order Poecilosclerida, but the genus Mycale is a 
member of the Mycalidae family, while Strongylacidon is from the family 
Desmacidonidae. 
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Figure 7.5: Activity/chromatography profile of Ircinia novaezelandiae. 
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Variabilin (212), is the biologically active component of Ircinia 
novaezelandiae and is difficult to handle chromatographically, as it contains a 
non-polar tail but a polar head. This is reflected in the activity being in fractions 2 and 
3 of the silica column and fraction 3 of the C18 reverse phase and phenyl reverse 
phase columns. Recovery of activity from the phenyl reverse phase column is slightly 
worse than that from the C18 reverse phase column, as the aromatic reverse phase 
material retains variabilin better than C18 reverse phase material. In all cases, 
recovery of activity is poor. For the C18 reverse phase and phenyl reverse phase 
columns, this is mainly because the standard profile of solvents used was too polar to 
elute much variabilin from the column. For the silica column, low recovery is due to 
strong absorption of the tetronic acid group on to the silica. If variabilin is methylated, 
recovery from silica is greatly improved213. 
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Figure 7.6: Activity/chromatography profile of Ritterella sigilfinoides. 
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A series of compounds of similar polarity to (204), the eudistomins (61), (63) 
and (209), are the biologically active components of Ritterella sigillinoides. Although 
the type of antiviral/cytotoxic activity is the same as that exhibited by the mycalamides 
(210-211), the activity/chromatography profile is different from those of both Myca/e 
sp. I and Strongyfacidon sp. I. 
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Tedania diversirhaphidiophora contains a very potent compound, tedanolide 
(213), but at a very low level, with the crude extract showing little antiviral/cytotoxic 
and P388 activity. The ICso of the pure compound is reported as 16 pg/ml. This 
compound is quite non-polar as evidenced by its chromatographic behaviour, with 
biological activity concentrated in fraction 3 of each of the chromatography columns. 
OH 
(213) 
The screening method therefore provides a means to distinguish between 
the eudistomins, tedanolide and the mycalamides, although all give very similar 
results in the antiviral/cytotoxicity assay and have the same cytotoxicity type, C7*. 
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Figure 7.8: Activity/chromatography profile of Axine/la sp. 2 
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There are two active components in the sponge Axinella species 2, a very 
polar compound, girolline (153), and a more non-polar compound, hymenialdisine 
(139). The activity/chromatography profile for the extract reflects this, as do the assay 
results. This is the only standard extract for which activity is eluted in fraction 1 of the 
Ci8 reverse phase and phenyl reverse phase columns, emphasising the very polar 
nature of girolline. In the antiviral/cytotoxicity assay, girolline exhibits cytotoxicity type 
C7* while hymenialdisine typically exhibits cytotoxicity type C11. The assay results 
for the crude extract show this also, with C7* predominating at high concentrations 
and C11 with dilution. The reason for this is that there is much more hymenialdisine 
than girolline in the sponge but girolline is more potent. Assay results of column 
fractions show the two different cytotoxicity types also, with fraction 1 of the Ci8 
reverse phase and phenyl reverse phase columns showing C7* and fractions 2 and 3 
of the Ci8 reverse phase and fraction 2 of the phenyl reverse phase column showing 
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C11. Fraction 4 of the silica column shows C7* cytotoxicity, but recovery is low, as the 
solvents used are not polar enough to elute girolline. It would seem that 
hymenialdisine does not behave well on silica gel, indicating the unsuitability of silica 
gel column chromatography for this extract. Both girolline and hymenialdisine are 
active in the P388 assay, as indicated by every fraction of the reverse phase column 
showing activity in this assay. Giroliine (153) is much more potent than 
hymenialdisine (139) with IC50 values of approximately 100 and 700 ng/ml 
respectively. 
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Petrosia hebes contains a number of polyacetylene compounds of the type 
(214-217) found in Petrosia ficiformis214 , which are responsible for the biological 
activity of the extract. These compounds are quite non-polar, as their 
chromatographic behaviour shows. Activity is concentrated in fraction 3 of both C18 
reverse phase and phenyl reverse phase columns and mainly in fraction 3 of the 
silica column. These compounds are inactive in the antiviral/cytotoxicity assay 
system but quite strongly active in the P388 assay. 
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Figure 7.10: Activity/chromatography profile of "Unknown" extract. 
The unknown extract had an activity/chromatography profile (Figure 7.10) 
that was remarkably similar to that obtained for Mycale sp. I and Strongylacidon sp. I. 
The active compounds in these species are the mycalamides (210-211). This 
"chemical screening" result suggested that the active component(s) in the unknown 
species could possibly also be the mycalamides. Subsequently, closer taxonomic 
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examination of this species showed it to also be Mycale sp. I. thereby demonstrating 
the value of the screening procedure. 
Raspailia sp. 5 
100 
90 
80 
>- 70 
------, 
~ 60 
U 50 
< 40 
~ 30 
20 
10 
II Silica activity 
m Ci8 activity 
fill PRP activity 
o -+----.----...... 
2 3 
Column Fraction 
Antiviral/cytotoxicity assay: 
4 
P3SS assay (IC50) (ng/ml): ND 
Antimicrobial assay: 
Figure 7.11: Activity/chromatography profile of Raspai/ia sp. 5 
ww 
2+ 
C11 200 
C11 50 
200 
An extract of the sponge Raspai/ia sp. 5 was screened by the procedure. as 
the results of a survey of sponges of the order Axinellida indicated that it could 
contain hymenialdisine (See Chapter Four of this thesis). The biological assay 
results and the chromatographic behaviour of the biological activity are consistent 
with this possibility (Figure 7.11). although the recovery of activity from 
chromatography on Raspai/ia sp. 5 is much better than that from Axinella sp. 2 and 1 H 
nmr spectra of the active fractions did not contain any signals characteristic of 
hymenialdisine (139). 
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Figure 7.12: Activity/chromatography profile of Sty/opus australis 
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An extract of the sponge Stylopus australis was put through the screening 
procedure, and although the type of activity exhibited was similar to that of the 
mycalamides and the eudistomins, the chromatographic behaviour was distinctly 
different from that of these compounds (Figure 7.12), indicating that the active 
component is probably none of these. 
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Figure 7.13: Activity/chromatography profile of Hymedesmia sp.1. 
An extract of the sponge Hymedesmia sp. I was also screened to gain some 
knowledge of the chromatographic behaviour of the biological activity. The results 
indicated that the active component is of medium polarity, but the 
activity/cl1romatography profile is again different from that of any of the standard 
extracts (Figure 7.13). 
From the results, it is clear that the C18 reverse phase and phenyl reverse 
phase columns could well have had another fraction taken from them to extend the 
information they give on more non-polar compounds. Judging from experience of 
reverse phase chromatography on a larger scale, the fourth fraction could be either 
dichloromethane or methanol/dichloromethane (1:1). 
EXTENSION TO ION EXCHANGE CHROMATOGRAPHY OF STANDARD 
EXTRACTS 
The initial screening procedure has since been extended to cover the 
potential ion exchange properties of biologically active components in an extract. 
This ion exchange chromatography protocol has been developed by Dr. M. H. G. 
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Munro, for use in the National Cancer Institute's screening programme of natural 
product extracts. The procedure utilises both anion and cation exchange materials 
eluted with volatile buffers, to determine if the biologically active component of an 
extract is charged or neutral. 
Ammonium acetate (0.025 M) was used as an equilibrating solvent for both 
anion and cation exchange resins. With a pH of approximately 6.5, use of this buffer 
ensures that most potential anions such as carboxyl, sulphate and sulphonate groups 
will be fully ionized and most amines will be protonated. Phenols are a major 
exception to this, as they would not be fully ionized at this pH. As an elution solvent, 
0.5 M acetic acid was chosen for both anion and cation exchange resins. For anions, 
two types of interactions are possible. Weak anions may be protonated or the 
increased ionic strength of the 0.5 M acetic acid may elute anions from the resin. 
Similarly for cations, the increased ionic strength allows elution, and for a weak 
cation exhange resin, changing the pH removes the cation exchange properties to 
permit elution of cationic material. Sodium citrate (0.5 M) was chosen as an elution 
solvent for strong anions. As the citrate anion is selectively retained on the resin, it 
will displace all but very strongly retained anions such as sulphonate. 
Aqueous natural product extracts were dry coated onto celite as previously 
described, to facilitate the loading of material onto the top of the resin column. 
This procedure was utilised for the standard extracts in the current study with 
several modifications. As the extraction procedure used by the Marine Chemistry 
group at Canterbury at that stage did not involve obtaining both organic and aqueous 
extracts separately, solubility of the more lipophilic extracts in the buffers would be a 
problem. It was therefore decided to test only those extracts known to contain 
cationic or anionic biologically active compounds of an appropriate polarity in the 
system; namely those of Latrunculia brevis, Axinella sp. 2, and Ritterella sigillinoides. 
These extracts displayed significant biological activity in the first or second fractions 
from the C18 and phenyl reverse phase initial chromatography columns. For each 
extract, the most active fraction from these columns was used for the ion exchange 
chromatography, thereby preconcentrating the biological activity. Solvent systems 
used were the same as those outlined above, but the strong anion exchange resin 
SAX was used instead of DEA. Column fractions were assayed for biological activity 
in the antiviral/cytotoxicity assay system, as only the location of ,the biological activity 
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was required and not quantitative information. The results are summarised in Table 
7.1. 
Table 7.1: Results of ion-exchange chromatography on Axinel/a sp. 2, Ritterella 
sigillinoides and Latrunculia brevis. 
lon-exchange Fraction Species 
resin number 
Axinel/a 
sp.2 
Ritterella Latrunculia 
sigillinoides brevis 
SAX 1 * * 
2 * (slight) 
3 
SCX 1 
2 
* denotes that biological activity was detected in that fraction by the 
antiviral/cytotoxicity assay. 
- denotes no detectable biological activity. 
* 
The results for the standard extracts correspond well to the expected 
behaviour of the charged active components. Discorhabdin A (204), the eudistomins 
(61), (63) and (209), and girolline {153} all contain amine functionalities and would 
be expected to be retained on a cation exchange resin and to have no affinity for an 
anion exchange resin. This was indeed the case, with biological activity located in 
the first fraction from the anion exchange column for each extract, implying no affinity 
for the resin. No biological activity was recovered from the cation exchange column 
for each extract, implying that the active components of the extracts had a strong 
affinity for the resin. 
GEL PERMEATION CHROMATOGRAPHY 
The molecular weight or molecular weight range of the biologically active 
component of an extract is another very useful parameter in this type of work. Hplc 
gel permeation chromatography was attempted in an effort to obtain this information. 
The gel permeation column used was an hplc analytical column, packed with 
PL gel, a highly cross-linked divinylbenzene. The pore size of 50 A was the smallest 
available and it was hoped that it would be suitable for use with compounds in the 
molecular weight range of approximately one hundred to one thousand daltons. 
Acetonitrile was chosen as a universal elution solvent, as it enables uv detect,ion to 
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be carried out at low wavelengths and is a good solvent of medium range polarity, so 
most of the active components of the standard extracts should have been soluble in it. 
The test mixture of toluene in acetonitrile was injected onto the column and 
gave a well shaped peak of reproducible elution volume when monitored by uv 
detection. Calibration of the column was then attempted using compounds of varying 
molecular weights: namely polyethylene glycol, napthalene and toluene. Napthalene 
gave spurious results, probably on account of having a high affinity for the gel used, 
so mycalamide A (210) was substituted and a calibration curve (Figure 7.14) 
constructed to determine the column volume. 
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Figure 7.14: Calibration CUNe for PL gel column in acetonitrile. 
Gel permeation chromatography was attempted, both on some pure active 
compounds and on some column fractions from the initial screening of the standard 
active extracts. Samples tested were mycalamide A (210), discorhabdin C (206), 
the TFA salt of ritterellin I (61), variabilin (212) and active column fractions from the 
initial chromatography columns on Mycale sp. I, Latrunculia brevis, Ircinia 
novaezelandiae, Tedania diversirhaphidiophora, Strongylacidon sp. I and Petrosia 
hebes. 
For each run, eight fractions were collected across a total of three column 
volumes of solvent. These fractions covered the molecular weight range of > 1000 to 
100 assuming that no absorption was taking place on the column. The fractions were 
initially submitted for P388 assay at constant volume in acetonitrile, but solvent 
blanks proved this to be too cytotoxic, so fractions were dried down and submitted for 
assay in methanol instead. 
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The results for both the pure compounds and the column fractions are 
summarised in Table 7.2. 
Table 7.2: Results of gel permeation chromatography in acetonitrile for pure 
compounds and partially purified crude extracts. 
Fractions 
MW>1000 MW 500 MW<100 
1 2 3 4 5 6 7 8 
Pure Compounds (MW) 
mycalamide A (503) * ., 
discorhabdin G (464) ., 
ritterellin I TFA salt (356) 
variabilin (398) 
Semi-crude extracts 
T. diversirhaphidiophora (640) ., ., 
Strongylacidon sp. (503) ., 
Mycale sp. I (503) ., ., ., 
Petrosia hebes (668) * 
Latrunculia brevis (427) ., 
I. novaezelandiae (398) ., * ., * ., * * ., 
., denotes that activity was detected in that fraction. 
For mycalamide A (210). biological activity was concentrated in fraction 4 
with an IGso of 854 ng/ml, although some biological activity was detected in fraction 3 
(4915 ng/ml). This activity coincided with the weak uv peak detected at 200 nm and 
was in the same region in which the mycalamide A in the standard sample was 
eluted. 
When a sample of red discorhabdin G (206) was injected onto the column. 
no peak was detected at the "-max of 260 nm and no colour was visible in the column 
effluent, indicating that the compound did not come off the column. When a sample 
was then injected onto the column using acetonitrile to which 0.5% glacial acetic acid 
by volume had been added, uv detection indicated that the compound was now 
eluting from the column and at approximately the same retention time as observed for 
mycalamide A. 
A sample of ritlerellin I TFA salt however. did not elute from the column. either 
with acetonitrile, or when glacial acetic acid was added. 
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Variabilin was the other pure compound tested and it appeared to be eluting 
from the column. but gave a surprisingly weak response by uv detection. 
The results for the column fractions of extracts were less encouraging. When 
a column fraction of the Tedania diversirhaphidiophora extract was injected onto the 
column, most of the biological activity was concentrated in the first fraction collected 
(518 ng/ml). with some activity in fraction 2. a result that was not consistent with the 
molecular weight of the active component, tedanolide. 
For a sample of semi-purified Strongylacidon extract, the biological activity 
was detected in fraction 3 from the gel permeation column (2441 ng/ml), not in 
fraction 4 as would be expected from the results obtained on pure mycalamide A. For 
a Mycale sp. I sample, most of the activity was concentrated in fraction 4 from the 
column (141 ng/ml) with some detected in the fractions on either side, fractions 3 and 
5 with IG50 values of 1339 and 5167 ng/ml respectively. 
Biological activity was detected in fraction 3 for a Petrosia hebes sample, 
with an IG50 of 4915 ng/ml. This is a greater elution volume than expected as the 
estimated molecular weights of the active compounds are 666 and 668. 
The Latrunculia brevis sample was run with acetic acid in the acetonitrile 
and weak activity was detected in fraction 5 from the column, with an IG50 of 10938 
ng/ml. 
When a sample of Ircinia novaezelandiae was injected onto the column, 
traces of biological activity were detected by the antiviral/cytotoxicity assay 
throughout the column fractions. However, large uv absorption peaks were detected 
for up to fifty minutes after injection of the sample, showing that the compounds in the 
extract are strongly retained by the gel. 
A plot of the logarithm of the molecular weight of the active compounds 
versus their actual elution volume, is shown in Figure 7.15. As this graph shows, the 
correspondence between molecular weight and elution volume is rather poor, with 
some compounds leaching off the column over a wide volume range. 
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Figure 7.15: Results of gel permeation chromatography in acetonitrile for pure 
compounds and partially purified extracts. . 
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It was then decided to attempt calibration of the column in methanol, as the 
fractions could be submitted directly for assay without being dried down, and the 
possibility existed when using acetonitrile that traces of solvent were interfering with 
the assays in some cases. It was thought best to calibrate the column with a number 
of compounds of varying molecular weights but with strong uv chromophores. 
Compounds chosen were toluene (molecular weight (MW) =92), napthalene 
(MW=128), 1,4-dibromonapthalene (MW=288), bromotl1ymol purple (MW=394), 
bromocresol purple (MW=540), bromocresol green (MW=698) and disulphine blue 
(MW=1158). For each compound, the wavelength at which maximum absorption of 
uv light occurred was determined by running an uv absorption spectrum and uv 
detection was then at the appropriate wavelength for each compound injected 
separately onto the column. The difference in retention time on the column between 
bromocresol green, bromocresol purple and bromothymol purple was less than 0.5 
minute. Disulphine blue had a longer retention time than these three compounds, 
though it is of higher molecular weight. This is possibly a consequence of it being a 
charged compound. 
Toluene in methanol had a longer retention time on the column than in 
acetonitrlie, yet other compounds appeared to have shorter retention times than 
would have been expected in acetonitrile, according to their molecular weight. 
Neither napthalene nor 1,4-dibromonapthalene seemed to elute from the 
column at all, supporting the observation that the gel must have high affinity for 
aromatics of this kind. 
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In light of the above results, use of the PL gel column for screening extracts 
was abandoned. The main problems with the use of this column were its high affinity 
for some aromatic compounds, its lack of clear differentiation of molecular weights 
between one hundred and one thousand and its intolerance to water in the solvent 
system, thus precluding the screening of some compounds on the grounds of 
solubility. 
If gel permeation is to be used in the screening of extracts in future, some 
modifications would be appropriate. The amount of material that can be loaded onto 
a gel permeation column is much lower than that which can be loaded onto a reverse 
phase or normal phase chromatography column, with a loading ratio of only one to 
one thousand. Thus sensitivity may be a problem when dealing with crude extract. 
Also, the use of one universal solvent is not particularly convenient. as there will 
always be compounds at either end of the polarity scale not soluble in a solvent of 
medium polarity and those of low solubility which may require a special solvent 
system. Therefore, for both solubility and sensitivity reasons, it would seem to be 
more convenient to use an active column fraction from the initial chromatography 
columns run on an extract for gel permeation attempts, rather than crude extract. In 
this way, the activity is preconcentrated to enhance its detection in the fractions 
collected and the polarity of the active component is known. With this information, a 
column of gel permeation material such as Fractogel PGM 2000 for example, can be 
made up in the solvent most suitable to the polarity of the active component and 
calibrated with known compounds. Fractions could be assayed for biological activity 
in the usual way. 
Thus it is recommended that both gel permeation and ion exchange 
chromatography be used as a secondary screen only as appropriate, after the initial 
screening by reverse phase and normal phase chromatography of the crude extract. 
MODIFICATIONS OF THE SCREENING PROCEDURE 
A modification of the procedure used in these initial studies, is now used 
routinely by members of the Canterbury Marine Chemistry group to assess the 
suitability of an extract for further large scale work and to determine the probability of 
whether the compound(s) under study are known or are novel structures. This now 
involves the use of commercially available cartridges of chromatographic stationary 
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phases and solvent systems similar to those described above, to assist in the 
selection of extracts for research. 
As the procedure has been used by the Canterbury group, it has undergone 
further modifications through constant critical evaluation of the information gained 
from the results. The procedure could obviously be adapted according to the 
requirements of any research group, depending on such factors as whether organic 
and aqueous extractions are performed separately and the range of chromatographic 
stationary phases and biological assays available. The most recent version of the 
procedure, developed by Dr. Murray Munro, involves obtaining both aqueous and 
organic extracts separately. 
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EXPERIMENTAL 
GENERAL EXPERIMENTAL PROCEDURES 
Melting pOints were obtained using an Electrothermal melting point 
apparatus and were uncorrected. Optical rotations were measured for methanol 
solutions using a Jasco J-20c automatic recording spectropolarimeter. Fab mass 
spectra were obtained on a VG7070F spectrometer, EIfCI mass spectra were 
obtained on a Kratos MS80RFA mass spectrometer, while Icms data were obtained 
from a Finnigan TSP46 spectrometer equipped with a thermospray source. SIMS 
mass spectra were obtained on a Hitachi M-80B double focusing mass spectrometer 
equipped with a primary ion (Xe) source. Gcms was performed on a Hewlett Packard 
HP-Ultra 2 capillary column, cross-linked 5% phenyl methyl silicone (50 m x 0.32 mm 
x 0.52 llm), using a Hewlett Packard 571 OA gas chromatograph linked to a Hitachi M-
80B mass spectrometer equipped with a M-0101 data system. Samples were run 
under a temperature programme from 200-310°C at 1 ° per minute with a split ratio of 
25:1. Ir spectra using either KBr discs or smears in chloroform or methanol, were 
obtained using a Pye Unicam SP-300 infrared spectrophotometer with the 1603 cm-1 
band of polystyrene as a reference. Uv spectra were obtained as methanol solutions 
using a Varian DMS 100 spectrophotometer. 
13C nmr spectra at 75 MHz and 1 H nmr spectra at 300 MHz were recorded 
on a Varian XL-300 spectrometer. Chemical shifts are expressed as parts per million 
(ppm) relative to the solvent reference used: CDCbfTMS: 1H 7.25 ppm. 13C 77.01 
ppm; CD30D: 1 H 3.30 ppm, 13C 49.30 ppm; D20: 1 H 4.70 ppm, 13C 67.40 ppm 
(dioxane as internal reference); d6-DMSO: 1 H 2.60 ppm, 13C 39.60 ppm; C6D6: 1 H 
7.27 ppm. The shifts are quoted as position (8), relative integral, multiplicity (s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet and br, broad), coupling constant 
(J, Hz) and the assigned atom label. 
Difference nuclear Overhauser effect (nOe) spectra were obtained in an 
arrayed experiment with the decoupler offset 10 000 Hz for the control experiment 
and subsequently cycled over the multiplet peaks of each proton to be irradiated215. 
Two dimensional correlation spectra were recorded on the XL 300 spectrometer in 
the usual manner216,217, using standard software. All data were displayed in the 
absolute value mode. 
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Flash column chromatography was performed using silica gel (Davisil 35-70 
Il) and C18 reverse phase material prepared by coating the silica gel with 
n-octadecyltrichlorosilane after the method of Evans et al 218. Columns were 
generally run under nitrogen pressure. Fractogel PGM 2000 (Merck) was used for 
gel permeation chromatography. Medium pressure liquid chromatography (mplc) 
was performed using a Milton-Royal pump, Rheodyne type 50 injector and a LKB 
2212 Helirac fraction collector on a Lobar diol column (Merck LiChroprep), with 
detection by means of a LKB 2142 differential refractometer and a LKB 2238 Uvicord 
II uv detector. 
High pressure liquid chromatography (hplc) was performed on a Varian 5000 
liquid chromatograph using a Varian UV-50 variable wavelength detector and a 
Hewlett Packard 3390A integrating recorder. Semi-preparative reverse phase 
chromatography was carried out on either Alltech C8, C18 or Cyanopropyl (CN) 
columns (250 x 10 mm) or on a Rainin Dynamax C18 column (250 x 21.4 mm). 
Analytical reverse phase chromatography was performed on an Alltech C18 column 
(250 x 4.6 mm). 
All solvents used were either spectral grade or distilled prior to use. 
WORK DESCRIBED IN CHAPTER TWO 
2.2 STUDIES OF THE BRYOZOAN, CRIBRICELLINA CRIBRARIA 
COLLECTION AND EXTRACTION OF BRYOZOAN 
Cribricellina cribraria (1 kg wet) was collected by SCUBA diving in April 
1987 from Sugar Loaf, Kaikoura, off the South Island of New Zealand. A voucher 
specimen, 87K15-02, is held at the Chemistry Department, University of Canterbury. 
The bryozoan was stored frozen, then in a typical extraction, 200 g was left overnight 
in methanol/toluene 4:1, (250 ml) and blended three times in the same solvent 
mixture. The combined extracts were filtered under vacuum, the filtrates combined 
and the solvent removed under reduced pressure. 
1-ETHENYL-9H-PYRIDO-[3,4-b]INDOL-8-0L 
(1-VINYL-8-HYDROXY-~-CARBOLlNE) (82) 
The resulting extract (7.6 g) was chromatographed on a reverse phase C18 
column (50 g), using a water/methanol to methanolldichloromethane gradient to give 
13 fractions. Alkaloids were shown to be concentrated in fractions 6 and 7 from the 
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reverse phase column by tic (ethyl acetate: acetone (1:1), fluorescent spots under uv 
light) and by P388 assay. These two fractions (116 mg) were recombined and 
rechromatographed on a reverse phase C18 column (10 g) using the same 
waterlmethanolldichloromethane gradient as previously. Alkaloids were 
concentrated in fraction 4 by tic and P388 assay. 
A further reverse phase C18 column on fraction 4 (37 mg) led to the isolation 
of 1-vinyl-8-hydroxy-~-carboline {82} (20 mg) as a yellow oil. For the isolation 
scheme used, refer to Figure A.1 in the Appendix. 
ms m/z found: M+'21 0.0787 (4), (C13HlON20 requires M~ 210.0793), 209.0702 (2). 
C13H9N20 requires 209.0715),184.0636 (0.4), (C11HsN20 requires 184.0637); UV 
"-max (MeOH) 369, 296, 244, 230 nm (log e 3.93, 3.97, 4.09, 4.06 respectively), "-max 
(NaOH-MeOH) 386, 287, 262, 240 nm (log e 3.82, 4.03, 4.06, 4.07 respectively); ir 
Vmax (smea~ 3590 br, 3140, 2990, 1630, 1570, 1510, 1480, 1430, 1280, 1230,780 
cm-1. For 1 Hand 13C nmr spectral data, refer to Tables 2.1 and 2.2. 
1-ETHENYL-8-METHOXY-9H-PYRIDO-[3,4-b] INDOLE 
(1-VINYL-8-METHOXY-~-CARBOLlI\IE) (88) 
1-vinyl-8-hydroxy-~-carboline (82) (15 mg) was dissolved in methanol (1 ml). 
Diazomethane in ether was added to the sample, which was left for 3 hours. After this 
time, tic and 1 H nmr spectroscopic analysis showed the formation of a complex 
mixture but with 1-vinyl-8-methoxy-~-carboline (88) as the major component. This 
was purified by reverse phase column chromatography to yield 4 mg of a yellow-
green oil. 
ms m/z found M.f 224.0949 (76), (C14Hi2N20 requires M.f 224.0949), 223.0848 (35), 
(C14H 11 N20 requires 223.0872) 209.0729 (45), (C13H9N20 requires 209.0715), 
194.0832 (13), (Ci3HlON2 requires 194.0844); UV "-max (MeOH) 363,285,267,249, 
220 nm (log e 3.23, 3.43, 3.69, 3.93, 3.96 respectively); ir Vmax (smear) 3550, 3050, 
2925,1625,1575,1420,1310,1260,1240,1050 cm-i . For 1H and 13C nmr spectral 
data refer to Tables 2.1 and 2.2. 1JCH (HETCOR) H3 <-> C139.19, H4 <-> C1i4.32, H5 
<-> Ci13.S6, H6 <-> C120.7S, H7 <-> C107.97, H1' <-> C132.9S, H2'a, H2'b <-> C119.09, 
H8' <-> C55.62; 2JCH, 3JCH (HMBC) H3 <-> C4, H4 <-> C4b, H5 <-> C4a, C4b, C7, 
C8a, H6 <-> C4b, C8, H7 <-> C5, C8, C8a, H1' <-> C1, C4a, H2'a <-> C1, C1', H2'b 
<-> C1, H8' <-> C8, C8a. 
1-ETHYL-9H-PYRI DO[3,4-b] I N DOL-8-0L 
(1-ETHYL-8-HYDROXy-p-CARBOLlNE) (S9) 
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1-vinyl-8-hydroxy-p-carboline (S2) (4 mg) in methanol (1 ml) was stirred with 
platinum dioxide (0.5 mg) under hydrogen until absorption ceased. After filtration of 
the solution through a bed of celite in methanol to remove the catalyst, 1-ethyl-S-
hydroxy-p-carboline (S9) (4 mg) was isolated as a pale yellow oil. 
ms m/z found M+' 212.0948 (100), (C13H12N20 requires M+' 212.0950), 211.0S65 (99), 
(C13H11 N20 requires 211.0871). 184.0647 (17), (C11 HaN20 requires 184.0636), UV 
Amax (MeOH) 341, 287, 278, 243, 219 nm (log E 2.98, 3.25, 3.20, 3.88, 3.52 
respectively); Amax (NaOH-MeOH) 358, 2SS, 279, 253, 226 nm (log E 2.91 , 3.18, 3.26, 
3.77,3.64 respectively); ir Vmax (smear) 3390 br, 3005, 2950, 1640, 1590, 1490, 
1440,1385,1245,1230 cm-1. For 1H and 13C nmr spectral data refer to Tables 2.1 
and 2.2. 2JCH. 3JCH (HMBC) H3 <-> C1, C4, C4a, H4 <-> C3, C4a, H5 <-> C4a, C7, 
C8a, H6 <-> C4b, C8. H7 <-> C5, C8a, H1' <-> C1, C4a, C2', H2' <-> C1, C1'. 
1-ETHENYL-8-ACETOXY-9H-PYRIDO-[3,4-b] INDOLE 
(1-VINYL-8-ACETOXy-p-CARBOLlNE) (90) 
1-vinyl-8-hydroxy-p-carboline (S2) (5 mg) was dissolved in pyridine/acetic 
anhydride (1:1) (1 ml) and left stirring overnight. Solvent was removed and 2 ml of 
water was added. Extraction with ethyl acetate (3 x 1 ml) led to the isolation of 3 mg 
of (90) as a yellow oil. 
ms m/z found M-f! 252.0895 (35), (C15H12N202 requires M+' 252.0899), 210.0806 
(100), (C13H10N2 requires 210.0794), 195.0910 (17). (C13H11 N2 requires 195.0923). 
16S.0655 (14), (C11 HaN2 requires 168.0688); UV Amax (MeOH) 349. 298 sh, 287, 
272. 244, 221 nm (log E 2.79, 2.91, 3.13, 3.19, 3.57, 3.58 respectively). UV Amax 
(NaOH-MeOH) 373, 288, 254, 237. 233 nm (log E 2.61, 3.18, 3.45, 3.54, 3.54 
respectively); irvmax (smear) 3370, 2950,1740,1630,1590,1440,1270,1240,1210. 
1105, 1040. SOO cm-1. For 1 Hand 13C nmr spectral data. refer to Tables 2.1 and 2.2. 
1JCH (HETCOR) H3 <-> C139.4a, H4 <-> C115.a2. H5 <-> C121.45, H6 <-> C120.63, H7 
<-> C122.54, H1' <-> C132.64, H2'a <-> C120.08, H2'b <-> C12o.oa, H8' <-> C21.26· 
1-ETHYL-8-METHOXY-9H-PYRIDO-[3,4-b] INDOLE 
(1-ETHYL-8-METHOXY-p-CARBOLlNE) (91) 
1-vinyl-8-methoxy-p-carboline (SS) (2 mg) in methanol (1 ml), was stirred 
with platinum dioxide (0.5 mg) under hydrogen for 30 minutes. Tic analysis (ethyl 
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acetate/acetone (1:1), fluorescent spot under uv light) indicated that a single product 
of lower Rf had formed. After filtration of the solution through a bed of celite in 
methanol to remove the catalyst, 1-ethyl-8-methoxy-~-carboline (91) was isolated as 
a pale yellow oil, the 1 H nmr and mass spectra of which, were consistent with 
literature values6S. 
1-ETHYL-4-METHYL-SULPHONE-~-CARBOLINE (92) 
Fractions from the flash reverse phase columns on the extract were shown to 
contain a component, fluorescent under uv light at Rf = 0.9 on tic (silica, ethyl 
acetate/acetone, (1:1)). Reverse phase hplc of these fractions, using an Alltech 
cyanopropyl semi-preparative column, flow rate 5 ml/minute, methanol/water (2:3) 
and uv detection at 220 nm, led to the isolation of 4 mg of (92) as a pale green oil. 
ms m/z found M+', 274.0777 (100), (C14H14N202S requires M+' 274.0776),246.0470 
(12), (C12H10N202S requires 246.0463), 195.0931 (13), (C13H11N2 requires 
195.0922), 168.0734 (7), (C11 HsN2 requires 168.0687); UV "-max (MeOH) 350, 304, 
299, 258, 250, 213 nm (log e 2.62,3.03,2.94,3.32,3.29,3.43 respectively); ir Ymax 
(smear) 3390, 2990, 1650, 1600, 1570, 1485, 1430, 1335, 1160, 1010, 785 cm-1. For 
1 Hand 13C nmr spectral data refer to Table 3.4. 
ISOLATION OF HARMAN (55) 
A fraction (21 mg) from the second reverse phase chromatography column 
on the extract, was subjected to further chromatography on C18 reverse phase 
material using a water to methanol gradient to yield 15 fractions. Tic analysis 
revealed a spot, fluorescent under uv light to be present in several fractions and 
fractions 9 and 10 from the column were clean in this component by 1 H nmr 
spectroscopy in CDCI3. These were combined to give a yellow oil (6 mg), the 1H, 13C 
nmr and mass spectra of which were identical with literature values for harman65,76. 
IDENTIFICATION OF 1-ETHYL-~-CARBOLINE (56) 
Some of the column fractions containing harman by tic analysis, contained 
another spot at higher Rf on silica gel, also fluorescent under uv light. The 1 H nmr 
spectra of these fractions in CDCI3 showed no additional signals to those of harman, 
apart from a mutually coupled quartet and triplet ascribed to an ethyl group. This 
component had the same Rf value on silica gel as a synthetic sample of 1-ethyl-~-
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carboline and the mass spectrum was identical to that reported in the literature for 
1-ethyl-~-carboline69 . 
ISOLATION OF PAVETnNE (57) 
Signals characteristic of a vinyl group as in compound (82) were seen in the 
1 H nmr spectrum in CDCI3 of one column fraction (2 mg) which also contained 
harman and 1-ethyl-~-carboline. The sample was dissolved in chloroform and 
streaked along the baseline of a silica gel tic plate (6 x 10 cm). The plate was 
developed in ethyl acetate/acetone (1 :1) and visualised under uv light. The uv active 
band at highest Rf was scraped off the plate, the silica eluted with ethyl 
acetate/acetone and filtered to yield <1 mg of a yellow-green oil. This was identified 
as pavettine from its 1 H nmr and mass spectra77 and by tic comparison with an 
authentic sample. 
HOMARINE (94) 
Fraction 2 from the initial reverse phase chromatography column on the 
crude extract, contained a pale lemon precipitate (117 mg), which was identified as 
homarine by 13C nmr spectroscopy78. 
STEROLS 
Fraction 8 from the initial reverse phase chromatography column on the 
extract (141 mg) was further partitioned by column chromatography on silica gel, 
using a petroleum ether to ethyl acetate gradient to yield 10 fractions. Fraction 5 from 
the column (19 mg) was determined to contain cholest-4-en-3-one (107) as a major 
component by 13C nmr spectroscopy81. Fraction 7 from the column (82 mg) was 
determined to contain predominantly cholesterol (101) by 13C nmr spectroscopy81, 
while fraction 6 (25 mg) was a mixture of sterols. Fractions 5-7 were combined (127 
mg) and a sub-sample of this mixture (55 mg) sent to Professor Carl Djerassi for 
analysis by gcms. 
2.3 STUDIES OF THE BRYOZOAN, MARGARETTA BARBATA 
BIOLOGICAL ACTIVITY OF MARGARETTA BARBATA 
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Fraction CB5 8.6 (211 mg), originally from a reverse phase column of a crude 
extract of Margaretta barbata (87K16-01)79, was reassayed in the three biological 
assay systems and 1 Hand 13C nmr spectra obtained in CDCI3. Analytical hplc was 
performed on this fraction, using an Alltech cyanopropyl column and a flow rate of 1 
ml per minute in methanol/water (3:2) with uv detection at 220 nm. 
Antiviral(cytotoxicity assay of the four resulting cuts revealed that activity was spread 
throughout the fractions. 
A sub-sample of the original material (28 mg) was taken up in ethanol/water 
(19:1) (5 ml) and extracted with petroleum ether (3 x 20 ml). then back extracted with 
ethanol/water (10 ml). Tic analysis and biological assay of the resulting partitions 
showed that this was unsuccessful and the fractions were recombined. 
Reverse phase flash column chromatography using C 18 material (10 g) and 
a water to methanol to dichloromethane gradient was performed on the semi-crude 
material (135 mg) and 13 fractions were taken. Fractions 1-3 were recombined (58 
mg) and further partitioned by reverse phase column chromatography on C18 
material (10 g) using a similar solvent gradient, to yield 11 fractions. P388 assay 
showed that the biological activity was concentrated in fraction 6 from this column (17 
mg). A 1 H nmr spectrum of this fraction in CDCI3 was broad and unresolved. 
Methylation of a sub-sample of this fraction (0.5 mg) with diazomethane in 
ether did not alter the biological activity so the whole sample (16.5 mg) was 
methylated by the same procedure and submitted to reverse phase hplc using a 
Rainin Dynamax C18 column and a flow rate of 10 ml per minute in methanol/water 
(9:1) with uv detection at 220 nm to yield 6 fractions. Biological activity was 
concentrated in fractions 2 and 3 by P388 assay, so these were combined (3 mg). 
The 1 H nmr spectrum of these combined fractions in CDCI3 was again broad and 
unresolved and addition of a drop of TFA failed to sharpen the signals. The residue 
that was insoluble in CDCI3 (1 mg) was checked by P388 assay and found to be 
inactive, so 1.8 mg of active material remained. Further work on this sample was 
abandoned due to lack of material. 
Tic analysis of fraction 5 (16 mg) from the second reverse phase column on 
CB 5 8.6 in ethyl acetate/acetone (1 :1). revealed a number of spots, fluorescent under 
uv light and the 1 H nmr spectrum of this fraction in CDCI3 revealed signals 
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reminiscent of a ~-carboline nucleus. Semi-preparative reverse phase hplc of this 
fraction, using an Alltech cyanopropyl column and a flow rate of 5 ml per minute in 
methanol/water-TFA (3:2) with uv detection at 220 nm, led to the isolation of a yellow 
oil, the 1 Hand 13C nmr, uv and mass spectra of which, were consistent with those 
reported for harman (55)65.76, Another fraction containing less than 1 mg of material, 
was determined to contain harman and 1-ethyl-~-carboline (56) by mass 
spectrometry, 
WORK DESCRIBED IN CHAPTER THREE 
SYNTHESES OF ~-CARBOLINE ALKALOIDS 
GENERAL SYNTHETIC METHOD77,88. 
In a typical preparation, 500 mg of commercial L-tryptophan was dissolved in 
water (125 ml) to which 0.5 ml concentrated sulphuric acid had been added. 1-2 ml 
of freshly distilled aldehyde was added and the solution refluxed for ten minutes. It 
was then removed from the heat and 25 ml of a 10% potassium dichromate solution 
slowly added. The solution was left at room temperature for five minutes then 
reboiled and allowed to cool. Sulphur dioxide gas was bubbled into the solution or 
solid sodium sUlphite added to destroy the excess oxidising agent. The solution was 
made basic by addition of solid sodium carbonate and extracted with 
dichloromethane (4 x 75 ml). The organic partition was dried over sodium sulphate, 
filtered and the solvent removed. The resulting crude product was purified by reverse 
phase flash column chromatography on C18 material using a water to methanol 
gradient. Column fractions were analysed by tic and 1 H nmr spectroscopy in CDCI3. 
Those fractions that contained the pure ~-carboline alkaloids were combined and 
used for further nmr spectroscopic experiments and for biological assays. 
NOR HARMAN (58) 
Yield: 7%. Recrystallised as colourless needles from petroleum ether/ethyl 
acetate. m.p.198°C, lit. 199-201°C219. The 1H nmr220, 13C nmr65 and uv94 spectra 
were consistent with literature values. 
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1-ETHYL-~-CARBOLINE (56) 
Yield: 12%. Recrystallised from chloroform/methanol to yield a small quantity 
of clear, cubic crystals (10 mg). m.p. 194°C, lit. 194-195°C221. 1 H nmr69, 13C nmr65, 
uv69 and mass spectra69 were consistent with literature values. 
1-PROPYL-~-CARBOLINE (113) 
Yield: 15%. -the uv87, ir and mass spectra83 were consistent with literature 
data. 
1-ISOPROPYL-~-CARBOLINE (114) 
Yield: 9%. The ir and mass spectra were consistent with literature data83. 
1-HEXYL-~-CARBOLINE (115) AND 1-PHENYL-~-CARBOLINE (116) 
A modification of the above procedure was used. Tryptophan (500 mg) was 
dissolved in water (30 ml) to which concentrated sulphuric acid (0.1 ml) had been 
added. 1-2 ml of freshly distilled aldehyde was added and the sol ution left to reflux 
with vigorous stirring. The reflux period was overnight for 1-hexyl-~-carboline and 
four hours for 1-phenyl-~-carboline. The remainder of the preparation procedure was 
carried out as above. 
1-HEXYL-~-CARBOLINE (115) 
Yield: 1% of a clear oil. The uv and mass spectra were consistent with 
literature data87. 
1-PH ENYL-~-CARBOLIN E (116) 
Yield: 19%. Uv and ir spectra were consistent with literature values94. 
1-METHYL-1,2,3,4-TETRAHYDRO-~-CARBOLlNE-3-CARBOXYLIC ACID (117)89 
L-tryptophan (300 mg) was dissolved in hot water (10 ml). The solution was 
cooled and 1 ml of freshly distilled acetaldehyde added with stirring. The vessel was 
loosely capped and the solution left stirring overnight at room temperature. A thick 
white preCipitate was formed and removal of solvent under reduced pressure yielded 
350 mg of crude product which was purified by reverse phase flash column 
chromatography on C18 material to give 198 mg of 1-methyl-1,2,3,4-tetrahydro-~-
carboline-3-carboxylic acid (117) as a white powder. Yield: 51 %. The mass 
spectrum was consistent with literature data82. 
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CONVERSION OF (117) TO HARMAN 
1-methyl-1 ,2,3,4-tetrahydro-~-carboline-3-carboxylic acid (117) (145 mg) 
was dissolved in water (40 ml) and refluxed. A 10% potassium dichromate solution 
(7.5 ml) and acetic acid (1.5 ml) were added and the solution refluxed for one minute 
longer, then cooled. 1 M sodium sulphite solution (100 ml) was slowly added, then 
the solution made basic by addition of solid sodium carbonate. Extraction with 
dichloromethane (3 x 75 ml) then ethyl acetate (3 x 75 ml). drying over sodium 
sulphate, filtering and removal of solvent gave 69 mg of semicrystalline harman 
which was purified by reverse phase column chromatography. Yield: 60%. 
A second preparation of harman by this method without purification of the 
acid precursor (117) resulted in a 55% yield of harman. The 1H nmr, 13C nmr65 and 
mass spectra76 of the synthetic product were consistent with literature values. 
METHYL-1-METHYL-1 ,2,3,4-TETRAHYDRO-~-CARBOLlNE-3-CARBOXYLATE (118) 
A sample of compound (117) (20 mg) was dissolved in the minimum amount 
of ethanol, to which diazomethane in ether was added. The resulting product was 
purified by flash column chromatography on C18 reverse phase material, using a 
water to methanol gradient, to yield 15 mg of (118) as a white powder, the mass 
spectrum of which was consistent with literature data82. 
NMR SPECTROSCOPY OF ~-CARBOLINE ALKALOIDS 
For 1H and 13C nmr spectral data of the natural product alkaloids and their 
derivatives, refer to Tables 2.1-2.2 and Table 2.4. For the 1 Hand 13C nmr spectral 
data of the synthetic alkaloids, refer to Tables 3.1-3.3. 
ASSAY 
Alkaloids were submitted for assay in the three biological assay systems 
outlined in Chapter One of this thesis, as methanol solutions. For the 
antimicrobial/antifungal assay. the MIC of the compounds against each test organism 
was determined from a series of two-fold dilutions. 
PARTITION COEFFICIENT DETERMINATION 
The method used for the determination of the partition coefficient of 1-propyl-
~-carboline will be outlined as an example of the general method employed. The 
164 
experimentally determined partition coefficient is the average result of five such 
measurements. 
PREPARATION OF EQUILIBRATED SOLVENTS 
Distilled water and octanol were placed together in glass-stoppered 5 ml 
centrifuge tubes. The tubes were inverted 100 times over five minutes and then 
centrifuged for five minutes at 2000 rpm. The phases were transferred into separate 
I'lasks by means of droppers. 
PREPARATION OF STANDARD SOLUTION 
9.3 ± 0.05 ml methanol was added to a sample of 1-propyl-~-carboline (18.6 
± 0.0001 mg) with a 10 ml graduated pipette, to give a 2 ± 0.022 mg/ml solution. 
DETERMINATION OF STANDARDS 
0.25 ± 0.005 ml of the standard solution was transferred into each of two 10 
ml volumetric flasks via a 1 ml graduated pipette and the solvent removed. The 
octanol standard was made up to the mark with equilibrated octanol, while the water 
standard was made up to the mark with equilibrated water and methanol (0.5 ml) to 
aid solubility. This yielded 10 ± 0.025 ml standard solutions. The uv spectra of each 
of the standards were recorded and the extinction coefficients of the compound in 
each solvent determined. 
MEASUREMENT OF PARTITION COEFFICIENTS 
1 ± 0.005 ml of the standard methanol solution of 1-propyl-~-carboline was 
transferred to a glass stoppered centrifuge tube via a 1 ml pipette and the solvent 
removed. 1 ± 0.005 ml each of equilibrated octanol and water were added, again via 
pipettes and the mixture shaken and centrifuged as for the solvent equilibration. Uv 
spectra of each phase were recorded, directly for the aqueous phase, and by dilution 
of the octanol phase. 0.25 ± 0.005 ml of this phase was withdrawn into a 10 ml 
volumetric flask and made up to a 10 ± 0.025 ml solution with equilibrated octanol. 
The concentration of compound in each phase was calculated from the absorption 
and the previously determined extinction coefficients and used to calculate log P. 
The average value of five such determinations was 2.50 ± 0.23 for 1-propyl-~­
carboline (113) and 2.26 ± 0.21 for 1-isopropyl-~-carboline (114). 
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CALCULATION OF LOG P VALUES 
a) Using substituent constants, 1t. The 1t value for a methylene group is 0.50101 . 
Using the experimentally determined log P for 1-propyl-~-carboline (113) of 2.50, the 
values are calculated as follows. For 1-ethyl-~-carboline (56), log P = 2.50 - 0.50 = 
2.00. The other log P values were calculated in a similar manner. 
b) Using fragmental constants, f. The fragmental constant for a methylene group is 
0.66, a hydrogen 0.23 and a methyl group 0.89102. Again using the value of 2.50 for 
log P of 1-propyl-~-carboline (113), log P of norharman (58) is calculated as 2.50 - (2 
x 0.66) - 0.89 + 0.23 = 0.52. 
DETERMINATION OF Rf VALUES 
Silica gel plates (9.5 x 12.5 cm) were used. Alkaloids were spotted onto the 
plates as 1 mg/ml solutions in methanol. Plates were developed in a sealed glass 
chromatography chamber lined with filter paper which had been pre-soaked in the 
eluting solvent. Solvents systems used were either chloroform/methanol (9:1) or 
ethyl acetate/acetone (1:1). Plates were visualised under ultraviolet light and the 
cOIllPounds circled with pencil. The Rf values were calculated as the distance from 
the reference line to the middle of the compound spot, over the distance travelled by 
the solvent front. Four plates of each solvent system were developed and the results 
averaged, to yield a Rf value for each alkaloid in each solvent system. For Rf values 
of the alkaloids, refer to Table 3.8. 
DETERMINATION OF HPLC RETENTION INDICES 
Reverse phase hplc retention indices were determined using a Philips PU 
4100 liquid chromatograph coupled to a Philips PU 4120 photo diode array detector. 
Alkaloids were injected as 1 mg/ml methanol solutions (5-10 J..LI per injection) onto a 
Hamilton analytical PRP-1 column, using methanol/water-TFA (3:1) and a flow rate of 
1 ml per minute. The elution time for a non-retained compound (To) was determined 
to be 284 seconds from the retention time of methanol. Retention indices were 
measured as the time at which the maximum uv absorption was recorded for each 
compound. Multiple injections of each sample were run and the results averaged. 
For the hplc retention indices of the alkaloids, refer to Table 3.8. 
WORK DESCRIBED IN CHAPTER FOUR 
4.2 STUDIES OF THE SPONGE, AX/NELLA SPa 2 
COLLECTION AND EXTRACTION OF SPONGE 
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Axinella sp. 2, (200 g), was collected by SCUBA diving in April 1986 from 
the sponge garden, Goat Island, Leigh, off the North Island of New Zealand and 
stored frozen. A voucher specimen, 86L01-02, is held at the Chemistry Department, 
University of Canterbury. 
Freshly thawed sponge, (196 g). was blended three times with 
methanol/toluene, (4:1), filtered and the solvent evaporated from the combined 
filtrates. The resulting extract (9.6 g), was chromatographed on a reverse phase C18 
column (50 g), using a water/methanol to methanol! dichloromethane gradient to give 
12 fractions. 
GIROLLINE (153) 
Fractions 1, 2 and 3 from the reverse phase column showed significant 
activity on both P388 and antiviral/cytotoxicity assay systems. These fractions were 
combined (7.36 g), taken up in methanol/water (4:1) and filtered to leave 3.26 g of 
methanol soluble material, which was chromatographed on Fractogel PGM 2000 
(400 g), using water as solvent. The activity was retained, but after continued elution 
with 0.25 M acetic acid (600 ml), crude girolline acetate (740 mg) was obtained, 
which was converted to the hydrochloride by addition of 10 ml conc. HCI, then taken 
to dryness. The sample was then dissolved in methanol and filtered to leave 477 mg 
of methanol soluble material. Semi-preparative high p'ressure liquid chromatography 
on a C18 RP Alltech column using methanol/water-TFA (0.05% TFA), 1 :4, 4 ml/min. 
with uv detection at 220 nm, yielded a fraction of 297 mg of girolline, clean by 1 H nmr 
spectroscopy in 020. Elemental analysis of 5 mg of this fraction revealed only 1.5% 
carbon, indicating the presence of a large amount of inorganic salts. _ A further gel 
permeation column using 10 g of fractogel PGM 2000 and water as solvent, led to the 
isolation of a fraction of 24 mg of an opaque oil, again pure by nmr spectral analysis. 
ms FAB 367 [M + matrix + NaJf, 331 [M + matrix + Na - HCI]+; 1 H nmr (020) 6.89 (1 H, 
d, J=1.0 Hz, H-5), 5.15 (1 H, d, J=3.5, 1.0 Hz, H-7). 4.59 (1 H, dt, J=9.3, 3.S Hz, H-8), 
3.60 (1H, dd, J=13.8, 3.S Hz, H-9), 3.44 (1H, dd, J=13.8, 9.3 Hz, H-10); 13C nmr 
(CD30D) 149.15 (C-2), 128.06 (C-4), 112.07 (C-S), 67.97 (C-7), 62.22 (C-8), 44.S2 
167 
(C-9); UVAmax (MeOH) 213 nm; irvmax 3500 br, 3310, 2250,1680,1635,1415,610 
cm-1. For the isolation scheme used, refer to Figure A.3 in the Appendix. 
TAURINE (141) 
A fraction (1.3 g) from the first gel permeation column of the water soluble 
partition of the extract was shown to contain taurine by 1 Hand 13C nmr spectroscopy. 
On standing, a white precipitate settled out, the 1 Hand 13C nmr spectra of which were 
identical. with those reported for taurine143,144. 
HOMARINE (94) 
Fractions from the gel permeation columns of the water soluble material from 
the extract were analysed by 1 H nmr spectroscopy in D20. Homarine was identified 
in several fractions by comparison of the 13C nmr data with literature values78. 
HYMENIALDISINE (139) 
Over time, a pale yellow solid settled out of fraction 6 (584 mg) from the initial 
reverse phase flash column on the extract. The solvent was removed via a dropper to 
leave 220 mg wet solid. A small quantity of good quality crystals (10 mg), was 
obtained by recrystallisation from methanol but a better yield, (76 mg), was obtained 
by recrystallisation from methanol/water, (1:1) using TFA fumes to aid dissolution and 
TEA fumes to neutralise the solution to give pale yellow needles. 
mp. 220° C (decomposition); ms mlz 323/325 found 322.9766, (C11HlON50270Br 
requires 322.9780); UV Amax (MeOH) 346, 265, 228 nm (log £ = 4.13, 4.05, 4.05 
respectively), Amax (MeOH-KOH) 382, 275, 237 nm; ir Vmax 3320 br, 1720, 1630, 
1490, 1370 cm-1. For 1 Hand 13C nmr spectral data, refer to Tables 4.2 and 4.3. 
X-RAY CRYSTALLOGRAPHIC MEASUREMENTS OF HYMENIALDISINE (139) 
The X-ray crystallographic analysis was performed by Dr. Richard Coil, using 
a Nicolet XRD P3 four-circle diffractometer with A(MoKa) = 0.71069 A. Yellow 
crystals were obtained from a methanol solution. A specimen of dimensions 0.5 x 
0.23 x 0.125 mm3 was selected for the X-ray measurements. The cell parameters 
were determined by least squares refinement of 25 accurately centred reflections in 
the range 6 < 28 < 31°. 
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Crystal data: Cn H1ONs02Br.CH30H, monoclinic, a = 7.185 (3), b = 16.309 
(6), c = 11.833 (4) A, ~ = 92.90 (3)°, V = 1384.81 A3, Deal = 1.71 g.cm-3, space group 
P211n, (z = 4), F(O 00) = 647.82. 
Using ro scans ala scan rate of 250 scans per hour and a background scan 
ratio of 0.5, a total of 2839 reflections were collected over a scan range of 1.6 at a 
temperature of 143 K. Of these, 1234 reflections were unique and used in the 
structure refinement. Crystal stability was monitored by recording three check. 
reflections every 100 reflections and no significant variations were observed. The 
data was corrected for Lorentz polarisation effects. The structure was solved by the 
Patterson heavy-atom method. Hydrogen atoms were inserted at calculated 
positions using a riding model and the thermal parameters refined from a starting 
value of 0.05. The refinement using least squares procedures converged with R = 
0.0538, roR = 0.0394 and a maximum least-squares shift error of 0.006. The function 
minimised in the refinement was L ro(IFol -lFcI)2 where ro == [a2(Fo) + 0.00121 Fo2]-1. 
All programs used for the data collection and structure solution are contained in the 
SHELXTL (Version 4.0) package222. 
Table 8.1: Bond angles (0) for hymenialdisine 
C(2) - N(1) - C(5) 108.4(6) C(14) - N(13) - C(12) 107.0 (7) 
C(14) - N(15) - C(11) 108.5 (6) N(13) - C(14) - N(15) 112.7 (6) 
N(13) - C(14) - N(14) 125.4 (7) N(15) - C(14) - N(14) 121.9 (7) 
0(12) - C(12) - N(13) 126.5 (8) 0(12) - C(12) - C(11) 125.1 (7) 
N(13) - C(12) - C(11) 108.4 (7) Br - C(2) - N(1) 120.4 (6) 
Br - C(2) - C(3) 128.7 (6) N(1) - C(2) - C(3) 110.8 (7) 
C(10) - C(4) - C(5) 124.6 (6) C(10) - C(4) - C(3) 128.6 (6) 
C(5) - C(4) - C(3) 106.0 (7) C(4) - C(10) - C(11) 120.4 (7) 
N(1) - C(5) - C(4) 108.6 (7) N(1) - C(5) - C(6) 119.1 (7) 
C(4) - C(5) - C(6) 131.6(7) N(15) - C(11) - C(12) 103.4 (6) 
N(15) - C(11) - C(10) 125.9 (7) C(12) - C(11) - C(10) 130.5 (7) 
0(6) - C(6) - N(7) 122.1 (7) 0(6) - C(6) - C(5) 121.3 (7) 
N(7) - C(6) - C(5) 116.6 (7) C(2) - C(3) - C(4) 106.1 (7) 
Om - Cm - Hm(1) 109.0(4) Om - Cm - Hm(2) 109.8 (4) 
Hm(1) - Cm - Hm(2) 109.5 Om - Cm - Hm(3) 109.6 (4) 
Hm(1) - Cm - Hm(3) 109.5 Hm(2) - Cm - Hm(3) 109.5 
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Table 8.2 : Atomic coordinates (x 10) and temperature factors (A x 10) for 
hymenialdisine. 
Atom x y z U 
Br 985 (1 ) 1496 (1 ) 328 (1 ) 25 (1) * 
O(12} 5789 (7) 5712 (3) -2344 (4) 16 (1) 
O(6} 1403 (8) 2276 (3) -4194 (4) 26 (2)* 
N(7) 978 (8) 3662 (4) -4139 (5) 17 (2)* 
N(1 ) 1011 (9) 2206 (4) -1833 (5) 16 (2)* 
N(13) . 7687 (10) 507 (4) -957 (5) 15 (2)* 
1\1(15) 5819 (9) 4005 (3) -573 (5) 18 (2)* 
C(14) 7463 (11 ) 4384 (4) -328 (7) 14 (3)* 
N(14} 8675 (9) 4101 (3) 456 (5) 16 (2)* 
C(12} 6114 (12) 5158 (5) -1638 (7) 16 (3)* 
C(8) 603 (11 ) 4419 (4) -3504 (6) 17 (3)* 
C(2) 1454 (12) 2320 (5) -720 (7) 19 (3)* 
C(4) 2259 (10) 3478 (6) -1635 (6) 13 (3)* 
C(10) 3191 (11 ) 4238 (4) -1944 (6) 12 (3)* 
C(5) 1454 (11 ) 2919 (4) -2410 (7) 13 (2) 
C(11 ) 4848 (11 ) 4454 (4) 1421 (6) 14 (3)* 
C(6) 1284 (11 ) 2924 (5) -3636 (7) 16 (3)* 
C(3) 2267 (10) 3075 (4) -533 (6) 15 (3)* 
C(9) 2338 (11 ) 4782 (5) -2898 (7) 19 (3)* 
Om -1252 (8) 6264 (3) -3427 (4) 26 (2)* 
Cm -1007 (13) 7037 (5) -2889 (7) 30 (4)* 
Hm(1) -2054 7380 -3098 52 (8) 
Hm(2) 115 7290 -3126 52 (8) 
Hm(3) -927 6965 -2083 52 (8) 
* Equivalent isotropic U defined as one third of the trace of the orthogonalised U 
tensor. 
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Table 8.3 : Bond lengths (A) for hymenialdisine (139) 
Br - C(2) 1.870 (8) 0(12) - C(12) 1.244 (9) 
0(6) - C(6) 1.252 (9) N(7) - C(6) 1.356 (10) 
N(1) - C(2) 1.352 (10) N(1) - C(5) 1.393 (10) 
N(13) - C(14) 1.360 (10) N(13) - C(12) 1.362 (11) 
N(15) - C(14) 1.352 (10) N(15) - C(11) 1.404 (9) 
C(14) - N(14) 1.322 (10) C(12)-C(11) 1.500 (11) 
C(2) - C(3) 1.377 (10) C(4) - C(1 0) 1.464 (11) 
C(4) C(5) 1.398 (11) C(4) - C(3) 1.460 (10) 
C(10) - C(11) 1.353 (11) C(5) - C(6) 1.449 (11) 
Om-Cm 1.419 (9) Cm- Hm(1) 0.960 
Cm - Hm(2) 0.960 Cm - Hm(3) 0.960 
OROIDIN 
After time, fractions 4 to 7 from the initial reverse phase flash column on the 
extract, which had been shown to contain oroidin by tic and 1 Hand 13C nmr 
spectroscopy were reexamined by 1 Hand 13C nmr spectroscopy in DMSO-d6. No 
signals characteristic of oroidin were observed. A sample of 103 g of a fresh 
collection of Axinel/a sp. 2 (88L02-01) (96 g) was extracted in the manner described 
above, to yield 5.2 g of crude extract. The resulting extract was chromatographed on 
a reverse phase flash column using C18 material (50 g) and the solvent gradient 
employed in the first extraction, to yield 12 fractions. Fraction 7 from this column was 
shown to contain oroidin by 1 Hand 13C nmr spectroscopy. Various combinations of 
mplc and hplc were attempted on this fraction without success. Semi-preparative 
hplc using a cyanopropyl column, methanol/water-TFA (2:3), a flow rate of 5 ml per 
minute and uv detection at 280 nm, resulted in the isolation of a fraction (3 mg), the tic 
and spectral properties of which were consistent with those of oroidin116,134. 
TLC SURVEY OFAXINELLIDA 
Samples surveyed were as listed in Table 4.4. Survey samples were each 2 
g which had previously been extracted using methanol/toluene (3:1), made up to a 
volume of 20 ml and the solution stored at -18°C. Samples were spotted at a high 
loading on silica gel tic plates, which were developed using ethyl 
acetate/acetone/formic acid/water (10:6:1 :1). Plates were visualised under ultraviolet 
171 
light and by dipping in Sakaguchi reagent145. Pure hymenialdisine and oroidin and 
a sample of crude Axinella sp. 2 extract (86L01-02) were used as references. A sub-
sample was taken of an extract thought to contain hymenialdisine, namely 87MS02-
04, and this sample was screened by the procedure outlined in Chapter Seven of this 
thesis. For the results of this screening, also refer to Chapter Seven, p. 144. 
ISOLATION OF STEROLS 
Fraction ten from the initial reverse phase flash column on the second 
extraction of sponge was examined by 1 Hand 13C nmr spectroscopy in CDCI3, which 
indicated that it consisted mainly of sterols. A sub-sample of this fraction (40 mg), 
was subjected to normal phase column chromatography on silica gel (10 g), using a 
petroleum ether to ethyl acetate gradient. Fractions shown to contain sterols by tic 
(dichloromethane/methanol (9:1), by visualisation with anisaldehyde dip), were 
combined. This combined fraction (30 mg), was shown to consist mainly of (154) by 
comparison of the 13C nmr data with literature values146. 
A sample of 25 mg from this combined fraction was despatched to Professor 
Carl Djerassi for gcms analysis of the sterol content. 
WORK DESCRIBED IN CHAPTER FIVE 
5.1 STUDIES OF THE SPONGE, STYLOPUS AUSTRALIS 
COLLECTION AND EXTRACTION OF SPONGE 
Sty/opus australis n. sp. (185 g wet) was collected by SCUBA diving in April 
1986 from Goat Island Canyon, Leigh, off the North Island of New Zealand. A 
voucher specimen, 86L02-01, is held at the Chemistry Department, University of 
Canterbury. The sponge was stored frozen, and then in a typical extraction, 85 g was 
blended with methanol/toluene (4:1). The resulting extract (4.4 g) was partitioned 
between ethyl acetate and water. The extract from the aqueous phase (3.8 g) was 
taken up in methanol, and filtered to remove an insoluble purple pigment. 
3P.4P-DIHYDROXY-PREGN-5-EN-20-0NE-3-SULPHATE (164) 
The methanol soluble extract (3.2 g) was chromatographed on a reverse 
phase C18 column (50 g), using a water/methanol to methanolldichloromethane 
gradient223• Fraction 5 (182 mg) was rechromatographed on a column of silica gel (5 
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g), using a dichloromethane/methanol gradient, yielding fractions 7-12 which were 
pure by tic (silica gel, dichloromethane/methanol (3:1), blue-purple spot with 
vanillin/H2S04 reagent) and by 13C nmr spectroscopy. These were recombined to 
give a white solid (101 mg), recrystallised from ethyl acetate/methanol as white 
needles. 
mp 120-121°C; [0:]55 = -100°, (c = 0.1, MeOH); cd (MeOH) A£ (nm) 0 (324), +11 
(284), 0 (240); ord (MeOH) e (nm) +4.5 (302), 0 (286), -9.2 {257}; ms m/z found 
411.1833 [M+ -H]- (C21H3106S requires 411.1841 ),331 [M+-HS03]-, 313 [M+-H-
H2S04]- ; ir Umax (KBr) 3600 br, 2995, 1700, 1620, 1460, 1385, 1360, 1255, 1215 
cm-1. For 1H and 13C nmr spectral data, refer to Tables 5.1 and 5.2. 
3~,4~-DIHYROXY -PREGN-5-EI'J-20-0N E-3-S U LPHATE-4-ACET ATE (173) 
Sulphate (164) (10 mg) was treated with acetic anhydride (2 ml) and 
pyridine (2 ml) at room temperature overnight. Water (1 ml) and one drop of HCI (2 
M) were added, and the product (173) extracted with chloroform (3 x 0.5 ml) as a 
brown oil. This was recrystallised from chloroform to yield (173) (8 mg) as a white 
solid. 
mp 122-123°C; ms m/z 453 [M-H]-, 395 [M-C2H3021" ; ir Vmax (smear) 2995, 1735, 
1705, 1635, 1460, 1380, 1235, 1195 cm-1. For 1 Hand 13C nmr spectral data, refer to 
Tables 5.1 and 5.2. 
3~,4~,20~-TRIHYDROXY-PREGN-5-EI\IE-3-SULPHATE (174) 
Sulphate (164) (5 mg) was dissolved in ethanol (0.5 ml) and excess NaBH4 
added. The reaction was left stirring and monitored by tic. After two hours the 
reaction mixture yielded a single spot on tic at Rf = 0.45 (silica gel, 
dichloromethane/methanol (3:1), purple spot with vanillin/H2S04 reagent). The crude 
product was purified by preparative tic on silica gel (6 x 8 cm), using the same 
conditions as above, but dichloromethane/methanol (1:1) was used to initially move 
the compound off the baseline. Visualisation of a small strip of silica with 
vanillin/H2S04 reagent led to the location of the product, which was eluted with 
methanol and filtered to yield 3 mg of product (17 4), pure by 1 Hand 13C nmr 
spectroscopy. 
ord (MeOH) e (nm) -8.5 (280); ms FAB found 459.1794 [M-H+2Na]- (C21H3306SNa2 
requires 459.1794), 414 [M]-; irvmax (smear) 3560 br, 2950, 2900,1580,1460,1430, 
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1380, 1240, 1090 cm-1• For 1 Hand 13C nmr spectral data, refer to Tables 5.1 and 
5.2. 
ACID HYDROLYSIS OF SULPHATE (164) IN HCI224 
5 mg of (164) was dissolved in methanol (0.5 ml)/2 M HCI (1 ml). The closed 
vial was put in a water bath over steam for three hours, with occassional shaking. 
After cooling, the sample was extracted with chloroform (3 x 1 ml) to give 3.4 mg of a 
dark brown oil. Tic analysis showed no clearly defined spots and a 1 H nmr spectrum 
revealed no identifiable signals. 
BASE HYDROLYSIS OF SULPHATE (164)225 
7 mg of (164) was dissolved in pyridine/dioxane (0.5 ml of each) and heated 
in an oil bath at 110°C under a nitrogen atmosphere with monitoring by tic. After 15 
minutes, the solution had darkened in colour and tic showed no starting material was 
present. The sample was partitioned between ethyl acetate and water and a 1 H nmr 
spectrum obtained of each fraction, with no clearly identifiable signals. 
BASE HYDROLYSIS OF SULPHATE (174) 
4 mg of (174) was dissolved in pyridine/dioxane (0.5 ml of each), heated in 
an oil bath at 110°C and the reaction monitored by tic. After 72 hours, both tic and 1 H 
nmr spectroscopy indicated that no reaction had occurred. 
MILD ACID HYDROLYSIS OF SULPHATE (164)225 
5 mg of (164) was dissolved in 50% acetic acid (1 ml) and solid barium 
hydroxide added to bring the pH to 4.5. 0.1 ml of methanol was added to aid 
solubility and the mixture heated to 60°C in an oil bath. After 72 hours both tic and 1 H 
nmr spectroscopy indicated that no reaction had occurred and addition of more acetic 
acid failed to produce a result. The same reaction was repeated without the buffer 
present, but again no reaction occurred. 
REDUCTION OF SULPHATE (164) BY LITHIUM ALUMINIUM HYDRIDE 
3 mg of (164) and a ten fold excess of lithium aluminium hydride (3 mg) were 
dissolved in 1 ml THF previously dried over "UthAI" and heated with stirring at 70°C 
in an oil bath. The reaction was monitored by tic which indicated at least 3 products, 
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none of which gave a positive sulphate test with methylene blue dip163. The 1H nmr 
spectrum of the reaction mixture in CDCI3 showed no recognisable signals. 
BIOLOGICAL ACTIVITY OF SPONGE 
The organic phase of the sponge from the initial partition (432 mg) was 
chromatographed on a silica gel column (15 g), using a dichloromethane/methanol 
gradient to yield 9 fractions. Fraction 4 from this column (71 mg) was 
rechromatographed on a silica gel column (1.7 g), using an ethyl acetate/ethanol 
gradient to yield 14 fractions, of which fractions 8-11 showed biological activity in the 
antiviral/cytotoxicity assay system. After obtaining the 1 H nmr spectrum of each of 
these fractions in CDCI3, further work was abandoned as it was apparent that they 
still contained complex mixtures of products and there were few similarities between 
the fractions. 
2,3-DIHYDROXY-1-HEXADECYLOXYPROPANE (CHIMYL ALCOHOL) (175) 
The organic phase from the ethyl acetate/water partitioning of the sponge 
extract (432 mg) was chromatographed on silica gel (15 g), using a 
dichloromethane/methanol gradient. Fraction 4 was rechromatographed on silica gel 
(1.7 g), using an ethyl acetate/ethanol gradient to yield 5 mg of a yellow oil, the 1 H 
and 13C nmr and mass spectra of which, corresponded to the literature data for the 
chimyl alcohol165,90. 
IDENTIFICATION OF STEROLS 
The 1 Hand 13C nmr spectra of a fraction from a silica column of the extract 
were used to identify cholesterol and 24-methylene cholesterol by comparison with 
the literature data81 ,226. These identifications were confirmed by subsequent gcms of 
the TMS ethers of the sterols. The minor sterols were also identified by gcms of the 
TMS ethers. 
TLC SURVEY OF HYMEDESMIIDAE SPONGES 
Sponges surveyed were Sty/opus sp. 1 (87L04-3), Sty/opus australis 
(86L02-01), Sty/opus sp. (87K14-01), Hymedesmia sp. 1 (87WH01-04), 
Hymedesmia sp. 2 (87K01-01) and three Hymedesmia species (84L03-27), (84L02-
28) and (84K07-13) respectively. The survey samples were each 2 g which had 
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previously been extracted using methanol/toluene (3:1), made up to a volume of 20 
ml and the solution stored at ~ 18°C. Samples were spotted at high loading on a silica 
tic plate which was developed using dichloromethane/methanol (3:1) as eluting 
solvent. Pure (164) was used as a reference. Samples were visualised with 
vanillin/H2S04 reagent. Any samples appearing to contain (164) were extracted on 
a small scale (10 g), using methanol/toluene (3:1) and a portion of the extract 
submitted to flash column chromatography using C18 reverse phase material. The 
appropriate fractions were checked for the presence of (164) by 1 H nmr spectroscopy 
in CD30D. 
ISOLATION OF STEROL MIXTURES 
20 g of each sponge was extracted by blending with chloroform (3 x 50 ml). 
Solvent was then removed under reduced pressure and the sample redissolved in 
chloroform. The solvent was again removed to typically yield 30~50 mg of extract. 
This extract was chromatographed on a column of silica gel (2 g), using a petroleum 
ether/ethyl acetate gradient. Fractions containing sterols by tic comparison with 
cholesterol, (petroleum ether/ethyl acetate (4:1). purple spot with vanillin/H2S04 
reagent), were combined and used for the preparation of TMS ethers. 
PREPARATION OF TMS ETHERS147 
In a typical derivatisation, sterol mixtures were dissolved in ethyl acetate, 
transferred to a centrifuge tube and dried under nitrogen. A stirrer was added and the 
tube sealed with a rubber septum. Pyridine (500 Ill), hexamethyldisilazane (200 Ill) 
and trimethylsilylchloride (TMSCI). (100 Ill), were added, and the solution left stirring 
under a nitrogen atmosphere for thirty minutes. After cooling in ice water, water (0.5 
ml) and hexane (0.5 ml) were added. The organic layer was transferred by pipette to 
a conical flask and the aqueous layer extracted twice more with hexane. The 
combined organic extracts were dried over Na2S04 and filtered. The solvent was 
removed under a nitrogen atmosphere and again the tube was sealed with a rubber 
septum. 
GCMS ANALYSES 
The sample was dissolved in the minimum amount of petroleum ether and 2 
III of this solution was injected onto the gcms capillary column. General retention 
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time range was between 80~110 minutes. For each peak for each sample, a mass 
spectrum was obtained as a sum of best scans with background subtraction, and the 
sterols present identified by comparison of relative retention times and mass spectral 
fragmentation patterns with literature data. Percentage composition was determined 
by gas chromatography. 
5.2 STUDIES OF THE SPONGE, HYMEDESMIA SPa 1 
COLLECTION AND EXTRACTION OF SPONGE 
Hymedesmia sp. 1 (400 g wet) was collected by SCUBA diving in July 1987 
from Wellington Harbour off the North Island of New Zealand. A voucher specimen, 
87WH01-04, is held at the Chemistry Department, University of Canterbury. The 
orange sponge was stored frozen, then 112 g was blended with methanol/toluene 
(4:1). The resulting extract (6.6 g) was partitioned between chloroform and water. 
O-RHODOIC ACID (182) 
The extract from the aqueous phase (5.4 g) was chromatographed on a 
reverse phase C18 flash column (80 g), using a water to methanol gradient to yield 
10 fractions. A 1 H nmr spectrum of the first fraction from this column in 020, revealed 
the presence of several components, present in sufficient quantity to warrant further 
investigation. This fraction (4.4 g) was further partitioned by gel permeation 
chromatography on Fractogel PGM 2000 (400 g), in water. 1 H nmr spectroscopy in 
020 revealed that the major component was concentrated in five fractions from this 
column which eluted just before those containing salt. These were recombined (572 
mg) and subjected to further gel permeation chromatography, using water as solvent. 
1 H nmr spectra in 020 were obtained of fractions taken at various intervals from the 
column. Some of those fractions containing desired components were subjected to 
reverse phase hplc on an Alltech C8 semi-preparative column, using methanol/water 
(2:3) as solvent, with a flow rate of 4 ml per minute and uv detection at 220 nm. This 
led to the isolation of rhodoic acid (182) (80 mg) as a clear oil. 
ms SIMS (TEA) 234 [M-3H+K]-, 218 [M-2H+l'Ja]-, 196 [M-H]-; 1H nmr (D20) 3.23 (2H, 
t, J;::;6.8 Hz, H-1), 3.42 (2H, t, J=6.8 Hz, H-2), 4.00 (1H, q, J;::;7.1 Hz, H-3), 1.51 (3H, d, 
J=7.1 Hz, H-4); 13C nmr (020) 47.40 (C-1), 42.34 (C-2), 57.25 (C-3), 14.82 (C-4), 
173.16 (C-5). Ir, cd and ord data were in accord with literature values 174. 
177 
HOMARINE (94) 
Fractions from the initial gel permeation column which eluted later than those 
containing D-rhodoic acid, contained salt and one other major organic component. 
This component was identified as homarine from comparison of the 13C nmr data with 
literature values78. 
TAURINE (141) 
A fraction from the hplc purification of D-rhodoic acid contained a single 
component which gave a pink spot with ninhydrin spray on tic. This component was 
identified as taurine by comparison of its 1 Hand 13C nmr spectra with those 
previously reported for taurine143.144. 
BIOLOGICAL ACTIVITY OF SPONGE 
The organic phase (1.1 g) of the initial chloroform/water partition of the crude 
sponge extract, was further partitioned by normal phase flash column 
chromatography on silica gel (40 g), using a petroleum ether to ethyl actetate 
gradient, to yield 18 fractions. The biological activity was located in the last six 
fractions from the column by antiviral/cytotoxicity assay, so these were recombined 
(245 mg) and rechromatographed on a C 18 reverse phase flash column (5 g), using 
a water to methanol to dichloromethane gradient to yield 13 fractions. 
Antiviral/cytotoxicity assay showed the biological activity to be localised in fractions 
5-9. The most active of these was analysed by reverse phase hplc on an Alltech C18 
analytical column, using methanol/water (7:3), a flow rate of 1 ml per minute and uv 
detection at 210 nm. Six fractions were collected and analysis by the 
antiviral/cytotoxicity assay indicated that the biological activity was spread throughout 
the column. Hplc on the other combined active fractions produced the same result. A 
1 H nmr spectrum in CDsOD of the first fraction from the hplc column, contained no 
clearly recognisable features, comprising very broad unresolved humps throughout 
the spectral range. 
A re-extraction of 103 g of sponge was performed as outlined previously, to 
yield 5.9 g of crude sponge extract. Partitioning of a sub-sample of the extract (58 
mg) between chloroform and water did not result in the activity partitioning cleanly, so 
the entire crude extract was subjected to reverse phase flash column 
chromatography on C18 material (80 g), using a water to methanol to 
178 
dichloromethane gradient as previously, to yield 11 fractions. The biological activity 
was concentrated into fractions 4-7 and reverse phase hplc on the most active 
fraction by antiviral/cytotoxicity assay (fraction 5), again resulted in activity being 
spread throughout the column fractions. 
Gel permeation was attempted using a fraction (30 mg) from a reverse phase 
column of the first extraction of the sponge. This was chromatographed on Fractogel 
PGM 2000 (40 g), in methanol to yield 20 fractions. Activity was spread through the 
fractions, but was most concentrated in the latter five fractions from the column, 
indicating perhaps that the active component is a small molecule. 
As both tic and 1 H nmr spectroscopy of fractions from the column were 
uninformative and no suitable means of concentration of the activity had been found, 
work on the biological activity of the sponge was abandoned. 
WORK DESCRIBED IN CHAPTER SIX 
6.1 STUDIES OF THE SPONGE, HYMENIACIDON HAURAKI 
COLLECTION AND EXTRACTION OF SPONGE 
Hymeniacidon hauraki was collected by SCUBA diving in February 1987 
from Takatu Point and Leigh Reef, Leigh, off the North Island of New Zealand. The 
orange sponge was stored frozen and then 194 g of the Takatu Point sample was 
blended with methanol/toluene (4:1), filtered under vacuum and the solvent removed 
to yield 8.5 g of crude extract. 
ISOLATION OF FURAN FATTY ACID (183) 
510 g of H. hauraki was blended as outlined previously to yield 16.6 g of 
crude extract. This was partitioned between chloroform and water and the organic 
phase (410 mg) subjected to column chromatography on silica gel (15 g), using a 
petroleum ether to ethyl acetate gradient to yield 10 fractions. Fraction 7 from this 
column (35 mg), was used for nmr spectroscopic work, including 1 H, 13C, HETCOR, 
COSY and DEPT experiments. Fractions 7-9, shown to contain (183) by tic and 1H 
nmr spectroscopic analysis were recombined (71 mg), for further chromatographic 
purification on silica gel (2 g), using a petroleum ether to ethyl acetate to ethanol 
gradient to yield 10 fractions. Combination of fractions 2 and 3 from the column gave 
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37 mg of {8Z. 11 Z. 14Z. 17 Z )-3.6-epoxyeicos-3.5.8,11.14.17 -hexenoic acid (183) as 
a yellow oil. For the isolation scheme used. refer to Figure A.5 in the Appendix. 
ir (smear) vmax 3420. 2960. 1720, 1575, 1410, 1230. 1020. 990. 790. 720 cm-1; UV 
Amax (MeOH) 220.281 nm (log e = 3.13.2.40 respectively); HETCOR. H2 <-> C33.80, 
H4 <-> C108.99, H5 <-> C105.99. H7 <-> C26.28, H8 <-> C130.07. H9 <-> C124.64. 
H1 0,13.16 <-> C25.59. For 1 Hand 13C nmr spectral data. refer to Table 6.1. 
ATIEMPTED METHYLATION OF FURAN FATTY ACID (183) 
A sub-sample of (183) (2 mg) was dissolved in chloroform and 
diazomethane in ether added. Tic analysis of the reaction mixture versus starting 
material (petroleum ether/ethyl acetate (3:1). visualisation with iodine vapour), 
revealed the presence of two spots at Rf values of 0.81 and 0.87 for the reaction 
mixture and two spots at Rf values of 0.17 and 0.26 in the starting material. 1 H nmr 
spectra of each sample in CDCI3 indicated that decomposition was occurring and this 
was complete before further characterisation could be achieved. 
RE- EXTRACTION OF SPONGE 
50 g of H. hauraki (87TP01-09) was extracted in the manner previously 
described, except that dichloromethane was used instead of toluene. the blender was 
flushed with nitrogen and p-carotene (200 mg) was added to the extract prior to 
blending. The resultant extract (2.44 g) was dry-coated to celite (1 g) and partitioned 
by flash column chromatography on C18 reverse phase material using a water to 
methanol to dichloromethane gradient to yield 11 fractions. Fractions 5 and 6 from 
this column were shown to contain the furan compound by both tic {petroleum 
ether/ethyl acetate (1 :4), strong spot at Rf == 0.5. visualisation with iodine vapour) and 
1 H nmr analysis. These fractions were recombined (47 mg) for further 
chromatography. The ethyl acetate soluble material from these fractions (21 mg) was 
injected onto a diol lobar column which was run with petroleum ether/ethylacetate 
(4:1) as solvent. 5 ml per minute with both refractive index (RI) and uv detection. A 
total of 60 20 ml fractions was collected. Fractions were evaporated down and those 
in which no mass was detected were combined in groups. Examination of the 
fractions by tic indicated that tile furan compound was in the combined fractions 
16-21 (1 mg) and combined fractions 22-27 (0.5 mg) as a yellow oil, pure by 1 H nmr 
spectrosco py. 
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PREPARATION OF FURAN FATIY ACID METHYL ESTER (184) 
As attempts to obtain mass spectra of the furan fatty acid were unsuccessful, 
the methyl ester was prepared. A sub-sample of the furan fatty acid {250 Ilg} was 
dissolved in methanol, diazo methane in ether was added and the solution left for 
three hours. After this time, tic analysis (petroleum ether/ethyl acetate (1:1), 
visualisation with iodine vapour} revealed that the reaction mixture contained a single 
product at Rf = 0.9. This product was used for mass spectral analysis. 
ms m/z found M-!! 328.2033, {C21 H2S03 requires M-!! 328.2038}. 
ISOLATION OF CORBISTEROL (186) AND THE PEROXIDE (187) 
The extract was chromatographed on a reverse phase C18 column (50 g) 
using a water/methanol to methanolldichloromethane gradient to yield 13 fractions. 
Fractions 8 and 9 from this column were recombined (90 mg) and a sub-sample (35 
mg) was further partitioned by column chromatography on silica gel (0.8 g), using a 
petroleum ether to ethyl acetate gradient to yield 8 fractions. Fraction 4 from this 
column (0.8 mg) contained a major component, the 1H, 13C nmr and mass spectra of 
which, were used to identify it as corbisterol (186) by comparison with literature data. 
This identification was confirmed by subsequent gcms analysis of the TMS ethers of 
the sterol mixture of the sponge. 
Fraction 5 from the column (2 mg), contained the peroxide (187) which was 
identified by comparison of the spectroscopic data with literature values202, 
ISOLATION OF STEROL MIXTURES 
20 g of each sponge sample (87TP01-09) and (87LR01-05) was extracted 
with chloroform and the sterol mixture purified by an identical method to that used for 
the sterol mixtures analysed in Chapter Five of this thesis. Preparation of TMS ethers 
of the sterols and subsequent gcms analyses were also carried out by procedures 
identical to those outlined previously, (see Work Described in Chapter Five, p. 175). 
SCREENING OF INDIVIDUAL SPONGES 
Several samples of H. hauraki were divided into individual sponges and 
bagged separately. Samples were 87TP01-09 (six individuals), 88L01-01 (four 
individuals), 87S101-09 (four individuals), 87L02-47 (one individual) and 
88TAB02-02 (one individual), 20 g of each individual was extracted with chloroform, 
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filtered and the solvent removed. 1 Hand 13C nmr spectra of each extract were 
obtained in CDCI3. For each sample, A5,7 sterols were detected, and in five cases, 
peroxide formation was evident also. 
WORK DESCRIBED IN CHAPTER SEVEN 
7.1 "FINGERPRINTING" OF MARINE NATURAL PRODUCT 
EXTRACTS 
EXTRACTION OF ORGANISM 
In a typical extraction, 10 g of the organism was blended in methanol/toluene 
(3:1), (3 x 50 ml), using a Janke and Kunkel, Ika-Werk blender. The extract was 
fittered by vacuum and the solvent removed to yield approximately 0.5 g extract. 
PREPARATION OF EXTRACT 
For each column, approximately 10 mg of celite, pre-washed with methanol, 
was added to approximately 20 mg of crude extract in solution and the mixture was 
evaporated to dryness on a rotary evaporator. The celite was then scraped off the 
inside of the flask and carefully loaded onto the prepared column. 
PREPARATION OF COLUMN 
Pasteur pipettes containing 200 mg of the appropriate stationary phase, were 
used for chromatography. The stationary phase was slurry packed into the column in 
methanol for the C18 reverse phase and phenyl reverse phase columns and 
equilibrated back to water, before introduction of the extract. The silica gel was slurry 
packed in petroleum ether. 
CHROMATOGRAPHY 
Fractions were 1.5 ml, (approximately 3 column volumes), in each case. 
Pressure was applied to the column by use of a rubber eye dropper bulb. Solvent 
composition was as follows: for both C18 reverse phase and phenyl reverse phase 
chromatography, fraction 1 was distilled water, fraction 2, water/methanol (1:1), and 
fraction 3, methanol. For the silica gel chromatography, fraction 1 was petroleum 
ether, fraction 2, dichloromethane, fraction 3, ethyl acetate and fraction 4, ethanol. 
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ASSAY 
The crude extract was assayed for biological activity in antimicrobial, 
antiviral/cytotoxicity and P3SS assay systems. The extract was re-assayed a week 
later to check the stability of the biological activity, and then the activity was diluted 
out until a negative assay reading was obtained on the antiviral/cytotoxicity assay 
system. All fractions were initially submitted for antiviral assay at 1 mg/ml, 20 J.tl per 
cell well. Those fractions which showed activity at this level were diluted ten fold until 
a negative assay reading was obtained. In this way the minimum inhibitory 
concentration was determined. The fractions were also submitted for P3SS assay at 
appropriate concentrations, as determined by the antiviral assay results, to obtain an 
ICso value in ng/ml for each fraction. 
ION EXCHANGE CHROMATOGRAPHY 
Columns used were commercial Alltech Extract-elute cartridges, each 
containing 100 mg of either SAX or SCX ion exchange resin. Each sample to be 
chromatographed was dry coated to celite (20 mg) and scraped into a small vial. 
0.025 M ammonium acetate (0.5 ml) was added and the sample divided in two for 
SAX and SCX ion-exchange chromatography. 
Each cartridge was prepared by eluting with methanol (1 ml), then 0.025 M 
ammonium actetate (1 ml). The sample slurry was loaded onto each column with a 
dropper. Fractions were 1.5 ml in each case and solvent was passed slowly through 
the column without pressure. Solvent composition was as follows: for SAX; fraction 1 
was ammonium acetate (0.025 M), fraction 2, acetic acid (0.5 M) and fraction 3, 
sodium citrate (0.5 M). For SCX, fraction 1 was again ammonium acetate (0.025 M) 
and fraction 2, acetic acid (0.5 M). 
Samples put through this process were fractions from the chromatography 
columns on extracts of Axinella sp. 2, Ritterella sigillinoides and Latrunculia brevis. 
For each extract, an active column fraction of an appropriate mass was selected. 
The ion exchange column fractions were dried and submitted for assay in the 
antiviral/cytotoxicity assay system in methanol (100 J.tl). 
GEL PERMEATION CHROMATOGRAPHY 
The column used was a hplc analytical 5 J.t PL gel column with 50 A pore size 
from Polymer Laboratories. Solvent used was acetonitrile or acetonitrile with 0.5% 
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glacial acetic acid added and flow rate was 1 ml per minute with uv detection at 200 
nm. The column was calibrated with acetonitrile solutions of pure compounds 
(toluene, polyethylene glycol and mycalamide A (210) and with a mixture of these 
compounds. The column volume was determined to be 8 ml. 
Active column fractions from the initial chromatography columns on the 
extracts and pure active compounds were injected as approximately 1-3 mg/ml 
acetonitrile solutions. For each sample, eight fractions were collected, equivalent to a 
total of three column volumes of solvent. Fractions were dried down and submitted 
for P388 assay in methanol (200 Ill). 
The column was recalibrated in methanol using toluene, napthalene, 
1,4-dibromonapthalene, bromothymol purple, bromocresol purple, bromocresol 
green and disulphine blue, with IJV detection at an appropriate wavelength. Elution 
times of these compounds were inconsistent with the molecular weights and with the 
results obtained in acetonitrile. 
APPENDIX: 
SEPARATION TREES 
KEY TO USE OF SEPARATION TREES. 
ABBREVIATIONS 
RP column reverse phase (C18) flash chromatography column. 
Davisil column silica column chromatography. 
Fractogel PGM 2000 Gel permeation column. 
pTLC preparative thin layer chromatography. 
AM antimicrobial assay. 
FORMAT 
A typical example is shown below. 
MP547.5 
24 mg 
92 
wwww 1+ C7* 
girolline (153) 
184 
MP5 47.5 refers to the code number - Michele Prinsep, book 5, page 47, sample 5. 
24 mg is the sample mass. 
92 is the IGso value for the sample (ng/rnl). 
ww ww 1 + C7* is the antiviral/cytotoxicity assay result, expressed as in Section 1.2 of 
this thesis, p. 7. 
girolline (153) refers to the compound of this text number. 
87K1S-02 
200 9 bryozoan blended 
RP G18 column 
7.S9 9 
MPS 3S.1 MPS 3S.2 MPS 35.3 MP5 35.4 MP5 35.5 MP5 35.6 MPS 35.7 MP5 35.8 MP5 35.9 
6.4 9 118 mg 55 mg 88 mg 55 mg 36 mg 79 mg 160 mg 141 mg 
IGso (ng/ml) >125000 >125000 >125000 60442 <488 <975 4420 10890 26788 
MP5 35.13 MP5 35.12 MP5 35.11 MP5 35.10 
59 mg 3 mg 13 mg 112 mg 
4230 14803 >125000 >62500 
RP G18 column 115 mg 
MP5 8.1 MP5 8.2 MP5 38.3 MP5 38.4 MP 38.5 MP 38.6 M 5 38.7 M 5 38.8 M 5 38.9 
2 mg <1 mg 10 mg 37 mg 19 mg 21 mg 16 mg 11 mg 7 mg 
IG so (ng/ml) 8103 105 10405 191 5710 5432 19930 >25000 >12500 
MP5 38.11 MP5 38.10 
M ~5 53.1-4 MP5 b.5 MP5 153.6 
3 mg 3 mg 15 mg 
IGso (ng/ml) 82 
I 
RP G18 column 
MP5 153.7 
5 mg 
135 
I 
MPJ 53.8 
6 mg 
1-vinyl-8-hydroxy-p-carboline (82) 
20 mg 
3 mg 
IGso (ng/ml) >12500 
MPt 53.9-14 
5 mg 
Figure A.1: Separation tree for Cribricellina cribraria 
4 mg 
>12500 
.,....L 
co 
01 
CBS 8.6 
2mg, acetylation'---------=::-o;- 211 mg 
IG so (ng/mll ~601962.1 RP column 135 mg 
?? ww 20 G6 
± ± 1+ 2 C6 
- - - 0.5 
P388 4+ 5 1l9ldisc 
4681 
IGso (ng/ml) 9135 
AM - sm(1) - GR(3') 200 
MP 4 
40 mg 
IGso (ng/mll 1452 
I 
MP4 64.1 
8 mg 
ICso (ng/mI) >25000 
13 mg 
5890 
5 mg 
7539 
I 
RP column, 58 mg 
MP4 64.2 MP4 64.3 
5 mg 7mg 
>25000 >25000 
M~4 68.1 
ICso (ng/mll >12500 
15 mg 
23749 
MP4 64.4 
11 mg 
13376 
14 mg 
21489 
6 mg 
13360 
1 mg 
IC sa (ng/mll>3125 
MP4 64.5 MP4 64.6 
17 mg 17 mg 
7965 3f7 
much loss- 6mg left 
I 
RP hplc 
MP4176.1 MPJ 76.2 MPl 76.3 
1.4 mg 2.9 mg 
harman (55) harman and 
(55) 
MP4 60.1 
MP4 168.2 
1 m~ RP pTLC 
MP 68.3 MPI 68.4 
3641 <98 4921 
MP4 64.6 
bulk methylation 15.5 mg 
I 
>12500 
1 mg 
>12500 
>12500 
3 mg 
>12500 
>12500 
2 mg 
>12500 
MP4 64.7 MP4 64.8 MP4 64.9 
13 mg 3 mg 1 mg 
13360 >12500 >12500 
J 
0.5mg methylation MP4 64.10 
MP472.1 1 m% ICsa (ng/ml) >62 0 
and reassay 2569 
MP464.6 IGsa (ng/ml) 
1-ethyl-ll·carboline 1018 
(56) 
103 
::r.:-___ M_P4..:..JJBO.1 ICso (ng/mll 1410and reassay MP4 54.61Gso (ng/mll 
RP h~lc 816 
M~4 86.1 
7mg 
IGso (ng/mll >12500 
MP4 186.2 
4 mg 
>1510 
MP) 86.3 MPI 86.4 
3 mg 
3065 
3 mg 
331 
I 
methhnol chlJroform 
MP4 88.1 MP4 88.2 
1 mg 2 mg 
IGso(ng/ml)11513 270 
3 mg 
2597 
3 mg 
5167 
Figure A.2: Separation tree for Margaretta barbata 
NP8 3.1 
7.3 9 
ww ww - 200 
- - - 20 
I 
NP83.2 
37 mg 
3+ 3+ - 20 
- - - 2 
I 
NP8 40.1 
7.36 9 
ww ww 1+ 100 
NP83.3 
19 mg 
1+ 1 + 
2 
3+ 3+ 1+ 50 
Methanol/water 4:1 
4:1 MethanoVwater soluble 
NP8 40.2 
3.26 9 
ww 3+ 1+ SO 
1 + 1 + - 20 
- - - S 
AM 2 2 07600 
ICso ~ng/ml) S013 
Fractogel PGM 2000 400 9 
86L01-02 
196 9 sponge blended, 9.6 9 extract 
RP C18 column 
NP8 3.4 
50 mg 
20 - - 20 
NP83.S NP8 3.6 
181 mg S84 m~ 
± - 2+ C7* 20 - - - 0 
- - - 2 I 
h Ppt· 1d·· ymema ISlne 
(139) 
4:1 MethanoVwater insoluble 
NP8 40.3 
3.24 9 
- 200 
NP83.7 
335 mg 
± - 1+ C7 20 
- - - 2 
NP8 3.12 
72 m~ 
- ± 2+ C 20 
2 
watbr eluate 
MPS 13.1 
1.3 9 
I I 
MPS 13.2 
38 mg 
0.25 M acetic acid eluate 
MPS 13.3 
I 
MPS 
8 mg 
I 
Methanol soluble 
MPS 17.1 
RP hplc 477 mg 1037 ng/ml 
740 mg 
+ 10 ml cone. HCI 
ICso (ng/ml) 1046 
I 
MPS 30.1 
297 mg 
MPS 30.2 
4 mg 
MPS 30.3 
ICso (ng/ml) 883 
Fraetbge, PGM 2000 water eluant 
I I 
47.1-3 MPS 47.4 MPS 47.5 
180 mg 24 mg 
ICso (ng/ml)83S 92 
ww ww 1+ C7' 2 
2+ 2+ 1+ C7* 0.5 
- - - 0.2 
girolline (153) 
I 
MPS 47.6-12 
80 mg 
NP83.8 
9S mg 
- - - 20 
NP83.11 
273 mg 
3+ - - 20 
2+ - - 2 
Figure A.3: Separation tree for Axinel/a sp. 2 
NP83.9 
340 mg 
± - 1+ C7 20 
± - 1+ C7 2 
NP8 3.10 
280 mg 
3+ - - 20 
3+ 2 
I 
MeOH insoluble 
MPS 17.2 
263 mg 
I 
MP1 36.1-36.4 
2777 mg 
MP1 39.1 MP1 39.2 
170 mg 53 mg 
- - - 20 - - - 20 
MP2 
53 mg 5 mg 
- - - 20 20 
w6ter 
MP1 34.3 
3792 mg 
- - - 100 
Dlssolve in methanol,filter 
R.P. C18 column 
3222mg 
I 
MP1 36.5 
182 mg 
MP1 39.3 
24 mg 
- - 20 
1 mg 
- - ± 20 
MP1 39.4 
71 mg 
WWj±20 
Davisil column 
chimyl alcohol (175) 
I 
MP2 1.1-1.6 MP2 1.7 MP2 1.8 MP2 1.9 
13 mg [ 1 I 
86L02-01 
86 9 sponge 
I 
ethyl acetate/water partition 
I 
1 
eth~1 acetate 
MP1 34.2 
432 mg 
ww ww ± 100 
DaJsiI column 
MP1 36.6- 36.13 
220 mg 
MP1 39.5 MP1 39.6 
13 mg 12 mg 
- ± 20 - 20 
I 
MP1 36.5 MP2 131.1 
Davisil column 
I I 
MP2 1.10 MP2 1.11 
I I 
MP2 2.1 
101 mg - sterol sulphate (164) 
MP1 39.7 MP1 39.8 MP1 39.9 
5 mg 0.5 mg 2 mg 
- - 20 - - - 20 - - - 20 
M 2 4.12 
1 mg 2 mg 
ww ww ± 20 - - - 20 
- - - 2 
I MP2 4.14 MP2 4.13 
0.3 mg 1 mg 
3+ 2+ ± 20 2+ - ± 20 
I 1 
MP2 1.12 MP2 1.13-1.15 
I 28mg 
Figure A.4: Separation tree for Sty/opus australis 
......... 
co 
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MP2 22.1 
2 mg 
I 
MP2 25.1 
1 mg 
I I I 
MP2 22.2 MP2 22.3 MP2 22.4 
4 mg 35 mg 
I I I 
MP2 25.2 MP2 25.3 MP2 25.4 
27 rng 
I 
10 rng 3 mg 
MP2 27.1 
furan fatty acid (183) 
I 
chloroform 
MP2 21.1 
0.41 9 
I 
Davisil column 
I 
I 
MP2 22.5 
17 mg 
J 
MP2 25.5 
1 mg 
87LR01-05 
510 9 sponge 
I 
chloroform/water partition 
I 
I 
water 
MP2 21.2 
16.21 9 
I I I I 
MP2 22.6 MP2 22.7 MP2 22.8 MP2 22.9 
19 mg 35 mg 
I 
20 mg 
I 
MP2 24.1 
Da1isil column 
16 mg 
I 
I 
MP2 22.10 
4 mg 
I I I I J 
MP2 25.6 MP2 25.7 MP2 25.8 MP2 25.9 MP2 25.10 
1 mg 3 mg 4 mg 5 mg 6 mg 
Figure A.5: Separation tree for Hymeniacidon hauraki 
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